000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1248|2840|lyfalmen|V0045|1735|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1248||1248|2840||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|27919|38013|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||27919||27919|38013||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|41953|55763|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||41953||41953|55763||2 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|7848|11924|lyfalmen|V0457|6628|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7848||7848|11924||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|20173|28216|lyfalmen|V0475|13785|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20173||20173|28216||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|26056|35656|lyfalmen|V0540|20024|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||26056||26056|35656||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4041|6684|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4041||4041|6684||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|3935|7636|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||3935||3935|7636||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|10824|16020|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||10824||10824|16020||1 000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4429|7218|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||4429||4429|7218||2 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|IKR|2175|4116|lyfsjukr|||1|5|0|1,6700|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||2175||2175|4116||1 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4140|6820|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4140||4140|6820||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2648|4767|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2648||2648|4767||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13251|19361|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||13251||13251|19361||1 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2610|4715|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2610||2610|4715||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|32063|43254|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||32063||32063|43254||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3078|5359|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3078||3078|5359||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|87239|113041|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||87239||87239|113041||2 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|4608|7465|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4608||4608|7465||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1240|2829|lyfalmen|V0037|1016|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1240||1240|2829||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4123|6797|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4123||4123|6797||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13635|19889|lyfalmen|V0115|11919|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||13635||13635|19889||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1785|3579|lyfalmen|V0050|2126|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1785||1785|3579||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|23041|31843|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||23041||23041|31843||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5184|8257|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5184||5184|8257||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2946|5177|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2946||2946|5177||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18718|26886|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||18718||18718|26886||1 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|14417|20966|lyfalmen|V0637|18426|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||14417||14417|20966||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25945|35516|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||25945||25945|35516||1 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2064|3963|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2064||2064|3963||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4137|6816|lyfalmen|V0444|6669|1|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||4137||4137|6816||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1660|2361|lyfalmen|V0291|2361|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2361||1 001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6375|7048|lyfalmen|V0297|6765|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||4305||4305|7048||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3240|5582|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3240||3240|5582||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3098|3806|lyfalmen|V0292|3806|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|3806||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2271|4248|lyfalmen|V0004|2453|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2271||2271|4248||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4764|5389|lyfalmen|V0296|5389|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3100||3100|5389||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3342|5722|lyfalmen|V0005|2344|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3342||3342|5722||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3924|6523|lyfalmen|V0723|6523|1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3924|6523||2 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21859|30348|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||21859||21859|30348||2 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2655|4777|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2655||2655|4777||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|12915|18898|lyfalmen|V0492|8271|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||12915||12915|18898||1 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2018|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2353||1 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|903|2365|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||903||903|2365||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|21435|29812|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||21435||21435|29812||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11987|13475|lyfalmen|V0089|2586|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||8975||8975|13475||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|6703|10348|lyfalmen|V0515|3346|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||6703||6703|10348||1 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|10943|16184|lyfalmen|V0253|5930|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||10943||10943|16184||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|21054|29330|lyfalmen|V0516|5806|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||21054||21054|29330||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|8003|12138|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8003||8003|12138||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|11818|17388|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||11818||11818|17388||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7021|13491|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7021||7021|13491||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5702|8970|lyfalmen|V0356|7825|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5702||5702|8970||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5346|8480|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5346||5346|8480||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2659|4782|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2659||2659|4782||1 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|30348|41085|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||30348||30348|41085||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|1884|3715|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1884||1884|3715||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|33929|44846|lyfalmen|||2|500|0|166,6700|Actavis Group hf|Actavis Group hf|Klózapín||33322||33322|44846||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1002|2071|lyfalmen|V0151|1689|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||689||689|2071||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|498|1808|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||498||498|1808||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2606|lyfalmen|V0322|2414|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2606||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1825|3634|lyfalmen|V0469|1944|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1825||1825|3634||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|16243|23479|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||16243||16243|23479||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6792|10471|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6792||6792|10471||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3452|5874|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3452||3452|5874||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|508|1821|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||508||508|1821||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000|30.06.2016|R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1006|2507|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1006||1006|2507||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3911|6505|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||3911||3911|6505||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|5484|8670|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5484||5484|8670||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|7658|11663|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||7658||7658|11663||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|IPI|0|0|0|100|DKK|18076|26002|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||18076||18076|26002||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|5571|5092|lyfalmen|V0381|3861|1|10|0|2,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||2884||2884|5092||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6603|12698|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6603||6603|12698||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2786|4957|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2786||2786|4957||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3716|6237|lyfalmen|V0226|2532|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3716||3716|6237||2 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|6986|10738|lyfalmen|V0228|4512|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||6986||6986|10738||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1901|3739|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||1901||1901|3739||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2477|2437|lyfalmen|V0494|1810|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||955||955|2437||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2426|4128|lyfalmen|V0318|4128|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2184||2184|4128||1 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987|31.05.2016|R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1667|3417|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1667||1667|3417||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2807|4986|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2807||2807|4986||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4346|4432|lyfalmen|V0320|3669|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2405||2405|4432||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1549|2993|lyfalmen|V0317|2993|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1359||1359|2993||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|850|2086|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||700||700|2086||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1798||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|32086|43283|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||32086||32086|43283||3 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|7349|11237|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7349||7349|11237||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|721|2115|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||721||721|2115||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4647|7518|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4647||4647|7518||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|295|1528|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||295||295|1528||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|792|2212|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||792||792|2212||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1003|2503|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1003||1003|2503||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1540|3242|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||1540||1540|3242||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2999|5250|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2999||2999|5250||2 005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|15403|22323|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||||15403|22323||1 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|7517|6391|lyfalmen|V0148|3083|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3828||3828|6391||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2842|4204|lyfalmen|V0353|4013|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2239||2239|4204||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2190|4137|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2190||2190|4137||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2459|4024|lyfalmen|V0337|3737|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||2108||2108|4024||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|17105|24666|lyfalmen|V0356|23475|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17105||17105|24666||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2700|4838|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2700||2700|4838||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|47999|62039|lyfalmen|V0451|56198|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||46915||46915|62039||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1535|3235|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1535||1535|3235||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5130|8183|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5130||5130|8183||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5281|8391|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5281||5281|8391||1 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1603|3329|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1603||1603|3329||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3207|5536|lyfalmen|V0020|1562|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3207||3207|5536||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|5046|8068|lyfalmen|V0020|4687|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5046||5046|8068||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3686|6196|lyfalmen|V0020|2344|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3686||3686|6196||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4670|7550|lyfalmen|V0324|1988|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4670||4670|7550||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|15387|26521|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||15387||15387|26521||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7495|11438|lyfalmen|V0325|1988|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7495||7495|11438||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2354|4362|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2354||2354|4362||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13177|18360|lyfalmen|V0326|3673|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12524||12524|18360||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|þpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3062|5337|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3062||3062|5337||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RPO|0|0|1|100|IKR|1816|2014|lyfalmen|V0169|2014|2|14|0|12,2500|LYFIS ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|2014||2 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4955|7942|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4955||4955|7942||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|86057|111546|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||86057||86057|111546||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4744|7652|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4744||4744|7652||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|65745|85855|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||65745||65745|85855||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2066|3966|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2066||2066|3966||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3058|5972|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||3058|5972||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.07.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|5685|8947|lyfalmen|V0478|8947|1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||5685||5685|8947||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|11288|16659|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||11288||11288|16659||1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|427198|536895|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||427198||427198|536895||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12562|18413|lyfalmen|V0099|3829|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||12562||12562|18413||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11036|16312|lyfalmen|V0117|6630|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11036||11036|16312||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|16298|23555|lyfalmen|V0118|10811|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||16298||16298|23555||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1765|3552|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1765||1765|3552||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|19763|28324|lyfalmen|V0195|25379|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||19763||19763|28324||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|83065|107761|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||83065||83065|107761||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|212704|270124|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||212704||212704|270124||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2617|4724|lyfalmen|V0374|3488|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2617||2617|4724||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6938|10672|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||6938||6938|10672||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|96351|124565|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||96351||96351|124565||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|20034|28040|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||20034||20034|28040||1 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5704|8973|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5704||5704|8973||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|212128|269408|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||212128|269408||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4220|6931|lyfalmen|V0618|5616|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||4220||4220|6931||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|15163|21993|lyfalmen|V0589|9060|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||15163||15163|21993||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1540|2499|lyfalmen|V0290|2430|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2499||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3432|5846|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||3432||3432|5846||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1321|2940|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1321||1321|2940||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|321|1564|lyfalmen|V0502|853|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||321||321|1564||2 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1286|2892|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1286||1286|2892||1 008243|D07AC0101|Betnovat|húðlausn|1|mg/g|30|ml|1|plglas|í hársvörð|D07AC01|01.01.1985|31.07.2016|R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|452|1744|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||452||452|1744||1 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|971|2459|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||971||971|2459||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|966|2452|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||966||966|2452||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|2469|4521|lyfalmen|V0226|4521|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2469||2469|4521||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|3721|6244|lyfalmen|V0227|6244|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3721||3721|6244||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|5039|8058|lyfalmen|V0228|8058|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5039||5039|8058||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|125327|161452|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||125327||125327|161452||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002|30.06.2016|R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|458|1753|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||458||458|1753||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002|30.06.2016|R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|602|1941|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||595||595|1941||2 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5494|9469|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5494||5494|9469||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|9249|17718|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||9249||9249|17718||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RAT|0|0|1|100|XEU|||lyfalmen|V0575|2197|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||2197||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2479|4534|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2479||2479|4534||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|88707|114897|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||88707||88707|114897||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|92024|119093|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||92024||92024|119093||2 008904|D10AF0101|Dalacin|húðlausn|10|mg/ml|60|ml|1|glas||D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1859|3681|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1859||1859|3681||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6054|9455|lyfalmen|V0145|8823|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6054|9455||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12005|17646|lyfalmen|V0145|17646|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12005|17646||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1503|2766|lyfalmen|V0064|2764|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||1194||1194|2766||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4383|5527|lyfalmen|V0064|5527|2|60|0|60,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||3200||3200|5527||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6791|10469|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6791||6791|10469||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3022|4325|lyfalmen|V0063|4325|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||2327||2327|4325||2 009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|LYFIS ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6791|10469|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6791||6791|10469||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|10288|15283|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||10288||10288|15283||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6791|10469|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6791||6791|10469||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|IPI|0|0|0|100|DKK|44734|59280|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||44734||44734|59280||1 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4454|7253|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4454||4454|7253||1 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|978|2468|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||978||978|2468||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1079|2607|lyfalmen|||1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1079||1079|2607||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1248|2840|lyfalmen|||1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1248||1248|2840||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1563|3274|lyfalmen|||1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1563||1563|3274||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5711|8983|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5711||5711|8983||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6355|9869|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6355||6355|9869||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5711|8983|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5711||5711|8983||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|IPI|0|0|0|100|DKK|162008|207073|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||162008||162008|207073||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4315|7061|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4315||4315|7061||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|48480|64018|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||48480||48480|64018||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8455|11518|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||7553||7553|11518||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9162|12718|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8425||8425|12718||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7284|11148|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7284||7284|11148||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9162|12718|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8425||8425|12718||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7385|11287|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7385||7385|11287||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8455|10801|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||7032||7032|10801||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1091|1880|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1091||1091|1880||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1845|3662|lyfalmen|V0329|1810|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||1845||1845|3662||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|173875|221832|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||173875||173875|221832||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|5864|9193|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5864||5864|9193||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|11011|16278|lyfalmen|V0331|2636|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||11011||11011|16278||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|15526|22492|lyfalmen|||1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||15526||15526|22492||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dæluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|12273|18015|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||12273|18015||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|18415|26469|lyfalmen|V0605|4983|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||18415||18415|26469||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9682|14449|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||9682||9682|14449||1 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5300|8417|lyfalmen|V0724|8417|1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5300|8417||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7903|12000|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||7903||7903|12000||1 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1069|2594|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1069||1069|2594||2 010705|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010716|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2499|lyfalmen|V0006|1553|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1000||1000|2499||2 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|290312|366647|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||290312||290312|366647||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|290312|366647|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||290312||290312|366647||3 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|39419|52558|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||39419||39419|52558||2 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2700|2499|lyfalmen|V0058|2499|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||1000||1000|2499||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|17373|25034|lyfalmen|V0204|15014|1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17373||17373|25034||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|17171|24756|lyfalmen|V0716|12951|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17171||17171|24756||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3200|3875|lyfalmen|V0059|3875|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||2000||2000|3875||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|29580|40114|lyfalmen|V0683|17377|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||29580||29580|40114||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|29379|39859|lyfalmen|V0684|17377|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||29379||29379|39859||1 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|14369|20900|lyfalmen|V0729|20900|1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||14369||14369|20900||2 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3880|6463|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3880||3880|6463||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4032|6672|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4032||4032|6672||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13972|20353|lyfalmen|V0327|2831|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13972||13972|20353||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1029|2539|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1029||1029|2539||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2103|3141|lyfalmen|V0069|2974|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1467||1467|3141||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5626|8866|lyfalmen|V0357|8118|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5626||5626|8866||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5384|8207|lyfalmen|V0691|7333|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5147||5147|8207||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|6943|7575|lyfalmen|V0624|6800|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4688||4688|7575||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1657|3257|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1657||1657|3257||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4052|6699|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4052||4052|6699||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|55282|72621|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||55282||55282|72621||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2275|4471|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2275||2275|4471||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1425|2170|lyfalmen|V0152|2101|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2170||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3925|3955|lyfalmen|V0323|3167|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3955||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3567|6032|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3567||3567|6032||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|1974|3839|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||1974||1974|3839||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5706|8976|lyfalmen|V0604|2715|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||5706|8976||1 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|24250|33372|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||24250||24250|33372||1 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|3422|5832|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3422||3422|5832||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|5826|9141|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5826||5826|9141||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|8658|9800|lyfalmen|V0622|8801|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6305||6305|9800||1 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2015||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|LYFIS ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|718|2110|lyfalmen|||1|80|0|4,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||718||718|2110||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|3784|6330|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||3784||3784|6330||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|5369|8512|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||5369||5369|8512||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2399|2514|lyfalmen|V0250|2514|2|100|0|16,6667|LYFIS ehf|ratiopharm GmbH|Gabapentín||1011||1011|2514||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3141|3450|lyfalmen|V0251|2924|2|100|0|22,2200|LYFIS ehf|ratiopharm GmbH|Gabapentín||1691||1691|3450||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5067|8096|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5067||5067|8096||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6156|11850|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6156||6156|11850||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|8196|12403|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8196||8196|12403||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1509|2966|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1509||1509|2966||2 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|5672|8929|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||5672||5672|8929||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|2377|4394|lyfalmen|V0042|4394|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2377||2377|4394||1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3937|7640|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||3937||3937|7640||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9435|18071|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9435||9435|18071||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|990|1946|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||990||990|1946||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|114835|148403|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||114835|148403||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|295473|325493|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||257223||257223|325493||1 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|75062|97639|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||75062|97639||3 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1095|2629|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1095||1095|2629||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1656||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|655|1627|lyfalmen|V0562|1627|2|100|0|33,3300|LYFIS ehf|ratiopharm Oy|Íbúprófen||367||367|1627||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2104|4018|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2104||2104|4018||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|330|1576|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||330||330|1576||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4040|6683|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4040||4040|6683||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5298|8414|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5298||5298|8414||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2088|3996|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2088||2088|3996||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3981|6602|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||3981||3981|6602||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|159646|204135|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||159646||159646|204135||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|290571|366969|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||290571||290571|366969||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2116|4035|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2116||2116|4035|30.6.2016|1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6484|10047|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6484||6484|10047||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|15612|22611|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||15612||15612|22611||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|48553|64111|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||48553||48553|64111||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2174|3875|lyfalmen|V0479|3806|2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2000||2000|3875||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2751|4909|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2751||2751|4909||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|16879|24354|lyfalmen|V0357|24354|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||16879||16879|24354||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|315|1556|lyfalmen|V0563|1556|2|30|0|15,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||315||315|1556||2 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2176|4277|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||2176||2176|4277||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|71192|92744|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||71192|92744||2 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|4988|9634|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||4988||4988|9634||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|794|1980|lyfalmen|V0564|1980|2|100|0|50,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||623||623|1980||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|807|2233|lyfalmen|V0596|1843|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||807||807|2233||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1004|2256|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||824||824|2256|31.5.2016|2 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1117|2143|lyfalmen|V0559|2143|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||742||742|2143||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|22784|31518|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||22784||22784|31518||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|59041|77376|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||59041||59041|77376||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|39566|52744|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||39566||39566|52744||1 015072|V04CX0005|Hexvix|stofn|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.08.2016||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|53294|70107|lyfsjukr|||1|1|0||PhotoCure ASA|PhotoCure ASA|Carbon monoxide||53294||53294|70107||3 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2345|3791|lyfalmen|V0673|3737|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||1939||1939|3791||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6888|10603|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||6888||6888|10603||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|þpakki||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|807|2233|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||807||807|2233||1 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|938|2413|lyfalmen|||1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||938||938|2413||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1677|2435|lyfalmen|V0234|1383|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||954||954|2435||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2395|2435|lyfalmen|V0233|1757|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||954||954|2435||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8091|12259|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8091||8091|12259||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|273694|345979|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||273694||273694|345979||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|78641|102166|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||78641||78641|102166||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4573|7416|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4573||4573|7416||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|11626|17124|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11626||11626|17124||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4573|7416|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4573||4573|7416||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12568|18421|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12568||12568|18421||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4573|7416|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4573||4573|7416||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|11503|16955|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11503||11503|16955||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|60655|79417|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||60655||60655|79417||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|18941|27193|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||18941||18941|27193||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|37883|50615|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||37883||37883|50615||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2758|4754|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2758||2758|4754||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5228|9011|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5228||5228|9011||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2057|3545|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2057||2057|3545||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2870|4947|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2870||2870|4947||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5019|8651|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||5019||5019|8651||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1726|3498|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1726|3498||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1939|3791|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||1939||1939|3791||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1359|2993|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1359||1359|2993||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2759|4755|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2759||2759|4755||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|1538|3239|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1538||1538|3239||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1010|2512|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1010||1010|2512||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1070|2595|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1070||1070|2595||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2355|4364|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2355||2355|4364||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5873|9206|lyfalmen|V0686|3180|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||5873||5873|9206||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8902|13375|lyfalmen|V0687|5326|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||8902||8902|13375||1 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|4407|7188|lyfalmen|||2|1000|0|1000,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||4407||4407|7188||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1555|3263|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1555||1555|3263||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12788|18724|lyfalmen|V0689|6119|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||12788||12788|18724||1 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7090|10881|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||7090||7090|10881||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|IPI|0|0|0|100|DKK|82901|107554|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||82901||82901|107554||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3243|5586|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3243||3243|5586||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2285|4267|lyfalmen|V0685|1226|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2285||2285|4267||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|1130|2678|lyfalmen|||2|200|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1130||1130|2678||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|15143|21965|lyfalmen|V0690|14104|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15143||15143|21965||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7030||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|29580|40114|lyfalmen|V0682|17377|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||29580||29580|40114||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2174|lyfalmen|V0169|1726|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||764||764|2174||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|125008|161055|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||125008||125008|161055||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|6470|10028|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6470||6470|10028||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2643|4760|lyfalmen|V0240|4760|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2643||2643|4760||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|4878|7836|lyfalmen|V0433|7836|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4878||4878|7836||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|44328|58767|lyfalmen|V0721|41928|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||44328||44328|58767||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|65306|85300|lyfalmen|V0722|62144|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||65306||65306|85300||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|24279|33409|lyfalmen|V0720|24090|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||24279||24279|33409||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|69523|90633|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||69523||69523|90633||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1540|3242|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1540|3242||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|34133|45440|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||33791||33791|45440||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2663|4788|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2663||2663|4788||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|16539|31548|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||16539||16539|31548||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1322|2942|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1322||1322|2942||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|228149|289333|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||228149||228149|289333||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|APC|0|0|0|100|XEU|5824|9138|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5824||5824|9138||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|APC|0|0|0|100|SEK|5341|8474|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5341||5341|8474||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|124656|160617|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||124656||124656|160617||1 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|29523|40041|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||29523||29523|40041||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|96951|125324|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||96951||96951|125324||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|DKK|39761|52990|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||39761||39761|52990||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|DKK|107365|139112|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||107365||107365|139112||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|4843|7788|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||4843||4843|7788||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|8805|13241|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||8805||8805|13241||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|7646|11646|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||7646||7646|11646||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1015|2519|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2519||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2424|4459|lyfalmen|||1|30|0|150,0000|Vistor hf|Meda AB|Prednisón||2424||2424|4459||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2711|lyfalmen|V0168|2662|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2711||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5792|11159|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5792||5792|11159||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8989|13495|lyfalmen|V0197|10757|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||8989||8989|13495||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8233|12454|lyfalmen|V0107|3737|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8233||8233|12454||1 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|908|1753|lyfalmen|V0243|1405|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||458||458|1753||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6275|9759|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6275||6275|9759||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|11828|17402|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||11828||11828|17402||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|15954|23081|lyfalmen|V0441|20090|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||15954||15954|23081||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|783|2200|lyfalmen|V0414|1943|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||783||783|2200||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5054|8079|lyfalmen|V0438|6664|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5054||5054|8079||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|1524|3210|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||1517||1517|3210||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|13135|19201|lyfalmen|V0440|16556|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||13135||13135|19201||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|29203|39637|lyfalmen|V0111|13232|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||29203||29203|39637||1 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|41580|55291|lyfsjukr|||1|3|0||Williams & Halls efh|medac Gesellschaft|BCG bóluefni||41580||41580|55291||2 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|7726|11756|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||7726||7726|11756||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|305|1538|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||302||302|1538||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|78156|101552|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||78156||78156|101552||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|52034|68513|lyfsjukr|||1|60|0|30,0000|Vistor hf|Viiv Healthcare UK Ltd|Fosamprenavír||52034||52034|68513||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|921|1810|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||921||921|1810||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|5042|8062|lyfalmen|V0221|6859|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||5042||5042|8062||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5565|8782|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||5565||5565|8782||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3649|6145|lyfalmen|V0220|5366|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||3649||3649|6145||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|154511|197748|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||154511||154511|197748||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16916|24405|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||16916||16916|24405||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2009|3887|lyfalmen|V0219|3236|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||2009||2009|3887||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20231|28289|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20231||20231|28289||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18191|26160|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||18191||18191|26160||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24481|33664|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||24481||24481|33664||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|77255|100413|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||77255||77255|100413||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6197|9652|lyfalmen|V0223|7436|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6197||6197|9652||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9648|14402|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9648||9648|14402||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|38627|51556|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||38627||38627|51556||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|19314|27706|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||19314||19314|27706||2 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|0|1|0|1|0|1|THE|0|0|0|100|XEU|640847|802614|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||640847||640847|802614||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3630|7057|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3630||3630|7057||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|347|1554|lyfalmen|V0633|1554|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||314||314|1554||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|28195|53662|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||28195||28195|53662||1 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5894|9235|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5894||5894|9235||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|40648|54112|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||40648||40648|54112||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5894|9235|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5894||5894|9235||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1099|2086|lyfalmen|V0496|2082|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||700||700|2086||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|980|2017|lyfalmen|V0648|2009|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||650||650|2017||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1543|2774|lyfalmen|V0649|2774|2|100|0|400,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||1200||1200|2774||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|3206|5535|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3206||3206|5535||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|14084|20507|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||14084||14084|20507||2 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|155475|198947|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||155475||155475|198947||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|901|2101|lyfalmen|V0159|1948|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||711||711|2101||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|NED|0|1|0|100|XEU|146601|187911|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||146601||146601|187911||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|11125|16435|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11125||11125|16435||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|11125|16435|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11125||11125|16435||2 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|11125|16435|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11125||11125|16435||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|11125|16435|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11125||11125|16435||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|11125|16435|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11125||11125|16435||2 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|303|1539|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||303|1539||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|GGL|0|0|0|100|GBP|56798|74539|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||56798||56798|74539||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1118|2493|lyfalmen|V0160|2361|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||996||996|2493||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|2414|4445|lyfalmen|||2|100|0|25,0000|LYFIS ehf|ratiopharm GmbH|Diltíazem||2414||2414|4445||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2299|4287|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||||2299|4287||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|22990|31778|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||22990||22990|31778||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|1959|3819|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||1959||1959|3819||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|83881|108793|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||83881||83881|108793||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|43766|58056|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||43766||43766|58056||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|3243|4064|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2137||2137|4064||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|6160|4687|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2590||2590|4687||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|20347|28436|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||20347||20347|28436||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|504|1816|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||504||504|1816||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1562|3272|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1562||1562|3272||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|10887|4552|lyfalmen|V0599|4552|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Diltíazem||2492||2492|4552||2 020711|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|LUM|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Medimpex UK Limited|Levonorgestrel|||||||1 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1915|3301|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1915||1915|3301||1 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCP|0|0|0|100|DKK|51627|67999|lyfalmen|||1|180|0||Vistor hf|UCB Pharma Ltd.|sodium oxybate||||51627|67999||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2240|3861|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2240||2240|3861||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1484|3165|lyfalmen|V0174|2613|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1484||1484|3165||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2523|4595|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2523||2523|4595||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2010|3889|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2010||2010|3889||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1637|lyfalmen|V0188|1505|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1637||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1450|3118|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1450||1450|3118||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2196|lyfalmen|V0189|2097|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2196||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|5512|8709|lyfalmen|V0437|8709|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||5512||5512|8709||3 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|14782|21468|lyfalmen|V0490|2243|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||14782||14782|21468||1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|4309|7053|lyfalmen|V0436|7053|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||4309||4309|7053||3 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1363|2998|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1363||1363|2998||1 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3715|6236|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3715||3715|6236||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11530|16992|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||11530||11530|16992||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11702|17229|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11702||11702|17229||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6129|9558|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6129||6129|9558||1 021625|A07EC0203|Pentasa Sachets|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|13023|19047|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13023||13023|19047||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13634|19888|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||13634||13634|19888||1 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|19441|27881|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||19441||19441|27881||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15679|22703|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||15679||15679|22703||1 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20986|29244|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||20986||20986|29244||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7839|11912|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||7839||7839|11912||1 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|3956|6567|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||3956||3956|6567||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|16801|24247|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||16801||16801|24247||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|2996|5246|lyfalmen|V0692|2460|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||2996||2996|5246||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5060|8087|lyfalmen|V0693|3424|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5060||5060|8087||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|16394|23687|lyfalmen|V0694|10205|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||16394||16394|23687||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|66304|86562|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||66304||66304|86562||3 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|71403|93011|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||71403||71403|93011||2 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|2321|4317|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2321||2321|4317||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|100059|130025|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||100059||100059|130025||2 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|3822|6383|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||3822||3822|6383||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|249436|315809|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||249436||249436|315809||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|262351|331871|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||262351||262351|331871||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10907|18799|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10907||10907|18799||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|13907|20264|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||13907||13907|20264||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1958|3375|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||1958||1958|3375||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1119|2662|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1119||1119|2662||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1237|2132|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1237||1237|2132||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3279|2629|lyfalmen|V0056|1970|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1095||1095|2629||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5813|3508|lyfalmen|V0057|2038|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1733||1733|3508||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1854|3196|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1854||1854|3196||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|525|1845|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||525||525|1845||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1580|3297|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1580||1580|3297||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1200|2068|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1200||1200|2068||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4039|6681|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4039||4039|6681||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3148|lyfalmen|V0321|3148|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3148||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2460|lyfalmen|V0321|1889|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||972||972|2460||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4413||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|22619|31309|lyfalmen|||1|8|0|40,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||22619||22619|31309||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|11309|16688|lyfalmen|||1|4|0|20,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||11309||11309|16688||1 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.04.2012|30.06.2016|R|0|0|0|0|G|0|APP|0|0|0|100|GBP|18316|26332|lyfalmen|||1|6|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||18316||18316|26332||1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2767||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|3059|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|3059||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|3448|lyfalmen|V0125|2144|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3448||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|69075|90067|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||69075||69075|90067||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|22210|30792|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||22210||22210|30792||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|34675|46558|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||34675||34675|46558||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2774|lyfalmen|V0125|2144|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1200||1200|2774||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|17180|24769|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||17180||17180|24769||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|4288|lyfalmen|V0125|4288|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||2300||2300|4288||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|14000|19015|lyfalmen|V0256|19015|2|100|0|44,4400|LYFIS ehf|ratiopharm GmbH|Gabapentín||13000||13000|19015||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|7500|10757|lyfalmen|V0254|10757|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Gabapentín||7000||7000|10757||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|17738|25537|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||17738||17738|25537||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2303|3637|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1827||1827|3637|30.6.2016|2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2972|4153|lyfalmen|||2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2202||2202|4153|30.6.2016|2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|16567|23925|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||16567||16567|23925||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|14780|21465|lyfalmen|V0029|6168|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||14780||14780|21465||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2255|4226|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2255||2255|4226||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|118546|140863|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||108773||108773|140863||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2361|lyfalmen|V0066|2338|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2361||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2567|lyfalmen|V0449|2567|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2567||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2086|lyfalmen|V0448|1930|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2086||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|5940|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|5940||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|3737|lyfalmen|V0673|3737|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1900||1900|3737||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|64192|83891|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||64192||64192|83891||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2407|4435|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2407||2407|4435||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1996|3869|lyfalmen|V0222|3097|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||1996||1996|3869||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|0|0|0|0|G|0|TBB|0|0|0|100|DKK|15855|22945|lyfalmen|V0726|20933|1|30|0|30,0000|Vistor hf|Teva B.V.|Rasagilín||15855||15855|22945||1 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1485|2505|lyfalmen|V0048|2505|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||1005||1005|2505||1 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|0|0|0|0|G|0|TBB|0|0|0|100|DKK|55196|72513|lyfalmen|V0711|53229|1|100|0|100,0000|Vistor hf|Teva B.V.|Rasagilín||55196||55196|72513||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1992|3440|lyfalmen|V0049|3440|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1684||1684|3440||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|4010|5641|lyfalmen|V0054|5641|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3283||3283|5641||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20986|29244|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||20986||20986|29244||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6606|10215|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6606||6606|10215||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|352|1607|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||352||352|1607||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6606|10215|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6606||6606|10215||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11132|16444|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11132||11132|16444||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11150|16469|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11150||11150|16469||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11264|16626|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11264||11264|16626||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4763|7678|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4763||4763|7678||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|46884|62000|lyfalmen|V0715|52354|1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||46884||46884|62000||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11264|16626|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11264||11264|16626||1 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1356|2989|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1356||1356|2989||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4763|7678|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4763||4763|7678||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6606|10215|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6606||6606|10215||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6606|10215|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6606||6606|10215||1 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1356|2989|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1356||1356|2989||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2162|2774|lyfalmen|V0106|2774|2|100|0|66,6660|LYFIS ehf|ratiopharm GmbH|Metóprólól||1200||1200|2774||2 025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5410|lyfalmen|V0483|5410|2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5410||2 025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4935|lyfalmen|V0482|4935|2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4935||2 025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3875|lyfalmen|V0450|3875|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3875||2 025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|535|1859|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||535||535|1859||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|16801|24247|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||16801||16801|24247||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1480|2223|lyfalmen|V0051|2223|2|100|0|33,3333|LYFIS ehf|ratiopharm GmbH|Metóprólól||800||800|2223||2 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|68915|89864|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||68915||68915|89864||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|64369|84115|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||64369||64369|84115||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8325|15965|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||8325||8325|15965||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|13513|19721|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||13513||13513|19721||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|4559|7397|lyfalmen|V0205|1272|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4559||4559|7397||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|12217|17938|lyfalmen|V0205|3816|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||12217||12217|17938||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|39072|52119|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||39072||39072|52119||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6001|9382|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||6001||6001|9382||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20986|29244|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||20986||20986|29244||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|873|2269|lyfalmen|V0597|2269|2|28|0|3,7300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||833||833|2269||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2923|4682|lyfalmen|V0598|4682|2|98|0|13,0700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2586||2586|4682||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|44792|59354|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||44792|59354||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|38958|51975|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||38958||38958|51975||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3371|5810|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3371||3371|5810|| 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1693|3327|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1693||1693|3327||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.09.2015||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|820|2024|lyfalmen|V0447|2024|2|100|0|20,0000|Alvogen|Alvogen ehf|Lóperamíð||655||655|2024||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|8044|13865|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||8044||8044|13865||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|16801|24247|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||16801||16801|24247||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|37057|49570|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||37057||37057|49570||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|185288|236026|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||185288||185288|236026||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1579|3296|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1579|3296||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5982|9356|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||5982|9356||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3119|5415|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3119|5415||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|12354|18126|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||12354|18126||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|18512|26602|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||18512|26602||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|24671|33905|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||24671|33905||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1180|2746|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1180||1180|2746||1 026692|L01XE2701|IMBRUVICA|filmhtfl|140|mg|120|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|997137|1245739|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||997137|1245739||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4765|3907|lyfalmen|V0099|3907|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||2023||2023|3907||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|964|2449|lyfalmen|V0160|2361|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||964||964|2449||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|667|2040|lyfalmen|V0159|1948|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||667||667|2040||2 027051|A10BX1201|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|17865|25712|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||17865||17865|25712||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3049|lyfalmen|V0672|3049|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3049||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|641|2004|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||641||641|2004||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2146|4076|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2146||2146|4076||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5268|8373|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||5268||5268|8373||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|11345|7043|lyfalmen|V0341|7043|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||4302||4302|7043||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|12216|7043|lyfalmen|V0342|7043|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||4302||4302|7043||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2317|4311|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2317||2317|4311||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|5958|9323|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||5958||5958|9323||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|524|1843|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||524||524|1843||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|604|1954|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||604||604|1954||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|17817|25646|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17817||17817|25646||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|20468|28589|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||20468|28589||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|20205|28256|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20205||20205|28256||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|27956|38059|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||27956||27956|38059||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|41309|54948|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||41309|54948||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|3732|6259|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||3732||3732|6259||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|19733|28283|lyfalmen|V0387|28283|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||19733||19733|28283||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||2567|| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|17635|25395|lyfalmen|V0386|25395|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||17635||17635|25395||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1675|3428|lyfalmen|V0364|3247|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||1675||1675|3428||2 028249|C10AA0507|Atorvastatin Hexal|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3072|2887|lyfalmen|V0114|2567|2|100|0|200,0000|Artasan ehf|Hexal A/S|Atorvastatín||1282||1282|2887||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|43971|58315|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||43971||43971|58315||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2282|4263|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2282||2282|4263||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|35483|47580|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||35483||35483|47580||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|36673|49085|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||||36673|49085||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1539|3240|lyfalmen|V0202|3240|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1539||1539|3240||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1725|3496|lyfalmen|V0428|2914|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1725||1725|3496||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|1278|2881|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||||1278|2881||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|5812|3930|lyfalmen|V0245|3528|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2040||2040|3930||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|10358|8775|lyfalmen|V0232|7844|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||5560||5560|8775||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|691|2066|lyfalmen|V0266|2066|2|30|0|1,0600|Alvogen|Alvogen|Pramipexól||686||686|2066||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|6909|13278|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||6909||6909|13278||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2820|3936|lyfalmen|V0267|3936|2|100|0|7,2000|Alvogen|Alvogen|Pramipexól||2044||2044|3936||1 028632|M05BA0805|Zoledronic Acid Hospira|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|1|VOG|0|0|0|100|XEU|2364|4376|lyfsjukr|||2|5|0|1,0000|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||2364||2364|4376||1 028739|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1473|3150|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||1473|3150||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1783|lyfalmen|V0551|1783|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||480||480|1783||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3201|lyfalmen|V0552|3201|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1510||1510|3201||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|1842|lyfalmen|V0555|1842|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|1842||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1907|lyfalmen|V0556|1907|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|1907||1 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|HEA|0|0|1|100|IKR|1121|2499|lyfalmen|V0625|1778|1|120|0|30,0000|Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Flútíkasón||1000||1000|2499||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5722|8998|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5722||5722|8998||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|14262|20752|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||14262||14262|20752||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2517|4587|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2517||2517|4587||1 029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|33372|44910|lyfalmen|V0802|44910|1|30|0|10,0000|Icepharma hf|ProStrakan Ltd.|Fentanýl||33372||33372|44910||2 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|33410|44958|lyfalmen|||1|30|0|20,0000|Icepharma hf|ProStrakan Ltd.|Fentanýl||33410||33410|44958||2 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|33410|44958|lyfalmen|||1|30|0|40,0000|Icepharma hf|ProStrakan Ltd.|Fentanýl||33410||33410|44958||2 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1103|2640|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1103||1103|2640||1 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|11022|16293|lyfalmen|V0801|14841|1|10|0|1,6700|Icepharma hf|ProStrakan Ltd.|Fentanýl||11022||11022|16293||2 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|287|1517|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||287||287|1517||1 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|33066|44523|lyfalmen|V0801|44523|1|30|0|5,0000|Icepharma hf|ProStrakan Ltd.|Fentanýl||33066||33066|44523||2 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|11124|16433|lyfalmen|V0802|14970|1|10|0|3,3300|Icepharma hf|ProStrakan Ltd.|Fentanýl||11124||11124|16433||2 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|33372|44910|lyfalmen|||1|30|0|15,0000|Icepharma hf|ProStrakan Ltd.|Fentanýl||33372||33372|44910||2 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|0|1|0|0|0|STR|0|0|0|100|SEK|33410|44958|lyfalmen|||1|30|0|30,0000|Icepharma hf|ProStrakan Ltd.|Fentanýl||33410||33410|44958||2 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|52891|69597|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||52891||52891|69597||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|17066|24612|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||17066||17066|24612||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3713|6233|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3713||3713|6233||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11089|16385|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11089|16385||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10758|15930|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||10758|15930||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|SEK|5243|8339|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5243||5243|8339||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|82769|107387|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||82769||82769|107387||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|165537|211462|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||165537||165537|211462||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|IPI|0|0|0|100|DKK|7135|10943|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7135||7135|10943||1 030546|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1844|1759|lyfalmen|||2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||463||463|1759|31.7.2016|2 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8030|12175|lyfalmen|V0277|6353|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||8030||8030|12175||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2886|5094|lyfalmen|V0276|2430|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2886||2886|5094||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|14289|24629|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||14289||14289|24629||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1140|2426|lyfalmen|V0051|2223|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||947||947|2426||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1636|3079|lyfalmen|V0106|2774|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||1422||1422|3079||2 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2598||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2528|4602|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2528||2528|4602||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2392|4415|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2392||2392|4415||2 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1692|3451|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||1692||1692|3451||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5054|8079|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5054||5054|8079||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19201|27550|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19201||19201|27550||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1651|3395|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1651||1651|3395||2 032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|4196|3107|lyfalmen|V0732|3107|2|56|0|14,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1442||1442|3107||2 032399|C09CA0106|Losatrix|filmhtfl|25|mg|98|stk|1|þpakki||C09CA01|01.08.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2877|3875|lyfalmen|||2|98|0|49,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||2000||2000|3875||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|1|0|0|G|0|OTS|0|0|0|100|DKK|18370|26407|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18370||18370|26407||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|12687|21867|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||12687||12687|21867||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1198|2771|lyfalmen|||2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1198||1198|2771||2 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|3035|lyfalmen|V0069|3035|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1390||1390|3035||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|18619|26749|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||18619|26749||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|37135|49669|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||37135|49669||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1065|1836|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1065||1065|1836||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2683|4815|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2683||2683|4815||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7973|15297|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||7973|15297||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9144|13708|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||9144||9144|13708||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5370|8513|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||5370||5370|8513||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|15850|22938|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||15850||15850|22938||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1277|2880|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1277||1277|2880||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|1389|2097|lyfalmen|V0189|2097|2|100|0|50,0000|LYFIS ehf|ratiopharm Oy|Díklófenak||708||708|2097||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|576|1505|lyfalmen|V0188|1505|2|30|0|15,0000|LYFIS ehf|ratiopharm Oy|Díklófenak||278||278|1505||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|16331|12977|lyfalmen|V0185|12977|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||8613||8613|12977||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|80091|104000|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||80091||80091|104000||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2160|4245|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2160|4245||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|XEU|1705|2461|lyfalmen|V0098|2461|2|100|0|100,0000|LYFIS ehf|ratiopharm Oy|Enalapríl og þvagræsilyf||973||973|2461||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|650|2017|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||650||650|2017||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|15204|22049|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||15204||15204|22049||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|NED|0|0|0|100|XEU|7231|11075|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7231|11075||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|NED|0|0|0|100|XEU|7231|11075|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7231|11075||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|58782|77048|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||58782||58782|77048||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1453|3122|lyfalmen|V0367|3122|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1453||1453|3122||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2431|4468|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2431||2431|4468||1 034988|L03AB0702|Rebif|stl|44|mcg/,5ml|1,5|ml|4|rörlyk|132 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|100324|130355|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||100324||100324|130355||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6503|10073|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6503||6503|10073||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1956|3814|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1956||1956|3814||1 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|2175|4116|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2175|4116||1 035153|N02AB0306|Instanyl|nefúði|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8391|12672|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||8391||8391|12672||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|13641|19898|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13641||13641|19898||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1168|2362|lyfalmen|V0050|2126|2|100|0|15,8300|LYFIS ehf|ratiopharm GmbH|Metóprólól||901||901|2362||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2047|lyfalmen|V0244|2047|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2047||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1161|2720|lyfalmen|V0048|2505|2|100|0|31,6600|LYFIS ehf|ratiopharm GmbH|Metóprólól||1161||1161|2720||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2073|3671|lyfalmen|V0049|3440|2|100|0|63,3300|LYFIS ehf|ratiopharm GmbH|Metóprólól||1852||1852|3671||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7522|11475|lyfalmen|V0080|6535|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7522||7522|11475||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4531|5975|lyfalmen|V0054|5641|2|100|0|126,6600|LYFIS ehf|ratiopharm GmbH|Metóprólól||3526||3526|5975||2 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4409|2636|lyfalmen|V0233|2636|2|18|0|18,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1100||1100|2636||2 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GZE|0|0|0|100|NOK|21296|28035|lyfalmen|V0680|25063|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||19553||19553|28035||1 036108|L03AB0702|Rebif|stl|22|mcg/,5ml|1,5|ml|4|rörlyk|66 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|100324|130355|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||100324||100324|130355||2 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6686|10325|lyfalmen|V0081|5717|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||6686||6686|10325||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|670|2044|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||670||670|2044||1 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|17254|24871|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17254||17254|24871||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1177|2742|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1177||1177|2742||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3878|6684|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||3878||3878|6684||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2323|4320|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2323||2323|4320||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|704|2091|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||704||704|2091||1 036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|9385|6186|lyfalmen|V0735|6124|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||3679||3679|6186||2 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|7432|6918|lyfalmen|V0532|6295|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4211||4211|6918||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|12043|9796|lyfalmen|V0533|9679|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6302||6302|9796||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|19313|18586|lyfalmen|V0534|18586|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||12688||12688|18586||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2162|4098|lyfalmen|V0434|4098|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2162||2162|4098||2 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1810|lyfalmen|V0151|1810|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1810||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2499|lyfalmen|V0322|2463|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2499||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3875|lyfalmen|V0323|3232|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3875||2 037793|L02BB0308|Bicacta|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.03.2016||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16027|8731|lyfalmen|V0421|7164|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||5528||5528|8731||1 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2240||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3465||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6813|10500|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||6813|10500||1 038123|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5801|11176|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||5801||5801|11176||2 038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2649|4372|lyfalmen|V0335|3038|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||2361||2361|4372||1 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|2667|3312|lyfalmen|V0321|3148|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1591||1591|3312||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2174|lyfalmen|V0110|2174|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2174||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|897|2357|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||897||897|2357||2 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|134303|172615|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||134303||134303|172615||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|12519|18353|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||12519|18353||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|27546|37541|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||27546||27546|37541||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|14342|12043|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|12043||2 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1541|3243|lyfalmen|V0415|3243|2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1541||1541|3243||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|5534|8739|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5534||5534|8739||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|3252|5598|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||3252|5598||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|15038|21821|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||15038|21821||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2884|5092|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||2884||2884|5092||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|367|1586|lyfalmen|V0541|1454|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||337||337|1586||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|529|1630|lyfalmen|V0542|1591|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||369||369|1630||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|925|2395|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||925||925|2395||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1622|3355|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1622||1622|3355||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2174|lyfalmen|V0110|2131|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2174||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|6719|4510|lyfalmen|V0182|4496|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||2461||2461|4510||1 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|1614|1887|lyfalmen|V0033|1876|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||556||556|1887||1 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8479|12793|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||8479||8479|12793||1 040421|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4862|9395|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||4862||4862|9395||2 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.05.2012|31.07.2016|R|1|0|0|0|G|0|APC|0|0|1|100|XEU|560|1893|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||560||560|1893||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1871||1 040620|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4207|8152|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4207||4207|8152||2 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|77829|101139|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||77829|101139||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1083|2613|lyfalmen|V0174|2613|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1083||1083|2613||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3128|3875|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||2000||2000|3875||2 040891|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2060|3958|lyfalmen|||2|28|0|56,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2060||2060|3958||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|8383|12661|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8383||8383|12661||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|8383|12661|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8383||8383|12661||2 041693|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.07.2016||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|50177|95366|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||50177||50177|95366||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3105|5352|vetorma|||0|100|0||Vistor hf|Intervet International BV|||3105||3105|5352||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|972|2460|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||972|2460||2 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9381|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9381||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9381|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9381||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1250|2843|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1250||1250|2843||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2205|4157|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2205||2205|4157||1 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3480|5912|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3480||3480|5912||1 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1891|3725|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1891||1891|3725||1 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2500|4563|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2500||2500|4563||1 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1826|3636|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1826||1826|3636||1 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2068|3969|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2068||2068|3969||1 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|1983|3852|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||1983||1983|3852||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2853|5049|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2853||2853|5049||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1736|3412|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1736||1736|3412||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2328|4575|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2328||2328|4575||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4656|9004|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4656||4656|9004||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5354|10328|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5354||5354|10328||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2102|4015|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2102||2102|4015||1 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|3318|5689|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||3318||3318|5689||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|470|1769|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||470||470|1769||2 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|13683|5806|lyfalmen|V0516|5806|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||3403||3403|5806||1 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|3565|6029|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3565||3565|6029||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|489|1795|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||489||489|1795||1 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044046|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|10|stk|1|þpakki||QJ01CA04|01.02.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|451|886|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||451|886||2 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|12572|18426|lyfalmen|V0637|18426|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12572||12572|18426||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|330780|416978|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||330780|416978||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|438666|551158|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||438666|551158||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5054|8079|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5054||5054|8079||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|14213|20685|lyfalmen|V0635|14992|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||14213||14213|20685||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|37862|50589|lyfalmen|V0636|31872|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||37862||37862|50589||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dæla|QN05CM90|01.01.2012|31.05.2016|R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|1860|3656|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||1860||1860|3656||2 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045475|A10BX1201|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6051|9451|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6051||6051|9451||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1841|lyfalmen|V0109|1804|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1841||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1711|lyfalmen|V0108|1677|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1711||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1795|3593|lyfsjukr|||1|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1795|3593||2 045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2910|5128|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2910|5128||2 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|345|1597|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||345||345|1597||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1796|3594|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíð||1796||1796|3594||1 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1345|2973|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1345||1345|2973||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|738|2009|lyfalmen|V0648|2009|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||644||644|2009||1 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|571|1678|lyfalmen|V0021|1397|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||404||404|1678||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|694|1956|lyfalmen|V0022|1535|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||606||606|1956||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|889|2234|lyfalmen|V0023|1810|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||808||808|2234||1 046485|L01BC0502|Gemcitabin Hospira|irþ|38|mg/ml|1|hgl|1|pakki||L01BC05|01.12.2015||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|6863|10568|lyfsjukr|||1|1|0||Icepharma hf|Hospira UK Ltd|Gemcitabín||6863||6863|10568||1 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2223|lyfalmen|V0625|2223|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||800||800|2223||2 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|4372|3816|lyfalmen|V0205|3816|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1957||1957|3816||1 047147|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|3000|4013|lyfalmen|V0353|4013|2|30|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||2100||2100|4013||2 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|834|2270|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||834||834|2270||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19549|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19549||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|62848|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|62848||5 047986|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|10934|7438|lyfalmen|V0420|4824|2|30|0|30,0000|Alvogen|Alvogen ehf|Bíkalútamíð||4589||4589|7438||1 047998|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|13129|8731|lyfalmen|V0421|7164|2|30|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||5528||5528|8731||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|4214|6922|lyfsjukr|||1|250|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||4214||4214|6922||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7747|11785|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||7747||7747|11785||1 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|6836|10531|lyfsjukr|||1|100|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||6836||6836|10531||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2342|2115|lyfalmen|V0324|1988|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||721||721|2115||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1397|3045|lyfalmen|V0319|2939|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1397||1397|3045||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3580|2115|lyfalmen|V0325|1988|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||721||721|2115||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5944|3803|lyfalmen|V0326|3673|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1948||1948|3803||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6405|3133|lyfalmen|V0327|2831|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1461||1461|3133||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1024|2532|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geðlyf||1024||1024|2532||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11036|16312|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||11036||11036|16312||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1558|3267|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1558||1558|3267||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|50902|67082|lyfalmen|V0187|13057|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||50902||50902|67082||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|696116|871353|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||696116||696116|871353||1 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|356|1612|lyfalmen|V0230|1612|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||356||356|1612||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|3694|6207|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3694||3694|6207||1 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|38260|51092|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||38260||38260|51092||3 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1735|3510|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1735||1735|3510||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3912|3485|lyfalmen|V0599|2731|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1717||1717|3485||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5402|8558|lyfalmen|V0376|3294|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5402|8558||1 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|340095|428563|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||340095||340095|428563||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|13527|19741|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13527||13527|19741||2 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|1095|2629|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||1095||1095|2629||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|4003|6632|lyfalmen|V0655|4701|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||4003||4003|6632||2 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1154|2017|lyfalmen|V0109|1804|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||650||650|2017||1 049597|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1827|2464|lyfalmen|V0110|2174|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||975||975|2464||1 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|10739|4716|lyfalmen|V0123|3725|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2611||2611|4716||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|936|2082|lyfalmen|V0496|2082|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||697||697|2082||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1215|2795|lyfalmen|V0649|2774|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1215||1215|2795||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1465||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1465||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1563||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|70741|92174|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||70741||70741|92174||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|159977|204547|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||159977||159977|204547||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|53546|70426|lyfalmen|V0470|67944|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||53546||53546|70426||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|7999|12132|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||7999||7999|12132||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|19997|28646|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||19997||19997|28646||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|39994|53285|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||39994||39994|53285||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|79841|103684|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||79841||79841|103684||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3448||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3229|5567|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||3229||3229|5567||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29894|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29894||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|60989|79840|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||60989|79840||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1119|1754|lyfalmen|V0731|1673|2|56|0|4,6667|Mylan AB|Generics (UK) Ltd.|Pregabalín||459||459|1754||2 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2740|4894|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2740||2740|4894||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10894|16117|lyfalmen|V0688|6132|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||10894||10894|16117||1 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4781|4775|lyfalmen|V0042|4394|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2654||2654|4775||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|4976|lyfalmen|V0002|4545|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2800||2800|4976||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3049|lyfalmen|V0006|2774|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1400||1400|3049||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|7275|3049|lyfalmen|V0001|2602|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1400||1400|3049||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1031|2295|lyfalmen|V0363|2295|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||852||852|2295||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3173|4383|lyfalmen|V0365|4383|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2369||2369|4383||2 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|19090|27398|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||19090||19090|27398||1 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1366|1970|lyfalmen|V0056|1970|2|100|0|100,0000|Alvogen|Alvogen|Amlódipín||616||616|1970||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|756|2163|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||756||756|2163||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|175|1363|lyfalmen|V0047|1363|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||175||175|1363||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|412|1689|lyfalmen|V0305|975|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||412||412|1689||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|265995|336403|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||265995||265995|336403||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|292|1510|lyfalmen|V0439|1510|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||282||282|1510||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|602|1951|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||602||602|1951||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|601|1949|lyfalmen|V0305|1949|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||601||601|1949||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|537514|674097|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||537514||537514|674097||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|503953|632356|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||503953||503953|632356||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2931|5156|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||2931||2931|5156||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír||||||| 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|30723|41559|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||30723||30723|41559||1 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|24978|34293|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||24978||24978|34293||1 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25402|34829|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||25402||25402|34829||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22273|30872|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||22273||22273|30872||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|18465|lyfalmen|V0682|17377|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||12600||12600|18465||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|13032|19059|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíð||13032||13032|19059||1 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|1149|2357|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||897||897|2357|31.5.2016|2 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3932|6534|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||3932||3932|6534||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|10549|15642|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||10549||10549|15642||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|31417|42437|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||31417||31417|42437||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5260|8362|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5260||5260|8362||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1542|3239|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1538||1538|3239||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|5380|8527|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||5380||5380|8527||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|25272|34665|lyfalmen|V0453|32281|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||25272||25272|34665||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|10189|15146|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||10189||10189|15146||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|1349|2979|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1349||1349|2979||1 053991|D10AF0101|Dalacin|húðlausn|10|mg/ml|30|ml|1|glas||D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1006|2507|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1006||1006|2507||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5685|2441|lyfalmen|V0490|2289|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||958||958|2441||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3418|5827|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||3418||3418|5827||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2085|3992|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2085||2085|3992||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2859|5057|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2859||2859|5057||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|37004|49503|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||37004||37004|49503||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1181|2748|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1181||1181|2748||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|400|1673|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||400||400|1673||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1305|2918|lyfalmen|V0061|2918|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1305||1305|2918||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|4183|8106|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||||4183|8106||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6986|12041|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||6986||6986|12041||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4756|7668|lyfalmen|V0707|7668|1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4756||4756|7668||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|17805|22648|lyfalmen|V0470|22648|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||15639||15639|22648||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|6277|4443|lyfalmen|V0187|4352|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||2413||2413|4443||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1767|3554|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1767|3554||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|670|2044|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||670||670|2044|31.5.2016|1 055257|G03AA0903|Benidette|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1167|2318|lyfalmen|V0065|2318|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||869||869|2318||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|8115|12292|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8115||8115|12292||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|1765|2499|lyfalmen|V0467|2499|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2499||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2485|4543|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2485||2485|4543||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2834|2770|lyfalmen|V0112|2499|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1197||1197|2770||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4425|2856|lyfalmen|V0113|2567|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|2856||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5897|2856|lyfalmen|V0114|2567|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|2856||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|28197|38364|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||28197||28197|38364||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|23721|40886|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||23721||23721|40886||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1040|2554|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1040||1040|2554||1 056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3270|3368|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1632||1632|3368||1 056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3270|3368|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1632||1632|3368||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2419|4452|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2419||2419|4452||1 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|189126|240800|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||189126||189126|240800||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8145|12333|lyfalmen|V0095|6486|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||8145||8145|12333||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6645|10268|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíð||6645||6645|10268||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3264|5615|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3264||3264|5615||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3322|5695|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3322||3322|5695||1 057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|18529|26626|lyfalmen|||2|84|0|84,0000|Alvogen|Alvogen|Galantamín||18529||18529|26626||1 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4304|7046|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4304||4304|7046||1 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2340|4343|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2340||2340|4343||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|311515|393017|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||311515||311515|393017||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|379945|478125|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||379945||379945|478125||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|11147|10468|lyfalmen|V0607|10445|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||6790||6790|10468||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|17753|25557|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||17753|25557||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|375|1638|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||375||375|1638||1 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|363599|457795|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||363599||363599|457795||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|132981|170971|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||132981||132981|170971||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|142513|245635|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||142513|245635||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|216490|373142|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||216490|373142||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|842|2281|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||842||842|2281||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|83757|108637|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||83757||83757|108637||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|33487|45055|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||33487||33487|45055||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4798|7726|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4798||4798|7726||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|888|2344|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||888||888|2344||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1508|3198|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1508||1508|3198||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2894|lyfalmen|V0006|1553|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2894||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|9720|14501|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||9720||9720|14501||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|82754|107368|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||82754||82754|107368||1 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|1|0|1|PFF|0|0|0|100|DKK|56102|73659|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||56102||56102|73659||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|29056|39451|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||29056||29056|39451||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|23877|32900|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||23877||23877|32900||1 059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|2567|lyfalmen|V0114|2567|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1050||1050|2567||2 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|4818|7754|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||4818|7754||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|7858|11938|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||7858||7858|11938||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|39292|52397|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||39292||39292|52397||1 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|1824|3236|lyfalmen|V0219|3236|2|5|0|7,5000|LYFIS ehf|ratiopharm GmbH|Fentanýl||1536||1536|3236||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|3235|5366|lyfalmen|V0220|5366|2|5|0|15,0000|LYFIS ehf|ratiopharm GmbH|Fentanýl||3083||3083|5366||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|4664|6859|lyfalmen|V0221|6859|2|5|0|22,5000|LYFIS ehf|ratiopharm GmbH|Fentanýl||4168||4168|6859||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|5585|7436|lyfalmen|V0223|7436|2|5|0|30,0000|LYFIS ehf|ratiopharm GmbH|Fentanýl||4587||4587|7436||2 060337|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7895|12944|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||6733||6733|12944||1 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|299416|377970|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||299416||299416|377970||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|159231|203619|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||159231||159231|203619||1 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|18216|26195|lyfalmen|V0713|26195|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||18216||18216|26195||1 060759|A10BB1203|Glimepirid Bluefish|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|907|1535|lyfalmen|V0022|1535|2|90|0|90,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||300||300|1535||2 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|DKK|123636|159349|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||||123636|159349||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|92942|120254|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||92942||92942|120254||2 061293|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|0|0|RAT|0|0|0|100|IKR|10093|15014|lyfalmen|V0204|15014|2|28|0|18,6670|LYFIS ehf|ratiopharm GmbH|Aripiprazól||10093||10093|15014||2 061414|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009|30.06.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2477|4868|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2477|4868||2 061442|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009|30.06.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1298|2551|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1298|2551||2 061451|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009|30.06.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|7667|14716|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||7667|14716||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|5371|8515|lyfalmen|V0133|7082|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||5371||5371|8515||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|5372|8516|lyfalmen|V0133|7082|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||5372||5372|8516||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1526|2630|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1526||1526|2630||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3646|6141|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3646||3646|6141||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|NEL|0|0|0|100|DKK|13948|20320|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||13948||13948|20320||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|NEL|0|0|0|100|DKK|19410|27838|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||19410||19410|27838||1 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|404|1678|lyfalmen|V0307|1550|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||404||404|1678||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2013|30.06.2016|R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2625|3051|lyfalmen|||2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||1401||1401|3051||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|14161|13057|lyfalmen|V0187|13057|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||8671||8671|13057||1 062575|J05AX1501|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AX15|01.09.2015||R|0|0|0|1|0|1|GIL|0|1|0|100|XEU|1873249|2335377|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir||||1873249|2335377||1 062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|50177|95366|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||50177||50177|95366||2 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|815|2244|lyfalmen|V0308|1992|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||815||815|2244||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|1987|3857|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1987||1987|3857||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|15838|27298|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||15838||15838|27298||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|11811|14599|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||9791||9791|14599||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|127843|164581|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||127843||127843|164581|31.7.2016|1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|5033|8050|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||5033||5033|8050||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1608|2533|lyfalmen|V0276|2430|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1025||1025|2533||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|4962|6427|lyfalmen|V0277|6353|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||3854||3854|6427||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2865||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1910|3751|lyfalmen|V0123|3725|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1910||1910|3751||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3652|6149|lyfalmen|V0458|3422|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3652||3652|6149||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|6844|10542|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||6844||6844|10542||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006|31.05.2016|R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2289|3945|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2289||2289|3945||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|129117|166165|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||129117||129117|166165||2 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|856|2300|lyfalmen|V0309|1933|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||856||856|2300||1 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1793|3590|lyfalmen|V0310|2821|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1793||1793|3590||1 064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|75062|97639|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||75062|97639||3 064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|114835|148403|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||114835|148403||3 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|823401|1029660|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||823401|1029660||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|381190|479674|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||381190|479674||2 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1882|3713|lyfalmen|V0311|2821|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1882||1882|3713||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|3811909|4746527|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||3811909|4746527||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|1497093|1867545|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1497093|1867545||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1970|3516|lyfalmen|V0009|3400|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1739||1739|3516||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6101|6175|lyfalmen|V0029|6168|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3671||3671|6175||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1041|2046|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1041||1041|2046||1 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5940|10238|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||5940|10238||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1848|3666|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||1848||1848|3666||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|882|2071|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||689||689|2071||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|43347|57526|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||43347||43347|57526||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|731|2128|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||731||731|2128||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|15865|20090|lyfalmen|V0441|20090|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||13781||13781|20090||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|420|1700|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||420||420|1700||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1717|3485|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1717||1717|3485||1 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|freyðit|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13905|20261|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||13905||13905|20261||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9792|14600|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9792||9792|14600||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|47961|63362|lyfalmen|V0451|56198|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||47961||47961|63362||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|954|2014|lyfalmen|V0163|2014|2|70|0|5,6000|LYFIS ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|2014||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1435|3097|lyfalmen|V0222|3097|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1435||1435|3097||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3094|5381|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||3094||3094|5381||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|518|1835|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||518||518|1835||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1566|3278|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1566||1566|3278||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|2911|5129|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||2911||2911|5129||1 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|3951|7666|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||3951||3951|7666||2 066235|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|8594|12951|lyfalmen|V0716|12951|2|28|0|28,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||8594||8594|12951||1 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5193|8270|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||5193||5193|8270||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|27295|37223|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||27295||27295|37223||1 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|828|2262|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||828||828|2262||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|XEU|1268|2867|lyfalmen|V0006|2774|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1268||1268|2867||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|852|2295|lyfalmen|V0036|2295|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||852||852|2295||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3426|5838|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3426||3426|5838||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7748|11787|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7748||7748|11787||1 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2295|4281|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2295|4281||2 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|107472|139245|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||107472||107472|139245||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|þpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|76445|99388|lyfsjukr|||1|14|0|7,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||76445||76445|99388||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1348|2978|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1348||1348|2978||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|4602|7456|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||4602||4602|7456||1 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2508|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||2748||1 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín||||||| 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2965|5203|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2965||2965|5203||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2208|4161|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríð||2208||2208|4161||1 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2063|3962|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríð||2063||2063|3962||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3246||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3429||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3201||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3379||1 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12444|18250|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12444||12444|18250||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|39280|52382|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||39280||39280|52382||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|354313|446246|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer Pharma AG|Riociguatum||354313||354313|446246||1 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5767|9060|lyfalmen|V0589|9060|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||5767||5767|9060||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|9421|14089|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9421||9421|14089||1 070971|N06AB0606|Sertralin Hexal|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3246|3232|lyfalmen|V0323|3232|2|100|0|200,0000|Artasan ehf|Hexal A/S|Sertralín||1533||1533|3232||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|53744|70676|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||53744||53744|70676||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|271809|343634|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||271809||271809|343634||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1523|1747|lyfalmen|V0247|1717|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||454||454|1747||2 071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.08.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2751|3245|lyfalmen|V0248|3216|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1542||1542|3245||2 071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|4962|3618|lyfalmen|V0249|3494|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1813||1813|3618||2 071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|8787|13217|lyfalmen|V0252|13217|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||8787||8787|13217||2 071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|4261|3192|lyfalmen|V0732|3107|2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1504||1504|3192||2 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010|31.05.2016|R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|10129|4898|lyfalmen|||3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2743||2743|4898||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|66689|87049|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||66689||66689|87049||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|576|1915|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||576||576|1915||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|438|1725|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||438||438|1725||2 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|1870|3607|lyfalmen|||2|30|0|30,0000|Alvogen|Pharmathen S.A.|Klópídógrel||1805||1805|3607|31.7.2016|1 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6173|11882|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6173||6173|11882||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6101|6168|lyfalmen|V0029|6168|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3666||3666|6168||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184025|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184025||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184025|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184025||5 072735|L01BA0110|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3037|5302|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3037||3037|5302||2 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|510|1824|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||510||510|1824||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|53715|70639|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||53715||53715|70639||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7785|7165|lyfalmen|V0286|7122|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||4390||4390|7165||1 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|407|1587|lyfalmen|V0500|1587|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||338||338|1587||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|334745|421909|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||334745|421909||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|1|0|100|DKK|591257|740938|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||591257||591257|740938||1 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3205|5534|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3205||3205|5534||1 073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|256759|324916|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||256759||256759|324916||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16331|12977|lyfalmen|V0185|12977|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||8613||8613|12977||1 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|268|1491|lyfalmen|V0047|1363|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||268||268|1491||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|842|2281|lyfalmen|V0305|1949|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||842||842|2281||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|453|1746|lyfalmen|V0439|1510|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||453||453|1746||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1232|2818|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1232||1232|2818||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|2397|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2397||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|3396|5853|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3396||3396|5853||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|899|2360|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||899||899|2360||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2799|4975|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2799||2799|4975||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|624|1981|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||624||624|1981||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|LYFIS ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|539|1864|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||539||539|1864||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|877|2329|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||877||877|2329||1 074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|6527|6124|lyfalmen|V0735|6124|2|56|0|56,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||3634||3634|6124||2 074617|QI06AA0402|Fel-O-Vax PCT vet.|stl|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000|31.05.2016|R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|20321|35025|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||20321||20321|35025||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|382|1648|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||382||382|1648||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|716|2108|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||716||716|2108||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|842|2281|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||842||842|2281||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|449|1740|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||449||449|1740||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|2076|3980|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||2076||2076|3980||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4829|7769|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4829||4829|7769||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14159|20611|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14159||14159|20611||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|5101|8143|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5101||5101|8143||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1333|2401|lyfalmen|V0363|2295|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||929||929|2401||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14936|21680|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14936||14936|21680||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|3144|5450|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||3144||3144|5450||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|4555|7392|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||4555||4555|7392||1 075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|7520|11473|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||7520||7520|11473||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2173|4113|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun||||2173|4113||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3600|4482|lyfalmen|V0445|4482|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||2441||2441|4482||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1071|2105|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1071||1071|2105||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|11213|16556|lyfalmen|V0440|16556|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||11213||11213|16556||1 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4883|7843|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4883||4883|7843||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4883|7843|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4883||4883|7843||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5317|8441|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5317||5317|8441||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|515|1831|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||515||515|1831||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|558|1890|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||558||558|1890||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5624|8863|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||5624||5624|8863||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17232|24840|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||17232|24840||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17320|24961|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||17320||17320|24961||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17320|24961|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||17320||17320|24961||1 076067|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|10|stk|1|þpakki||QJ01CA04|01.05.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|451|886|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||451|886||2 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2177|lyfalmen|V0143|1406|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||766||766|2177||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3195|lyfalmen|V0143|2813|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3195||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|4394|lyfalmen|V0143|4219|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2377||2377|4394||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2373|lyfalmen|V0144|1566|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||909||909|2373||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3521|lyfalmen|V0144|3133|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3521||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4898|lyfalmen|V0144|4699|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2743||2743|4898||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|GOV|0|0|0|100|IKR|445|1735|lyfalmen|V0045|1735|2|20|0|2,0000|Alvogen|Alvogen ehf|Risperídón||445||445|1735||1 076378|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1691|2430|lyfalmen|V0290|2430|2|60|0|6,0000|Alvogen|Alvogen ehf|Risperídón||950||950|2430||1 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1660|2361|lyfalmen|V0291|2361|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||900||900|2361||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1390|3035|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1390||1390|3035||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2430|lyfalmen|V0290|2430|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||950||950|2430||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|237159|300539|lyfsjukr|||1|1|0|6,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||237159||237159|300539||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|158107|202221|lyfsjukr|||1|1|0|4,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||158107||158107|202221||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|79174|102840|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||79174||79174|102840||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|39820|53065|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||39820||39820|53065||1 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|2677|4682|lyfalmen|V0598|4682|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2586||2586|4682||1 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|410|1687|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||410||410|1687||1 077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|2559|2511|lyfalmen|V0005|2511|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||1009||1009|2511||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|46813|61910|lyfsjukr|||1|1|0|1,4300|Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||46813||46813|61910||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|367|1627|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||367||367|1627||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|1042|2556|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1042||1042|2556||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2249|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2249||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2325|lyfalmen|V0671|2325|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2325||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4321|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4321||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|5664|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5664||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8004|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8004||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|9794|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|9794||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12299|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12299||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|696|2080|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||696||696|2080||1 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|8800|12684|lyfalmen|V0275|12471|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Quetíapín||8400||8400|12684||2 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12822|lyfalmen|V0419|11967|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||8500||8500|12822||1 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|434|1720|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||434||434|1720||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|661|2032|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||661||661|2032||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1222|2804|lyfalmen|V0560|2804|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1222||1222|2804||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1366|3002|lyfalmen|V0561|3002|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1366||1366|3002||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7806|5633|lyfalmen|V0069|2974|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3277||3277|5633||1 079109|J05AX1401|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1263193|1576638|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1263193||1263193|1576638||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|19940|10950|lyfalmen|V0688|10950|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||7140||7140|10950||1 079410|N05AX1207|Lemilvo|töflur|10|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|39459|31030|lyfalmen|V0683|31030|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||22398||22398|31030||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3057|5330|lyfalmen|V0315|5330|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3057||3057|5330||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6077|lyfalmen|V0184|5107|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6077||2 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1814|3619|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1814||1814|3619||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1663|lyfalmen|V0176|1663|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1663||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|2000|lyfalmen|V0418|2000|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|2000||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|2013|lyfalmen|V0177|2013|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|2013||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2730|lyfalmen|V0411|2730|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2730||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3508|6826|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3508|6826||2 080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|7220|5126|lyfalmen|V0733|4719|2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||2909||2909|5126||2 080256|A10BB0903|Gliclazide LYFIS|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|4081|lyfalmen|V0020|2344|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||2150||2150|4081||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|13129|8688|lyfalmen|V0421|7164|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||5497||5497|8688||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9535|16435|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||9535||9535|16435||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BLP|0|0|0|100|XEU|8471|6112|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Letrózól||3625||3625|6112||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2004|3881|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2004||2004|3881||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|5172|8241|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5172||5172|8241||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1461|2167|lyfalmen|V0143|1406|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||759||759|2167||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2528|4602|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2528||2528|4602||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3469|4321|lyfalmen|V0143|4219|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2324||2324|4321||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1475|2328|lyfalmen|V0144|1566|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||876||876|2328||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|13098|19150|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||13098||13098|19150||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|6512|4932|lyfalmen|V0144|4699|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2768||2768|4932||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|25822|35360|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||25822||25822|35360||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|2791|4958|lyfsjukr|||1|1|0|0,3300|Alvogen|Linepharma France|Mifepriston||2787||2787|4958||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|1|0|100|DKK|642670|804882|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||642670||642670|804882||1 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|4706|3879|lyfalmen|V0515|3346|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||2003||2003|3879||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4036|6677|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4036||4036|6677||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|1750|2636|lyfalmen|V0590|2585|2|84|0|84,0000|LYFIS ehf|ratiopharm GmbH|Desógestrel||1100||1100|2636|| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1842|3658|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1842||1842|3658||2 081900|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|6836|10531|lyfalmen|V0204|7507|2|14|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||6836||6836|10531||1 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4155|6841|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4155||4155|6841||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|5851|9176|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5851||5851|9176||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|14906|8321|lyfalmen|V0184|5005|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5230||5230|8321||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|26513|36234|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||26513||26513|36234||2 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|9024|15554|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||9024||9024|15554||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|44344|76431|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||44344||44344|76431||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|579|1919|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||579||579|1919||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RAT|0|0|1|100|XEU|643|1922|lyfalmen|V0229|1922|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Paracetamól||581||581|1922||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2508|4574|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2508||2508|4574||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4624|7487|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4624||4624|7487||1 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3229|5567|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3229||3229|5567||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3515|5960|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3515||3515|5960||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4029|6668|lyfalmen|V0080|6668|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||4029||4029|6668||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008|30.06.2016|R|1|0|0|0|G|0|HES|0|0|0|100|DKK|11755|17302|lyfalmen|||1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||11755||11755|17302||1 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|BGP|0|0|0|100|DKK|2767|4931|lyfalmen|V0706|4931|1|100|0|16,6700|Vistor hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||2767||2767|4931||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008|30.06.2016|R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12156|17854|lyfalmen|||1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12156||12156|17854||1 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4770|7688|lyfalmen|V0701|6628|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4770||4770|7688||1 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9495|5678|lyfalmen|V0686|5678|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3310||3310|5678||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5388|10393|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5388||5388|10393||2 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.06.2016|R|1|0|0|0|G|0|HES|0|0|0|100|DKK|26640|36395|lyfalmen|||1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||26640||26640|36395||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|883|2108|lyfalmen|V0231|2014|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||716||716|2108||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1771|2821|lyfalmen|V0311|2821|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1234||1234|2821||2 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|60024|78619|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||60024||60024|78619||1 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|226099|286784|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||226099||226099|286784||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|38100|50890|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||38100||38100|50890||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|11098|16397|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||11098||11098|16397||1 085171|A10BX0401|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BX04|01.10.2015||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|13898|20251|lyfalmen|||1|60|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||13898||13898|20251||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|30845|41713|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||30845||30845|41713||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2271|4248|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2271||2271|4248||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.06.2016|R|1|0|0|0|G|0|HES|0|0|0|100|DKK|26640|36395|lyfalmen|||1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||26640||26640|36395||1 085407|R03AC0206|Ventoline|innönd.l|1|mg/ml|20|lykjur|1|pakki|lausn f. eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|756|2163|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||756||756|2163||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4424|7211|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4424||4424|7211||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|18017|25921|lyfalmen|V0412|23216|1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||18017||18017|25921||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|34576|46432|lyfalmen|V0412|46432|1|750|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||34576||34576|46432||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|15156|20867|lyfalmen|V0652|20777|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||14345||14345|20867||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|79057|102692|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||79057||79057|102692||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|AGP|0|0|0|100|SEK|18393|25819|lyfalmen|V0579|25819|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||17943||17943|25819||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|28221|38395|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||28221||28221|38395||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3700|6215|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3700||3700|6215||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2339|4342|lyfalmen|V0465|3543|1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||2339||2339|4342||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|6906|10628|lyfalmen|V0465|10628|1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||6906||6906|10628||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|330|1576|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||330||330|1576||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1544|3247|lyfalmen|V0364|3247|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1544||1544|3247||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|3924|4698|lyfalmen|V0365|4383|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2598||2598|4698||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|52430|69014|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||52430||52430|69014||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|20153|28190|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||20153||20153|28190||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|7243|11091|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7243||7243|11091||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|7862|11943|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7862||7862|11943||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11678|17196|lyfalmen|V0012|5114|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||11678||11678|17196||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|25646|35138|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||25646|35138||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|46429|61424|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||46429|61424||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|45339|60045|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||45339||45339|60045||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|14670|21314|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) með prógestógen||||14670|21314||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|43489|57706|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||43489||43489|57706||2 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd||||||30.6.2016|1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|306|1543|lyfalmen|V0060|1499|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||306||306|1543||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|107598|139402|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||107598||107598|139402||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|207|1407|lyfalmen|V0312|414|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||207||207|1407||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|182|1373|lyfalmen|V0312|1241|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||182||182|1373||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1536|3236|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1536||1536|3236||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|28933|17320|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||11768||11768|17320||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|28933|17320|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||11768||11768|17320||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3746||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1812|3616|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1812||1812|3616||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|807|2233|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||807||807|2233||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1970|3400|lyfalmen|V0009|3400|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1655||1655|3400||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|28164|48543|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||28164||28164|48543||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3286|6405|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3286||3286|6405||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|22899|39469|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||22899||22899|39469||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|2724|4872|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||2724||2724|4872||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|GBP|996|2493|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||996||996|2493||1 088300|L01BA0110|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2807|4986|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2807||2807|4986||2 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1285|2891|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1285||1285|2891|30.6.2016|1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|3997|6624|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||3997||3997|6624|30.6.2016|1 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20454|18465|lyfalmen|V0684|17377|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||12600||12600|18465||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9697|14469|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||9697||9697|14469||1 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4226|6939|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4226||4226|6939||1 088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2543|4242|lyfalmen|V0334|3038|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||2267||2267|4242||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|6978|10727|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6978||6978|10727||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12884|18856|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12884||12884|18856||1 088882|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|16229|30960|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||16229||16229|30960||2 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|412862|519065|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||412862||412862|519065||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1285|2891|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1285||1285|2891||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|20356|28447|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||20356||20356|28447||2 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|115614|146676|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||113447||113447|146676||1 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5846||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|107598|139402|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||107598||107598|139402||1 089156|A03AA0406|Mebeverin dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3274|5629|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3274||3274|5629||2 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|18990|27260|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||18990||18990|27260||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|45575|60344|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||45575||45575|60344||1 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||| 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2018|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2018||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|21544|29950|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||21544||21544|29950||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|86176|111696|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||86176||86176|111696||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1406|3057|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1406||1406|3057||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2812|4993|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2812||2812|4993||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|659|2029|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||659||659|2029||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5052|8076|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5052||5052|8076||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|113232|146409|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||113232||113232|146409||3 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1264|2862|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1264||1264|2862||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|770|2182|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||770||770|2182||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|15381|22293|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||15381|22293||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2272|4249|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2272||2272|4249||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|3930|6531|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3930||3930|6531||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|11535|16999|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||11535||11535|16999||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|3440|5857|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3440||3440|5857||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|5699|8966|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5699||5699|8966||1 091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014||R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1023|2530|lyfsjukr|||2|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1023||1023|2530||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|6372|9893|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||6372|9893||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3445|5864|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3445||3445|5864||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|895|1700|lyfalmen|V0021|1397|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||420||420|1700||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1548|1996|lyfalmen|V0022|1535|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||635||635|1996||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1010|2512|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||1010||1010|2512||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8168|15667|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8168||8168|15667||2 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|4192|6892|lyfalmen|V0009|3400|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||4192||4192|6892||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1970|3834|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||1970||1970|3834||1 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|AUK|0|0|1|100|GBP|576|1915|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||576||576|1915||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|AUK|0|0|1|100|GBP|1060|2581|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1060||1060|2581||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2903|2709|lyfalmen|V0203|2709|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1153||1153|2709||2 092989|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|3737|lyfalmen|V0107|3737|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||1900||1900|3737||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|864|2311|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||864||864|2311||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1984|3853|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||1984||1984|3853||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3858|6432|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3858||3858|6432||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4579|7425|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4579||4579|7425||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5116|8164|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5116||5116|8164||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|1|0|1|0|1|ERZ|0|0|0|100|XEU|21348|28509|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||20405||20405|28509||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1272|2873|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1272||1272|2873||1 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5300|8417|lyfalmen|V0724|8417|1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5300|8417||2 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3924|6523|lyfalmen|V0723|6523|1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3924|6523||2 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|22920|39505|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||22920||22920|39505||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2172|4112|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2172||2172|4112||1 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|31945|43105|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||31945||31945|43105||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7401|11309|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||7401||7401|11309||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19159|27493|lyfalmen|V0588|20235|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||19159||19159|27493||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|360371|453781|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||360371||360371|453781||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|384252|483482|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||384252||384252|483482||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|3997|6624|lyfalmen|V0236|5993|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||3997||3997|6624||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|5716|8990|lyfalmen|V0236|8990|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||5716||5716|8990||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1544|3035|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1544||1544|3035||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|XEU|916|2249|lyfalmen|V0044|2249|2|25|0|1,2500|LYFIS ehf|ratiopharm GmbH|Acíklóvír||819||819|2249||2 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2500|1948|lyfalmen|V0324|1948|2|98|0|49,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||600||600|1948||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|14686|18918|lyfalmen|V0534|18586|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||12929||12929|18918||1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VII|0|0|0|100|GBP|70605|92002|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||70605||70605|92002||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|0|100|XEU|40995|54551|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||40995|54551||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|5593|9640|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||5593||5593|9640||2 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|34986|46951|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||34986||34986|46951||1 095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|45023|59646|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||45023||45023|59646||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011|31.05.2016|R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4638|3195|lyfalmen|||3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1506||1506|3195||2 095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|329350|415199|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||||329350|415199||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|6768|10438|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6768||6768|10438||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|14828|21531|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14828||14828|21531||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15049|21836|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15049||15049|21836||1 095704|J01MA0204|Ciprofloxacin Alvogen|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|2599|4699|lyfsjukr|||2|200|0|0,8000|Alvogen|Alvogen ehf|Cíprófloxacín||2599||2599|4699||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|17520|25237|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||17520||17520|25237||1 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1929|3777|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1929|3777||1 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|3014|5271|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||3014|5271||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|850|1549|lyfalmen|V0225|1451|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||310||310|1549||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|4482|6628|lyfalmen|V0701|6628|2|40|0|13,3400|Medical ehf|Teva Pharma B.V.|Búdesóníð||4000||4000|6628||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|92142|119242|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||92142||92142|119242||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2072|2331|lyfalmen|V0088|2308|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||878||878|2331||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2156|2609|lyfalmen|V0089|2586|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||1080||1080|2609||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|RGO|0|0|1|100|GBP|1577|3293|lyfalmen|||1|5|0||Vistor hf|Glaxo Group Limited|Retapamúlín||1577||1577|3293||1 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|12850|18809|lyfalmen|V0347|16508|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||12850||12850|18809||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|649103|812882|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||649103||649103|812882||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|601667|753885|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||601667||601667|753885||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|633333|793269|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||633333||633333|793269||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|694405|869225|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||694405||694405|869225||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|12998|19013|lyfalmen|V0349|17890|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||12998||12998|19013||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1137|2687|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1137||1137|2687||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|10662|15797|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||10662||10662|15797||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|63512|109469|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||63512||63512|109469||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|6988|13428|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||6988|13428||2 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1885|3717|lyfalmen|V0461|3717|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||1885||1885|3717||2 097498|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|463|1759|lyfalmen|V0333|795|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||463||463|1759||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9605|14343|lyfalmen|V0334|3038|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||9605||9605|14343||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17869|25717|lyfalmen|V0335|3038|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||17869|25717||1 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|31452|42481|lyfalmen|||1|1|0||Vistor hf|Amgen Europe B.V.|Evolocumab||31452||31452|42481||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5354|10328|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5354||5354|10328||2 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2221|2238|lyfalmen|V0023|1810|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||811||811|2238||1 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2619|4727|lyfsjukr|||2|2000|0|8,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2619|4727||2 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|949|1921|lyfalmen|V0329|1810|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||580||580|1921||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2897|3572|lyfalmen|V0678|3462|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1780||1780|3572||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4826|3572|lyfalmen|V0679|3462|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1780||1780|3572||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4930|9524|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||4930||4930|9524||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|556|1887|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||556||556|1887||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|556|1887|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||556||556|1887||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1022|1673|lyfalmen|V0243|1673|2|50|0|4,1600|LYFIS ehf|ratiopharm GmbH|Lamótrigín||400||400|1673||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1812|1948|lyfalmen|V0244|1828|2|50|0|8,3300|LYFIS ehf|ratiopharm GmbH|Lamótrigín||600||600|1948||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|5116|3600|lyfalmen|V0245|3600|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3600||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|9166|8004|lyfalmen|V0232|8004|2|100|0|66,6600|LYFIS ehf|ratiopharm GmbH|Lamótrigín||5000||5000|8004||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|2815|3861|lyfalmen|V0381|3861|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|3861||2 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|13953|20327|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||13953||13953|20327||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|ASZ|0|0|0|100|SEK|64876|84756|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||64876||64876|84756||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2306|2088|lyfalmen|V0284|2088|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||702||702|2088||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4310|3964|lyfalmen|V0285|3875|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2065||2065|3964||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|7714|7122|lyfalmen|V0286|7122|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4359||4359|7122||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3833|2190|lyfalmen|V0685|2190|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||776||776|2190||1 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1523|1984|lyfalmen|V0247|1717|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||626||626|1984||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2751|3454|lyfalmen|V0248|3216|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1694||1694|3454||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4962|3868|lyfalmen|V0249|3494|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1995||1995|3868||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|151197|193627|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||151197||151197|193627||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|291430|368037|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||291430||291430|368037||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|582840|730470|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||582840||582840|730470||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|568|1904|lyfalmen|V0414|1904|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||568||568|1904||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|5207|8394|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||5207||5207|8394||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|10020|14914|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||10020|14914||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1734|3249|lyfalmen|V0672|3049|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1545||1545|3249||1 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|2054|1721|lyfalmen|V0685|1226|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||435||435|1721||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|4241|6960|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||4241||4241|6960||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|9472|11839|lyfalmen|V0254|10757|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||7786||7786|11839||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|13857|20195|lyfalmen|V0256|19015|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||13857||13857|20195||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|57730|93061|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||57730||57730|93061||1 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1170|2132|lyfalmen|V0330|1810|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||734||734|2132||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2403|2902|lyfalmen|V0331|2636|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1293||1293|2902||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2264|2355|lyfalmen|V0088|2355|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||896||896|2355||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2874|2639|lyfalmen|V0089|2639|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||1102||1102|2639||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|10760|20584|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||10760||10760|20584||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5333|8463|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5333||5333|8463||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|15822|22900|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||15822||15822|22900||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|986|2479|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||986||986|2479||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1443|3108|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1443||1443|3108||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5454|8629|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5454||5454|8629||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|361|1619|lyfalmen|V0230|1612|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||361||361|1619||1 102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2715|3623|lyfalmen|V0693|3424|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1817||1817|3623||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|6281|9767|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||6281||6281|9767||1 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|17831|18386|lyfalmen|V0684|17377|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||12543||12543|18386||2 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3035|5300|lyfalmen|V0041|2593|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3035||3035|5300||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13781|20090|lyfalmen|V0441|20090|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||13781||13781|20090||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1499|lyfalmen|V0060|1499|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||274||274|1499||2 103114|L01BA0110|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2278|4258|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2278||2278|4258||2 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|93499|120958|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||93499||93499|120958||1 103610|L01DB0105|Doxorubicin Actavis|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3619|6103|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||3619||3619|6103||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2501|2785|lyfalmen|V0088|2308|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|2785||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|3172|3371|lyfalmen|V0089|2586|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3371||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2416|3558|lyfalmen|V0069|2974|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3558||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|1535|1876|lyfalmen|V0033|1876|2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír||548||548|1876||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|6400|4282|lyfalmen|V0182|4282|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||2296||2296|4282||1 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3473|3600|lyfalmen|V0334|3100|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3600||1 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|6528|4494|lyfalmen|V0335|3100|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||2450||2450|4494||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|1559|3268|lyfalmen|V0222|3097|2|5|0|3,6000|LYFIS ehf|ratiopharm GmbH|Fentanýl||1559||1559|3268||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|280102|353948|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||280102||280102|353948||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|106463|137990|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||106463||106463|137990||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3439|6695|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3439||3439|6695||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1932||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8368|12640|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8368||8368|12640||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2453|4499|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2453||2453|4499||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5880|9215|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5880||5880|9215||1 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|9189|13770|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||9189||9189|13770||1 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6780|10454|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6780||6780|10454||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3514|5959|lyfalmen|V0017|5341|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3514||3514|5959||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4552|7388|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4552||4552|7388||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|3936|6540|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||3936||3936|6540||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|95453|123430|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||95453|123430||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|11677|17194|lyfalmen|V0012|5114|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||11677||11677|17194|| 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1117|2660|lyfalmen|V0545|1885|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1117||1117|2660||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|3737|lyfalmen|V0107|3737|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||1900||1900|3737||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|11658|17168|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||11658||11658|17168||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|14656|21295|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14656||14656|21295||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1973|3838|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||1973||1973|3838||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2333|4333|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2333||2333|4333||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1594|3316|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1594||1594|3316||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3053|3316|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1594||1594|3316||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3049|5319|lyfalmen|V0191|4614|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3049||3049|5319||2 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|395519|497495|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||395519||395519|497495||1 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|16318|23582|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||16318||16318|23582||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|9024|13543|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||9024||9024|13543||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|6362|5481|lyfalmen|||2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||3167||3167|5481|30.6.2016|2 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3131|3747|lyfalmen|V0107|3737|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||1907||1907|3747||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|139947|179635|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||139947||139947|179635||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1360|2994|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1360||1360|2994||1 107265|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|10757|lyfalmen|V0197|10757|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7000||7000|10757||2 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4026|6664|lyfalmen|V0438|6664|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||4026||4026|6664||1 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|18530|23578|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||16315||16315|23578||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|799|2222|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||799||799|2222||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20582|18465|lyfalmen|V0683|17377|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||12600||12600|18465||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|8574|16437|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||8574|16437||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2097|4009|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2097||2097|4009||2 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2 108347|J05AX1401|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1263193|1576638|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1263193||1263193|1576638||1 108413|C10A00001|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|63098|82507|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||63098|82507||1 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|47365|62608|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||47365||47365|62608||1 108455|N04BD0203|Rasagilin WH|töflur|1|mg|30|stk|1|þpakki||N04BD02|01.04.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|14393|20933|lyfalmen|V0726|20933|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||14393||14393|20933||2 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008|31.05.2016|R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2929|5154|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||2929||2929|5154||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8466|12775|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||8466||8466|12775||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|64307|84036|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||64307||64307|84036||3 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1265|2863|lyfalmen|||1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1265||1265|2863||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20986|29244|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||20986||20986|29244||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|16801|24247|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||16801||16801|24247||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|1423|3081|lyfalmen|V0584|3081|2|28|0|7,4700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||1423||1423|3081||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|4977|7766|lyfalmen|V0585|7765|2|98|0|26,1300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||4827||4827|7766||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2602|4704|lyfalmen|V0586|4704|2|28|0|14,9300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2602||2602|4704||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|8440|12739|lyfalmen|V0587|12739|2|98|0|52,2700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||8440||8440|12739||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|14949|20238|lyfalmen|V0588|20235|2|98|0|104,5300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||13888||13888|20238||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|390|1659|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||390||390|1659||2 110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7900|9489|lyfalmen|V0694|9372|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||6079||6079|9489||1 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1755|3538|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1755||1755|3538||1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2361|lyfalmen|V0291|2361|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2361||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3806|lyfalmen|V0292|3806|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3806||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5389|lyfalmen|V0296|5389|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5389||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6765|lyfalmen|V0297|6765|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6765||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1331|2954|lyfalmen|V0065|2318|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1331||1331|2954||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|23041|31843|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||23041||23041|31843||1 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3403|5806|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3403||3403|5806||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|79732|103546|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||79732||79732|103546||1 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|0|0|0|0|0|EHF|0|0|0|100|XEU|14593|17229|lyfalmen|||2|1|0||Actavis Group PTC hf|Actavis ehf|Plast lyfjalykkja (IUD) með prógestógen||11702||11702|17229||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2551|4409|lyfalmen|V0373|4409|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2388||2388|4409||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 111863|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3231|5569|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3231||3231|5569||2 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|628|1987|lyfalmen|V0229|1922|1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||628||628|1987||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|18803|27003|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||18803||18803|27003||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|175889|224337|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer Pharma AG|Riociguatum||175889||175889|224337||1 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1700|3462|lyfalmen|||2|100|0|5,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1700||1700|3462||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|40598|31791|lyfalmen|V0717|31791|2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||23000||23000|31791||2 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4701|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4701||2 113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1598|3322|lyfalmen|V0415|3243|2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1598||1598|3322||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6702|10347|lyfalmen|V0024|8864|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6702||6702|10347||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|18505|26592|lyfalmen|V0024|26592|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||18505||18505|26592||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6037|9432|lyfalmen|V0025|7712|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6037||6037|9432||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|2001|3876|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||2001||2001|3876||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2490|4549|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2490||2490|4549||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|15993|23135|lyfalmen|V0025|23135|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||15993||15993|23135||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5086|8112|lyfalmen|V0681|8112|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5078||5078|8112||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|4276|7008|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4276||4276|7008||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|432763|543816|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||432763||432763|543816||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|542|1868|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||542||542|1868||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|687|2068|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||687||687|2068||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1046|2562|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1046||1046|2562||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|732|2130|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||732||732|2130||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|19806|28383|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||19806|28383||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|30524|41307|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||30524|41307||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3572|6039|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3572||3572|6039||1 114512|D06BB0401|Condyline|húðlausn|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|1911|3753|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||1911||1911|3753||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|9551|14268|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||9551||9551|14268||1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|5057|8083|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||5057||5057|8083||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|14473|lyfalmen|V0420|14473|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||9700||9700|14473||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5239|9030|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5239||5239|9030||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2129|2525|lyfalmen|V0278|2525|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1019||1019|2525||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2808|2591|lyfalmen|V0279|2591|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1067||1067|2591||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|8166|4058|lyfalmen|V0280|4058|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2133||2133|4058||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10066|3283|lyfalmen|V0282|3124|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1570||1570|3283||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|6628|lyfalmen|V0457|6628|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4000||4000|6628||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|10457|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||6782||6782|10457||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|17396|13785|lyfalmen|V0475|13785|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||9200||9200|13785||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20024|lyfalmen|V0540|20024|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|20024||2 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|82572|107138|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||82572||82572|107138||1 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1646|3388|lyfalmen|||1|10|0|2,5000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1646||1646|3388||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|7650|11652|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||7650||7650|11652||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1086|2532|lyfalmen|V0158|2361|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1024||1024|2532||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1955|2430|lyfalmen|V0276|2430|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||950||950|2430||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9876|14716|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9876||9876|14716||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1646|3388|lyfalmen|||1|10|0|3,6700|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1646||1646|3388||1 115348|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|165|1349|lyfalmen|V0505|1349|1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||165||165|1349||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9022|13540|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9022||9022|13540||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|44848|59424|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||44848||44848|59424||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|3220|5554|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3220||3220|5554||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|3255|5602|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3255||3255|5602||1 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|1702|3465|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1702||1702|3465||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2038|lyfalmen|V0056|1970|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2038|lyfalmen|V0057|2038|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|17076|12127|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||7995||7995|12127||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|655|1912|lyfalmen|V0562|1627|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||574||574|1912|| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|326|1571|lyfalmen|V0563|1556|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||326||326|1571||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|784|2182|lyfalmen|V0564|1980|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||770||770|2182||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|13679|19950|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||13679||13679|19950||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4615|5834|lyfalmen|V0081|5834|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3423||3423|5834||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5331|8460|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5331||5331|8460||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5712|8984|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5712||5712|8984||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|14665|21307|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||14665||14665|21307||1 116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|10697|8468|lyfalmen|||2|56|0|56,0000|Alvogen|Alvogen IPco S.á.r.l.|Memantín||5337||5337|8468||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|613|1966|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||613|1966||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|8444|16190|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||8444||8444|16190||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1348|2978|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1348||1348|2978||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3814|6372|lyfalmen|V0435|6258|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3814||3814|6372||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|12024|15519|lyfalmen|V0275|12471|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10460||10460|15519||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|21250|26570|lyfalmen|V0273|23147|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||18489||18489|26570||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1279|2883|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1279||1279|2883||2 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|33692|40227|lyfalmen|V0272|33688|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||29670||29670|40227||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|42500|56455|lyfalmen|V0261|43174|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||42500|56455||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|48408|63927|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||48408||48408|63927||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8403|14483|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||8403||8403|14483||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|5209|10053|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5209||5209|10053||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|10000|19143|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||10000||10000|19143||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1563|3274|lyfalmen|V0278|2525|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1563||1563|3274||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2563|3931|lyfalmen|V0279|2591|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2041||2041|3931||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8753|3304|lyfalmen|V0282|3124|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1585||1585|3304||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1511|3202|lyfalmen|V0283|2722|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1511||1511|3202||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14215|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14215||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8166|5111|lyfalmen|V0280|4058|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2898||2898|5111||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4656|9004|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4656||4656|9004||2 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|18952|27208|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||18952||18952|27208||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2734|4885|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2734||2734|4885||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|422|1703|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||422||422|1703||1 118967|C03DA0405|Eplerenon Actavis|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.09.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|6311|3747|lyfalmen|V0107|3737|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Eplerenón||1907||1907|3747||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1190|2760|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1190||1190|2760||1 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3525|5974|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3525||3525|5974||2 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|832|1933|lyfalmen|V0309|1933|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||589||589|1933||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|GBP|325573|410502|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||325573||325573|410502||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|GBP|291220|367776|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||291220||291220|367776||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|987|2481|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||987||987|2481||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|37092|49615|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||37092||37092|49615||2 120596|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|10|stk|1|þpakki||QJ01CA04|01.02.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|864|1698|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||864|1698||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|11032|lyfalmen|V0118|11032|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||7200||7200|11032||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|25347|34760|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||25347||25347|34760||1 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|391661|492697|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||391661||391661|492697||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4164|6854|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4164||4164|6854||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|6640|10261|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíð||6640||6640|10261||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|432|1717|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||432||432|1717||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|472|1772|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||472||472|1772||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1475|3152|lyfalmen|V0314|2734|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1475||1475|3152||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|314|1554|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||314||314|1554||1 121912|L01BA0110|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3206|5535|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3206||3206|5535||2 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón||||||| 122354|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|14937|19058|lyfalmen|V0682|17377|2|56|0|18,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||13031||13031|19058||1 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9049|15597|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9049||9049|15597||1 122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|256759|324916|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||256759||256759|324916||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|532|1854|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||532||532|1854||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|743|2145|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||743||743|2145||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1227|2811|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1227||1227|2811||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|27089|46691|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||27089||27089|46691||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|18493|26576|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||18493||18493|26576||1 123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|7844|11919|lyfalmen|V0115|11919|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||7844||7844|11919||2 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|27565|47511|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||27565||27565|47511||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|254|1472|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||254|1472||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|20364|28457|lyfalmen|V0579|25819|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||20364||20364|28457||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1573|3092|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1573|3092||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SNC|0|0|0|100|NOK|26989|36836|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||||26989|36836||1 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|8448|12750|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||8448||8448|12750||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|865|2313|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||865||865|2313||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|þpakki||C09AA02|01.01.1994|30.06.2016|R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|414|1692|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||414||414|1692||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|9656|14413|lyfalmen|V0464|14413|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||9656||9656|14413||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|883|2338|lyfalmen|V0066|2338|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||883||883|2338||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|10966|16216|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||10966||10966|16216||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|3875|lyfalmen|V0285|3875|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||2000||2000|3875||2 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|21896|30395|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||21896||21896|30395||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|7298|11167|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7298||7298|11167||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|30407|41159|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||30407||30407|41159||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|60815|79620|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||60815||60815|79620||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|121631|156855|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||121631||121631|156855||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|1|0|1|BGB|0|1|0|100|DKK|117305|151475|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||117305||117305|151475||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|29681|40241|lyfalmen|||1|100|0|75,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||29681|40241||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3191|5514|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3191|5514||1 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|6668|10300|lyfalmen|V0409|10300|2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||6668||6668|10300||2 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3593|5278|lyfalmen|V0011|5278|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3019||3019|5278||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|2595|lyfalmen|V0313|2595|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1070||1070|2595||2 128034|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|10|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|1|100|XEU|577|1916|lyfalmen|V0206|1355|2|10|0|6,6700|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||577||577|1916||1 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|6366|9884|lyfalmen|V0279|2591|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6366||6366|9884||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|12497|23880|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||12497||12497|23880||1 128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4323|4282|lyfalmen|||2|56|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Memantín||2296||2296|4282||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1065|2588|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1065||1065|2588||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3514|5959|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3514||3514|5959||1 129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2223|lyfalmen|V0003|1648|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2223||2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|25047|34380|lyfalmen|V0282|3124|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||25047||25047|34380||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|296|1530|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||296||296|1530||1 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|1|0|0|0|0|WEH|0|0|0|100|XEU|19543|25063|lyfalmen|V0680|25063|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||17394||17394|25063||2 129291|A02BC0113|Omeprazol Sandoz|sþ-hylki|40|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|4659|2602|lyfalmen|V0001|2602|2|100|0|200,0000|Artasan ehf|Sandoz A/S|Ómeprazól||1075||1075|2602||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MAB|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Meda AB|Natríumhýdrógenkarbonat|||||2945||1 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|2894|5106|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2894||2894|5106||1 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|14788|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14788||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1891|3725|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1891||1891|3725||2 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|276192|349086|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||276192||276192|349086||1 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|14942|28518|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||14942||14942|28518||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1478|3157|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1478||1478|3157||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|9832|14655|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||9832|14655||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|45651|73589|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||45651|73589||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2710|4852|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2710|4852||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|382|1648|lyfalmen|||2|100|0|33,3333|Vistor hf|Meda AB|Fenýtóín||382||382|1648||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|602|1951|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||602||602|1951||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|802|2226|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||802||802|2226||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|888|2344|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||888||888|2344||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|3607|6087|lyfalmen|||2|28|0|14,0000|Alvogen|Alvogen|Galantamín||3607||3607|6087||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4561|2883|lyfalmen|V0581|2774|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1279||1279|2883||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2836|2883|lyfalmen|V0580|2774|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1279||1279|2883||1 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|408257|513337|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||408257||408257|513337|| 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|8702|13100|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||8702||8702|13100||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|MAB|0|0|1|100|SEK|1201|2775|lyfalmen|||2|100|0|25,0000|Vistor hf|Meda AB|Kódein||1201||1201|2775||1 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5641|8886|lyfalmen|V0681|8112|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5641||5641|8886||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5697|10979|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||5697|10979||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0335|3100|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|508|1821|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||508||508|1821||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|þpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1034|2545|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1034||1034|2545||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|21978|30498|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||21978||21978|30498||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|29223|39662|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||29223||29223|39662||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|39737|52960|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||39737|52960||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|SPR|0|0|0|100|DKK|236475|299689|lyfsjukr|||1|2|0||Lyfjaver ehf|ViroPharma SPRL|C1 hemill||236475||236475|299689||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|7372|11269|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||7372||7372|11269||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|5779|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||5779||1 133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1810|lyfalmen|V0329|1810|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2626|4737|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2626||2626|4737||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3408|lyfalmen|V0333|3408|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3408||2 134019|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0334|3100|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 134085|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0335|3100|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2835|5024|lyfalmen|V0378|3878|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2835||2835|5024||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7638|11635|lyfalmen|V0378|11635|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7638||7638|11635||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|2342|4346|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||2342||2342|4346||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|51832|68258|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||51832||51832|68258||1 134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|BAB|0|0|1|100|DKK|||lyfalmen|V0362|2018|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8173||2 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|104044|134982|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||104044||104044|134982||2 134906|A02BC0307|Gasterix|sþ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4200|2912|lyfalmen|V0007|2912|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Lansóprazól||1300||1300|2912||2 134939|A02BC0307|Gasterix|sþ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2560|3875|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3875||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|354313|446246|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer Pharma AG|Riociguatum||354313||354313|446246||1 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|9066|13601|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9066||9066|13601||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|817|2247|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||817||817|2247||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1183|2750|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1183||1183|2750||1 135907|M01AH0107|Celecoxib LYFIS|hylki|200|mg|30|stk|1|þpakki||M01AH01|01.10.2015||R|1|0|0|0|G|0|LYF|0|0|1|100|IKR|3000|3049|lyfalmen|V0037|3049|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Celekoxíb||1400||1400|3049||2 136168|G03AB0401|Trinovum|töflur|||63|stk|1|þpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1034|2545|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1034||1034|2545||1 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|34956|46913|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||34956||34956|46913||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|5608|8841|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||5608||5608|8841||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|60024|78619|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||60024||60024|78619||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2790|4962|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||2790||2790|4962||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|395|1550|lyfalmen|V0307|1550|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||311||311|1550||2 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól|||||||1 137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5110|8156|lyfsjukr|||2|20|0||Alvogen HS|Hospira UK Ltd.|Oxalíplatín||5110||5110|8156||1 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|39000|43174|lyfalmen|V0261|43174|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||32000||32000|43174||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|18594|26715|lyfsjukr|||2|25|0|1,2500|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||18594||18594|26715||1 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5406|8563|lyfsjukr|||2|10|0|0,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5406||5406|8563||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|4721|7620|lyfsjukr|||2|10|0|1,0000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4721||4721|7620||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5336|8467|lyfsjukr|||2|10|0|1,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5336||5336|8467||1 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|12521|6613|lyfalmen|V0689|6119|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3989||3989|6613||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2628|4739|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2628||2628|4739||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1435|3097|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1435||1435|3097||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14811|21508|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||14811||14811|21508||1 138619|L01BA0110|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3151|5459|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3151||3151|5459||2 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|2396|4409|lyfalmen|V0373|4409|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2388||2388|4409||1 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|106101|137540|lyfsjukr|||1|56|0||Celgene AB|Celgene Europe Limited|Apremilast||106101||106101|137540||2 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4665||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1065|2588|lyfalmen|V0266|2066|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1065||1065|2588||1 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|13886|20235|lyfalmen|V0588|20235|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||13886||13886|20235||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|9591|14323|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9591||9591|14323||1 140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|5099|8140|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5099||5099|8140||2 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|66131|125634|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||66131||66131|125634||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|50276|66290|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||50276||50276|66290||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1046|2562|lyfalmen|V0413|2347|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1046||1046|2562||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3191|5514|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3191|5514||1 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3380|5774|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3380||3380|5774||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|14058|20472|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||14058|20472||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|37616|50277|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||37616||37616|50277||3 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3478|5909|lyfalmen|V0193|4778|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3478|5909||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|778|2193|lyfalmen|||2|28|0|7,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||778||778|2193||1 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3044||1 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5194|8271|lyfalmen|V0492|8271|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||5194||5194|8271||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5722|8998|lyfalmen|V0267|3936|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5722||5722|8998||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1594|3236|lyfalmen|V0127|3024|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1536||1536|3236||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|20014|28014|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||20014|28014||5 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3320|3758|lyfalmen|V0384|2897|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3758||2 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|699|2084|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||699||699|2084||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2329|4328|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2329||2329|4328||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1750|3531|lyfalmen|||2|100|0|16,6700|LYFIS ehf|ratiopharm GmbH|Carvedílól||1750||1750|3531||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16444||1 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1443|3108|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1443||1443|3108||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1951|3808|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1951||1951|3808||1 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|14249|9511|lyfalmen|V0687|9511|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6095||6095|9511||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|3326|5700|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3326||3326|5700|| 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|504|1623|lyfalmen|V0542|1623|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||364||364|1623||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|930|2402|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíð||930||930|2402||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1176|2741|lyfalmen|V0173|2303|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1176||1176|2741||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5683|8944|lyfalmen|V0387|8081|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5683||5683|8944||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5747|9032|lyfalmen|V0386|7256|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5747||5747|9032||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|504|1816|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||504||504|1816||1 143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1399|2916|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1303||1303|2916||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2340|4343|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2340||2340|4343||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1484|3165|lyfalmen|V0174|2613|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1484||1484|3165||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1796|3594|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1796||1796|3594||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|23915|32948|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23915||23915|32948||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|59939|78512|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||59939||59939|78512||1 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3242|5584|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3242||3242|5584||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|39965|53248|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||39965||39965|53248||1 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|8795|12739|lyfalmen|V0587|12739|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||8440||8440|12739||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|19983|28627|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||19983||19983|28627||1 144808|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|527|1848|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||527||527|1848||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|67538|88123|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||67538||67538|88123||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1543|3033|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1543||1543|3033||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2340|4599|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2340||2340|4599||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3601|7002|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3601||3601|7002||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5022|9698|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5022||5022|9698||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9024|13543|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9024||9024|13543||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|4977|7973|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||4977||4977|7973||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|26293|35956|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||26293||26293|35956||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|26587|36328|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||26587|36328||1 146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|7394|11299|lyfsjukr|||2|25|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||7394||7394|11299||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|15346|22244|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||15346||15346|22244||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|287|1517|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||287||287|1517||1 147263|L01BC0102|Arabine|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.09.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2756|4916|lyfsjukr|||2|20|0||Alvogen|Hospira Nordic AB|Cýtarabín||||2756|4916||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4559|7333|lyfalmen|V0691|7333|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4512||4512|7333||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2994||1 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|96892|125250|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||96892||96892|125250||2 148238|M01AH0107|Celecoxib LYFIS|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.10.2015||R|1|0|0|0|G|0|LYF|0|0|1|100|IKR|9436|6628|lyfalmen|V0196|6628|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Celekoxíb||4000||4000|6628||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1040|2305|lyfalmen|V0577|2305|2|20|0|6,6667|Alvogen|Orion Corporation|Pívmecillínam||859||859|2305||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1547|3251|lyfalmen|||2|30|0|10,0000|Alvogen|Orion Corporation|Pívmecillínam||1547||1547|3251||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|5318|8088|lyfalmen|||2|100|0|33,3300|Alvogen|Orion Corporation|Pívmecillínam||5061||5061|8088||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|GBP|57122|74949|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||57122||57122|74949||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|GBP|57122|74949|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||57122||57122|74949||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|373|1546|lyfalmen|V0601|1546|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||308||308|1546||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|735|2134|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||735||735|2134||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81241|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81241||5 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|11806|17372|lyfsjukr|||2|10|0||Alvogen|Hospira Nordic AB|Vínkristín||11806||11806|17372||1 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|25255|34643|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||25255||25255|34643||1 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3131|6111|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3131||3131|6111||2 149525|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.04.2015|31.07.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2464|4843|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2464|4843||2 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2118|4037|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2118||2118|4037||1 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4267|6995|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||4267||4267|6995||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|38180|50991|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||38180|50991||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|5514|8712|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5514||5514|8712||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|833|2269|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||833||833|2269||1 151250|J05AX6701|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AX67|01.10.2015||R|0|0|0|1|0|1|ABV|0|1|0|100|DKK|1704219|2125151|lyfsjukr|||1|56|0||Vistor hf|AbbVie Ltd.|Ombitasvir, paritaprevir og ritonavir||1704219||1704219|2125151||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|10954|16199|lyfalmen|V0606|4865|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||10954|16199||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|36063|48313|lyfalmen|V0607|10445|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||36063||36063|48313||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|365|1625|lyfalmen|V0633|1554|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||365||365|1625||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4062|6713|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4062|6713||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4346|3293|lyfalmen|V0148|3083|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1577||1577|3293||2 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|1064|2587|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1064||1064|2587||1 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1768|3475|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1768|3475||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1351|2982|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1351||1351|2982||1 151975|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|2801|lyfalmen|V0006|2774|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1220||1220|2801||2 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1007|2126|lyfalmen|V0050|2126|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||729||729|2126||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1646|3388|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1646||1646|3388||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|1909|3725|lyfalmen|V0123|3725|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||1891||1891|3725||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2635|4749|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2635||2635|4749||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4229|6943|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4229||4229|6943||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|7732|11765|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||7732||7732|11765||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152636|A02BC0113|Omeprazol Sandoz|sþ-hylki|10|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3076|4545|lyfalmen|V0002|4545|2|100|0|50,0000|Artasan ehf|Sandoz A/S|Ómeprazól||2487||2487|4545||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2086|lyfalmen|V0033|1876|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2086||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|16222|23450|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||16222||16222|23450||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|4701|lyfalmen|V0182|4496|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||2600||2600|4701||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|10757|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||7000||7000|10757||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|990|2485|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||990||990|2485||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1450|3118|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1450||1450|3118||1 153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1176|2223|lyfalmen|V0444|2223|2|5|0|25,0000|LYFIS ehf|ratiopharm GmbH|Brinzólamíð||800||800|2223||2 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|28636|38920|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||28636|38920||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1831|3642|lyfalmen|V0561|3002|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1831||1831|3642||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1281|2885|lyfalmen|V0560|2804|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1281||1281|2885||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|2197|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3568||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|185170|235880|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||185170||185170|235880||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|621|1977|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||621|1977||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|26168|35798|lyfalmen|V0452|35798|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||26168||26168|35798||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3482|5915|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3482||3482|5915||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|555|1886|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||555||555|1886||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|943|2420|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||943||943|2420||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|550|1879|lyfalmen|||2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||550||550|1879||2 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|20821|22171|lyfalmen|V0183|22171|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||15293||15293|22171||1 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|8132|12315|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||8132||8132|12315||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|912|2377|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||912||912|2377||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17528|25248|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||17528||17528|25248||1 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20027|28031|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||20027||20027|28031||1 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25053|34388|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||25053||25053|34388||1 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22857|31610|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||22857||22857|31610||1 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23169|32005|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||23169||23169|32005||1 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28081|38218|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||28081||28081|38218||1 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|14944|21691|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||14944||14944|21691||1 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2845|5038|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2845||2845|5038||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22083|30631|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||22083||22083|30631||1 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1314|2931|lyfalmen|V0336|2292|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1314||1314|2931||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3023|3038|lyfalmen|V0334|3038|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1392||1392|3038||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5996|3038|lyfalmen|V0335|3038|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1392||1392|3038||1 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2561|2909|lyfalmen|V0604|2909|2|30|0|15,0000|LYFIS ehf|ratiopharm GmbH|Memantín||1298||1298|2909||2 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1523|1717|lyfalmen|V0247|1717|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||432||432|1717||1 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2751|3216|lyfalmen|V0248|3216|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1521||1521|3216||1 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|4962|3494|lyfalmen|V0249|3494|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1723||1723|3494||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15285|22160|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15285||15285|22160||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1340|2967|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1340||1340|2967||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2223|lyfalmen|V0466|1777|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2223||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10450|6607|lyfalmen|V0253|5930|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3985||3985|6607||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|578|1918|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||578||578|1918||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1444|2585|lyfalmen|V0590|2585|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1063||1063|2585||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|5304|8423|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5304||5304|8423||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|16000|20392|lyfalmen|V0383|20392|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||14000||14000|20392||2 156439|L04AC1001|Cosentyx|stl|150|mg|2|áf.spr|1|þpakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|141400|155981|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||120928||120928|155981||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4654|7528|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4654||4654|7528||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|5210|8293|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5210||5210|8293||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|351|1605|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||351||351|1605||1 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|8467|12776|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||8467||8467|12776||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|607|1958|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||607||607|1958||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|10143|19414|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||10143||10143|19414||2 157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2458|4237|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2458||2458|4237||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|36848|49306|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||36848|49306||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1316|2934|lyfalmen|V0239|2934|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1316||1316|2934||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|5799|9104|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5799||5799|9104||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|879|2332|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||879|2332||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|23554|32492|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||23554|32492||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|821|2252|lyfalmen|V0239|1467|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||821||821|2252||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|39275|52376|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||39275|52376||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|51694|68083|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||51694||51694|68083||1 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|835|1944|lyfalmen|V0469|1944|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||597||597|1944||2 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1820|3236|lyfalmen|V0219|3236|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1536||1536|3236||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3120|5366|lyfalmen|V0220|5366|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3083||3083|5366||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4479|6862|lyfalmen|V0221|6859|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4170||4170|6862||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4856|7436|lyfalmen|V0223|7436|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4587||4587|7436||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3218|2774|lyfalmen|V0581|2774|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2774||2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|21493|lyfalmen|V0421|21493|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||14800||14800|21493||2 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|1|0|1|IPC|0|1|0|100|SEK|123028|158592|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||123028||123028|158592||1 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|428|1711|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||428||428|1711||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1298|2909|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1298||1298|2909||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|118463|152915|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||118463||118463|152915||1 159845|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|100|stk|1|þpakki||A02BC05|01.10.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|8980|5114|lyfalmen|V0012|5114|2|100|0|133,3300|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||2900||2900|5114||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3629|7055|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3629||3629|7055||2 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5300|2499|lyfalmen|V0010|2057|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2499||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|6510|4906|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2749||2749|4906||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2537|4614|lyfalmen|V0191|4614|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2537||2537|4614||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|705|2093|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||705||705|2093||1 160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|3208|5538|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||3208||3208|5538||1 160692|N03AX1607|Pregabalin Alvogen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.02.2016|31.07.2016|R|1|0|0|0|0|0|IPC|0|0|0|100|XEU|4091|6753|lyfalmen|||2|56|0|14,0000|Alvogen|Alvogen IPco S.á.r.l.|Pregabalín||||4091|6753||1 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1039|2552|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1039||1039|2552||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|590|1934|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||590||590|1934||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|797|2219|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||797||797|2219||1 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1115|2657|lyfalmen|V0169|2014|1|14|0|12,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1115||1115|2657||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2195|4143|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2195||2195|4143||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|525|1845|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||525||525|1845||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|53297|70111|lyfalmen|V0452|35798|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||53297||53297|70111||1 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|5626|8866|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||5626|8866||2 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|10627|15749|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||10627||10627|15749||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|126734|163202|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||126734||126734|163202||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|472026|592648|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||472026||472026|592648||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4687|lyfalmen|V0020|4687|2|180|0|90,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||2590||2590|4687||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1749|3530|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1749||1749|3530||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|4886|9440|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||4886||4886|9440||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2338|2646|lyfalmen|V0041|2646|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1107||1107|2646||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|445|1728|lyfalmen|V0500|1587|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1728||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2148|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2148||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|1948|lyfalmen|V0502|1706|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||600||600|1948||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1711|lyfalmen|V0108|1711|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1711||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1841|lyfalmen|V0109|1841|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1841||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2174|lyfalmen|V0110|2174|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2174||2 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1291|2899|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1291||1291|2899||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|9132|13691|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||9132||9132|13691||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|1061|2583|lyfalmen|V0671|2325|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1061||1061|2583||1 163239|L01BA0110|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3597|6073|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3597||3597|6073||2 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1189|2759|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1189||1189|2759||1 163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1514|3206|lyfalmen|V0213|3206|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1514||1514|3206||2 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5463|8641|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5463||5463|8641||1 163389|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.09.2015||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|10840|16042|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10840||10840|16042||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2252|4222|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2252||2252|4222||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|453736|569901|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||453736||453736|569901||2 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1710|3476|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1710||1710|3476||1 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|526|1714|lyfalmen|||2|30|0|20,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||430||430|1714||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|1450|2547|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm Oy|Íbúprófen||1035||1035|2547||2 164125|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3428|5840|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3428||3428|5840||1 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|34180|45932|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||34180||34180|45932||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8316|15948|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||8316||8316|15948||1 164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóður|QA07XA91|01.03.2014|31.05.2016|R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|39141|74429|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||39141||39141|74429||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2437|4476|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2437|4476||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8034|12180|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||8034||8034|12180||2 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|354313|446246|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer Pharma AG|Riociguatum||354313||354313|446246||1 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|953|2434|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||953||953|2434||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1171|2734|lyfalmen|V0314|2734|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1171||1171|2734||2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|5110|8156|lyfalmen|V0014|8156|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5110|8156||2 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|1316|2934|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||1316||1316|2934||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|5978|11512|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||5978||5978|11512||2 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|156922|200747|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||156922||156922|200747||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25709|35217|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||25709||25709|35217||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37433|50046|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||37433||37433|50046||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|570|1907|lyfalmen|V0506|1907|1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||570||570|1907||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|165|1349|lyfalmen|V0505|1349|1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||165||165|1349||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|175889|224337|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer Pharma AG|Riociguatum||175889||175889|224337||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3622|6108|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3622||3622|6108||1 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|49938|65862|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||49938||49938|65862||2 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|5172|9983|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||5172|9983||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4052|7858|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4052|7858||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|378446|476261|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||378446||378446|476261||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1311|2927|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1311||1311|2927||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|13512|19720|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||13512||13512|19720||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1806|2556|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1042||1042|2556||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3419|5828|lyfalmen|V0428|5828|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3419||3419|5828||2 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|0|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|388|1656|lyfalmen|V0333|795|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||388||388|1656||1 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1551|2453|lyfalmen|V0005|2344|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||967||967|2453||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|153425|196398|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||153425||153425|196398||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|417|1696|lyfalmen|V0119|1673|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||417|1696||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|3696|lyfalmen|V0007|2854|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3696||1 168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|2970|5210|lyfalmen|V0458|3080|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||2970||2970|5210||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2416|4448|lyfalmen|V0621|1239|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||2416||2416|4448||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2012|3892|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2012||2012|3892||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2155|4088|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2155||2155|4088||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2367|4380|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2367||2367|4380||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2676|4805|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2676||2676|4805||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2818|5001|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2818||2818|5001||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2643|4760|lyfalmen|V0240|4760|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2643||2643|4760||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4879|7838|lyfalmen|V0433|7836|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||4879||4879|7838||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|25196|34569|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||25196||25196|34569||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|11023|6613|lyfalmen|V0688|6132|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3989||3989|6613||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|125979|162263|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||125979||125979|162263||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|17866|25713|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||17866||17866|25713||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|4668|7547|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||4668||4668|7547||1 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|1168|2730|lyfalmen|V0411|2730|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1168||1168|2730||1 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|647|2013|lyfalmen|V0177|2013|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||647||647|2013||1 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|638|2000|lyfalmen|V0418|2000|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||638||638|2000||1 169784|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|393|1663|lyfalmen|V0176|1663|2|10|0|2,5000|Alvogen|Alvogen ehf|Cíprófloxacín||393||393|1663||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2402|4428|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2402||2402|4428||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2585|4680|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2585||2585|4680||1 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|17184|24774|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||17184|24774||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|42551|56519|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||42551|56519||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|4901|7868|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4901||4901|7868||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|85103|110339|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||85103||85103|110339||2 170486|C10A00001|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|181716|231584|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||181716|231584||1 170489|G04BD0705|Tolterodine Sandoz|forðahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2993|5242|lyfalmen|V0618|5242|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||2993|5242||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|11699|17225|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||11699||11699|17225||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1965|3827|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||1965||1965|3827||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|9886|14729|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||9886||9886|14729||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|23782|32780|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||23782||23782|32780||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|35673|47820|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||35673||35673|47820||1 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|30988|41894|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||30988|41894||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2903|2709|lyfalmen|V0203|2709|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1153||1153|2709||1 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|49758|65635|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||49758||49758|65635||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2372|4662|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2372||2372|4662||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2978|5221|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||2978||2978|5221||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3006|5260|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3006||3006|5260||1 171765|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.04.2015|31.07.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1291|2537|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1291|2537||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2552|4635|lyfalmen|V0247|1717|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2552||2552|4635||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4434|7225|lyfalmen|V0248|3216|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4434||4434|7225||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|38795|51769|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||38795||38795|51769||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|25864|35414|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||25864||25864|35414||2 172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|98074|126745|lyfalmen|V0484|126745|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||||98074|126745||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|8208|12420|lyfalmen|V0249|3494|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8208||8208|12420||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|14938|21683|lyfalmen|V0252|13217|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||14938||14938|21683||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|59487|77940|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||59487||59487|77940||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33649|lyfalmen|||3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33649||2 172567|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|16510|28457|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||16510||16510|28457||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19480|27934|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||19480||19480|27934||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|9032|13554|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||9032||9032|13554||1 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5301|8418|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||5301||5301|8418||2 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|9858|14691|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||9858||9858|14691||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2354|2109|lyfalmen|V0284|2088|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||717||717|2109||1 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|17087|24641|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||17087||17087|24641||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|530215|665019|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||530215||530215|665019||1 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|21998|30524|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||21998||21998|30524||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|341|1592|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||341||341|1592||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9204|10831|lyfalmen|V0118|10811|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||7054||7054|10831||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2788|4960|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||2788||2788|4960||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3384||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|4774|7693|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||4774||4774|7693||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|11463|16900|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||11463||11463|16900||1 173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|36053|31030|lyfalmen|V0684|31030|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||22398||22398|31030||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|12512|18344|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||12512||12512|18344||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1697|3458|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1697||1697|3458||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|509|1823|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||509||509|1823||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|519|1837|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||519||519|1837||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1241|2830|lyfalmen|V0368|2262|1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1241||1241|2830||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5114|lyfalmen|||2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5114|| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|4114|6785|lyfalmen|V0368|6785|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||4114||4114|6785||1 174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|256759|324916|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||256759||256759|324916||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|1262|2859|lyfalmen|||2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|2859||2 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|7393|6713|lyfalmen|V0389|6713|1|10|0|1,2500|Vistor hf|Novartis Healthcare A/S|Ondansetrón||4062||4062|6713||1 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4621|8937|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4621||4621|8937||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|13751|20049|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||13751|20049||1 175600|G03AA0904|Denise|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|1477|2361|lyfalmen|V0065|2318|2|63|0|84,0000|LYFIS ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||900||900|2361||2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|2220|2211|lyfalmen|V0033|1876|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||791||791|2211||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|4312|7057|lyfalmen|V0278|2525|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||4312||4312|7057||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3607|6087|lyfalmen|V0429|6087|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3607||3607|6087||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|2390|4412|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2390||2390|4412||1 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5713|11009|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5713||5713|11009||2 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7379|11279|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7379||7379|11279||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|715|2106|lyfalmen|V0231|2014|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||715||715|2106||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|3967|7697|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||3967||3967|7697||2 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|6534|10116|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||6534||6534|10116||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|29681|40241|lyfalmen|||1|100|0|50,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||29681||29681|40241||2 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|856045|1070260|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||856045||856045|1070260||1 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4998|3669|lyfalmen|V0320|3669|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1850||1850|3669||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|122827|158342|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||122827||122827|158342||1 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|8379|12655|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||8379|12655||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15497|22452|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15497||15497|22452||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|101126|131352|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||101126||101126|131352||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4296|7035|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4296||4296|7035||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2251|3426|lyfalmen|V0148|3426|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1674||1674|3426||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|691|2073|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||691||691|2073||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8474|12786|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||8474||8474|12786||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5304|8423|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5304||5304|8423||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5651||2 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|10417|15460|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||10417||10417|15460||1 182435|A10BB0903|Gliclazide LYFIS|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|4701|lyfalmen|V0020|4687|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||2600||2600|4701||2 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|14613|21236|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||14613||14613|21236||2 182707|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.2016||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4645|8006|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||||4645|8006||2 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|17877|34087|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||17877|34087||2 182862|N04BC0507|Pramipexole Sandoz|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|29959|31872|lyfalmen|V0636|31872|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||23064||23064|31872||1 182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016||R|0|1|0|1|0|1|AHL|0|0|0|100|IKR|9983|4457|lyfsjukr|||2|5|0|1,0000|Alvogen|Accord Healthcare Limited|Zoledronsýra||2423||2423|4457||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3262|5612|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3262||3262|5612||1 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4673|9036|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||4673||4673|9036||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1650|2270|lyfalmen|V0234|1383|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||834||834|2270||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5017|8028|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5017|8028||1 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|6035|11620|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||6035||6035|11620||2 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1030|2540|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Flúdrókortisón||1030||1030|2540||1 184046|L01XE2701|IMBRUVICA|filmhtfl|140|mg|90|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|747852|935698|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||747852|935698||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|585|1927|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||585||585|1927||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1517|2358|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||898||898|2358||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|3065|5341|lyfalmen|V0017|5341|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3065|5341||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|46451|61452|lyfalmen|V0185|12977|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||46451||46451|61452||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1211|2789|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1211||1211|2789||1 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|LYFIS ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2 186052|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|20|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|1|100|XEU|1153|2709|lyfalmen|V0206|2709|2|20|0|13,3400|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1153||1153|2709||1 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|12822|lyfalmen|V0419|12822|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|12822||1 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|834|2270|lyfalmen|V0597|2269|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||834||834|2270||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|11374|10658|lyfalmen|V0607|10658|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Memantín||6928||6928|10658||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5400|8555|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5400||5400|8555||1 187032|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|100|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|1|0|0|0|AGP|0|0|1|100|XEU|3445|5864|lyfalmen|V0210|5864|2|100|0|66,6600|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||3445||3445|5864||1 187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|3935|6171|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3668||3668|6171||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4507|lyfalmen|V0462|4507|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4507||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5054|8711|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5054||5054|8711||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|3739|6269|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||3739||3739|6269||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2632||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|66893|87307|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||66893||66893|87307||1 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1362|1918|lyfalmen|V0621|1239|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||578||578|1918||1 188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TBB|0|0|0|100|NOK|15371|22279|lyfalmen|V0726|19537|1|28|0|28,0000|Vistor hf|Teva B.V.|Rasagilín||15371||15371|22279||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2536|4613|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2536||2536|4613||1 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|5265|8369|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||5265||5265|8369||1 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3581|6051|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||||3581|6051||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|1|0|1|PSA|0|0|0|100|DKK|8366|12637|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||8366||8366|12637||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|39279|52381|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||39279||39279|52381||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6205|9663|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6205||6205|9663||1 189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|4608|7465|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4608||4608|7465||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2451|4496|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2451||2451|4496||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|890|2347|lyfalmen|V0413|2347|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||890||890|2347||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|431|1715|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||431||431|1715||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|399|1671|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||399||399|1671||1 190000|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3804|3623|lyfalmen|V0693|3424|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||1817||1817|3623||2 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1480|3159|lyfalmen|||1|90|0|45,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1480||1480|3159||1 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|234|1444|lyfalmen|||2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||234||234|1444||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|6693|10334|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||6693|10334||2 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012|31.07.2016|R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|2086|3993|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||2086||2086|3993||1 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|þpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1317|2935|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1317||1317|2935||1 190809|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|20505|28635|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||20505||20505|28635||1 190894|N04BC0507|Pramipexole Sandoz|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.09.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|11434|14992|lyfalmen|V0635|14992|2|100|0|20,8000|Artasan ehf|Sandoz A/S|Pramipexól||10077||10077|14992||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3435||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3347|5729|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3347||3347|5729||1 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6058|6721|lyfalmen|V0117|6630|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||4068||4068|6721||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3154|5463|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3154||3154|5463||1 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3290|5651|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3290||3290|5651||1 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|452|1744|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||452||452|1744||1 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|20549|10926|lyfalmen|V0689|10926|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||7123||7123|10926||1 192296|H05BX0103|Cinacalcet Sandoz|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|36683|43983|lyfalmen|V0721|41928|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Cinacalcet||32639||32639|43983||1 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3315|5685|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3315||3315|5685||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|4148|6087|lyfalmen|V0429|6087|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3607||3607|6087||1 192558|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|570|1907|lyfalmen|V0506|1907|1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||570||570|1907||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1393|3040|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1393||1393|3040||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5661|8914|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5661||5661|8914||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6460|10014|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6460||6460|10014||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|IRE|0|1|0|100|XEU|152579|195346|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||152579||152579|195346||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2356|2270|lyfalmen|V0233|1757|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||834||834|2270||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|839|2277|lyfalmen|V0447|2024|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||839||839|2277||1 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|20153|28190|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||20153||20153|28190||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2384||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|37982|61227|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||37982||37982|61227||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1948|lyfalmen|V0556|1907|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1948||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4734|9152|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4734||4734|9152||2 194545|N03AX1609|Pregabalin Sandoz GmbH|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|8640|7320|lyfalmen|||2|56|0|56,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||4503||4503|7320|31.7.2016|1 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5620|5278|lyfalmen|V0012|5114|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3019||3019|5278||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1492|3176|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1492||1492|3176||2 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||12944||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|52308|68860|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||52308||52308|68860||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|121826|157097|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||121826||121826|157097||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|873|2324|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||873||873|2324||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|593|1938|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||593||593|1938||1 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|315|1556|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Fenýlprópanólamín||315||315|1556||1 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|667|2040|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB|Fenýlprópanólamín||667||667|2040||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1907|3747|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||1907||1907|3747||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1681|3436|lyfalmen|||2|100|0|75,0000|LYFIS ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3436||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|6540|10124|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||6540||6540|10124||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|19090|27398|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||19090|27398||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|564|1673|lyfalmen|V0119|1673|2|100|0|25,0000|LYFIS ehf|ratiopharm GmbH|Allópúrinol||400||400|1673||2 197272|N03AX1607|Pregabalin Alvogen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016|31.07.2016|R|1|0|0|0|0|0|IPC|0|0|0|100|XEU|6362|9879|lyfalmen|||2|56|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Pregabalín||||6362|9879||1 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|1|0|1|SCO|0|1|0|100|XEU|54841|72064|lyfsjukr|||2|1|0|26,6700|Scope Pharma ehf|Hospira UK Limited|Infliximab||54841||54841|72064||1 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|738|2138|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||738||738|2138||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2415|4446|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2415||2415|4446||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1488|3170|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1488||1488|3170||1 197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|188950|240581|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||188950||188950|240581||1 198220|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.04.2015|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7104|13648|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7104||7104|13648||2 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2212|3049|lyfalmen|V0069|3035|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||1400||1400|3049||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6180|9628|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6180||6180|9628||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|31184|42142|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||31184||31184|42142||1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|545|1872|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||545||545|1872||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|81111|105290|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||81111|105290||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4021|6657|lyfalmen|V0126|6657|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4021||4021|6657||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|45992|60871|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||45992||45992|60871||2 199915|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|áfspr||QP52AF02|01.04.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1062|1830|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1062||1062|1830||2 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2223665|2771197|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2223665||2223665|2771197||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|539|1864|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||539||539|1864||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|28553|54341|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||28553||28553|54341||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1425|2789|lyfalmen|||2|20|0|7,5000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2789||2 371058|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.06.2016||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|5779|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||5779||1 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|8119|12297|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||8119||8119|12297||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8869||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3328|5703|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3328||3328|5703||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3001|5253|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3001||3001|5253||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|APP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Artasan ehf|Aspen Pharma Trading Limited|Estríól|||||2366||1 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4935|lyfalmen|V0482|4935|2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4935||2 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|7507|11455|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||7507||7507|11455||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|111272|143971|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||111272||111272|143971||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3588|6061|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3588||3588|6061||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4309|7053|lyfalmen|V0436|7053|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4309||4309|7053||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|5512|8709|lyfalmen|V0437|8709|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5512||5512|8709||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|5449|8139|lyfalmen|V0420|4824|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||5098||5098|8139||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|382|1484|lyfalmen|V0541|1484|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||263||263|1484||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1361|2995|lyfalmen|V0126|1664|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1361||1361|2995||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|316057|398666|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||316057||316057|398666||1 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|214011|271750|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||214011||214011|271750||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|459|1754|lyfalmen|V0500|1587|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||459||459|1754||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5038|8057|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5038||5038|8057||1 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6903|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6903||2 374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|17910|25774|lyfalmen|V0422|25774|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||17910||17910|25774||2 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3299|5663|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3299||3299|5663||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|10007|14896|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||10007||10007|14896||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3916|6512|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||3916||3916|6512||2 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5994|9372|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5994||5994|9372||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7074|10859|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7074||7074|10859||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|8284|12524|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8284||8284|12524||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|9198|12111|lyfalmen|V0383|10196|2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7984||7984|12111||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|25204|34579|lyfalmen|V0459|34579|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||25204||25204|34579||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|5813|9123|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||5813||5813|9123||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|15602|22597|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||15602||15602|22597||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|80150|104074|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||80150||80150|104074||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|750842|939417|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||750842||750842|939417||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|10960|18891|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10960||10960|18891||2 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|9692|7194|lyfalmen|V0182|4496|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4411||4411|7194||1 378432|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|491051|616310|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||491051||491051|616310||2 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1704|3468|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1704||1704|3468||1 378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|6061|4719|lyfalmen|V0733|4719|2|56|0|28,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2613||2613|4719||2 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|14088|20513|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||14088||14088|20513|| 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1526|3223|lyfalmen|V0677|2508|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1526||1526|3223||1 379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7177|12370|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||7177||7177|12370||2 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|134756|173179|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||134756|173179||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|86368|111939|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||86368||86368|111939||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|113606|146874|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||113606||113606|146874||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|146714|188051|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||146714||146714|188051||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|124459|160372|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||124459||124459|160372||1 379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|5021|6295|lyfalmen|V0532|6295|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3758||3758|6295||1 379875|N05BA0105|Stesolid|innhl|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1788|3583|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1788||1788|3583||1 379883|N05BA0105|Stesolid|innhl|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|2322|4318|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2322||2322|4318||1 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|18011|25913|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||18011||18011|25913|| 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1400|3049|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1400||1400|3049||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|25463|34906|lyfalmen|V0653|34906|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||25463|34906||1 380486|N06AB0606|Sertralin Hexal|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1708|2463|lyfalmen|V0322|2463|2|100|0|100,0000|Artasan ehf|Hexal A/S|Sertralín||974||974|2463||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|25897|lyfalmen|V0195|25897|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||18000||18000|25897||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4733|5213|lyfalmen|V0606|5213|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2972||2972|5213||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2730|4705|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2730||2730|4705||2 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010|31.05.2016|R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|6958|4394|lyfalmen|||3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2377||2377|4394||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|38741|51700|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||38741|51700||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6886|9679|lyfalmen|V0533|9679|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||6217||6217|9679||1 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4347|7105|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4347||4347|7105||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5545|8754|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||5545||5545|8754||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1108|1910|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1108||1108|1910||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1405|3056|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1405||1405|3056||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|34156|45901|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||34156||34156|45901||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2499|lyfalmen|V0006|1553|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1000||1000|2499||2 384125|A10BX1201|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6051|9451|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6051||6051|9451||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6540|10124|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6540||6540|10124||1 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|364833|459330|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||364833||364833|459330||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011|31.05.2016|R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|5627|3521|lyfalmen|||3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1743||1743|3521||2 386465|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5484|9080|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||4696||4696|9080||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|24967|13232|lyfalmen|V0111|13232|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||8798||8798|13232||1 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|8123|12303|lyfalmen|V0670|12303|1|15|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||8123||8123|12303||1 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|128143|164954|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||128143||128143|164954||2 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|799|1992|lyfalmen|V0308|1992|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||632||632|1992||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|100340|130375|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||100340||100340|130375||1 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5791|9093|lyfalmen|||2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||5791||5791|9093||2 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|131301|168882|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||131301||131301|168882||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|2532|4607|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2532||2532|4607||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|2764|4927|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2764||2764|4927||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4975|7970|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4975||4975|7970||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1437|1777|lyfalmen|V0466|1777|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||476||476|1777||1 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|58161|62144|lyfalmen|V0722|62144|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||46998||46998|62144||2 388877|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2016||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|16510|28457|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||16510||16510|28457||2 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|8429|12724|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||8429||8429|12724||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2286|4269|lyfalmen|V0410|4269|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2286||2286|4269||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|1626|3360|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||1626||1626|3360||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|624|1981|lyfalmen|V0128|1981|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||624||624|1981||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|495|1804|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||495||495|1804||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|763|2172|lyfalmen|V0367|1561|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||763||763|2172||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010|31.05.2016|R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2461|2177|lyfalmen|||3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||766||766|2177||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2820|3936|lyfalmen|V0267|3936|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2044||2044|3936||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|40455|53868|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||40455|53868||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|APC|0|0|0|100|SEK|308|1241|lyfalmen|V0312|1241|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||86||86|1241||1 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|14825|21527|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14825||14825|21527||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|70956|92446|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||70956||70956|92446||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2527|4600|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2527||2527|4600||1 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6035|9429|lyfalmen|V0429|6087|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6035||6035|9429||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2391|4413|lyfalmen|V0037|2033|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2391||2391|4413||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|21066|29345|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||21066|29345||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|11668|17182|lyfalmen|V0196|6628|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||11668||11668|17182||1 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|231229|287773|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||226894||226894|287773||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1259996|1572662|lyfsjukr|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1259996|1572662||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|299346|241795|lyfsjukr|||2|30|0||Alvogen|Accord Healthcare Limited|Imatiníb||189926||189926|241795||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1970|3834|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||1970||1970|3834||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|554|1885|lyfalmen|V0545|1885|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||554||554|1885||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|169284|216122|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||169284||169284|216122||2 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|12504|18333|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12504||12504|18333||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3938|5366|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3083||3083|5366||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|40753|54245|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||40753||40753|54245||2 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|9250|13854|lyfalmen|V0388|13854|1|50|0|2,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||9250||9250|13854||1 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3099||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|61854|80934|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||61854||61854|80934||3 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|2011|3708|lyfalmen|V0669|3708|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1879||1879|3708||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|128637|164575|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||127838||127838|164575||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5533|8738|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5533||5533|8738||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3895|3462|lyfalmen|V0679|3462|2|98|0|196,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||1700||1700|3462||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|16240|23475|lyfalmen|V0356|23475|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||16240||16240|23475||3 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|155183|198584|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||155183||155183|198584||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4283|7017|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4283||4283|7017||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3504|5945|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3504||3504|5945||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|18428|35132|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||18428||18428|35132||2 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|2471|lyfalmen|V0006|1553|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||980||980|2471||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4867|9404|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||4867||4867|9404||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013|31.05.2016|R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1122|2667|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1122||1122|2667||1 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2263|2523|lyfalmen|V0250|2514|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||1018||1018|2523||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|24361|33513|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||24361||24361|33513||2 397520|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|2737|3737|lyfalmen|V0337|3737|2|30|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1900||1900|3737||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|4776|7696|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||4776||4776|7696||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|27463|37436|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||27463||27463|37436||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5452||1 398490|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|40|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|1|0|0|0|AGP|0|0|1|100|XEU|2276|4255|lyfalmen|V0210|2346|2|40|0|26,6800|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||2276||2276|4255||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3875|lyfalmen|V0012|2864|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3875||2 399039|L04AC0601|Nucala|sts|100|mg|1|hgl|1|pakki||L04AC06|01.06.2016||R|0|0|0|1|0|1|GSD|0|0|0|100|GBP|145063|185998|lyfsjukr|||1|1|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumabum||145063||145063|185998||1 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|27309|37241|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||27309|37241||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|239|1451|lyfalmen|V0225|1451|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||239||239|1451||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|2049|2355|lyfalmen|V0244|2047|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||896||896|2355||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|7807|11868|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7807||7807|11868||1 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|30988|41894|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||30988|41894||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|98680|127511|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||98680||98680|127511||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1058|2578|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1058||1058|2578||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4406|7187|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||4406||4406|7187||1 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|50531|66612|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||50531||50531|66612||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|193|1388|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||193||193|1388||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|333|1581|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||333||333|1581||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|167|1352|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||167||167|1352||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4665|7543|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||4665||4665|7543||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|163009|208318|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||163009||163009|208318||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2017|2529|lyfalmen|V0037|2033|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1022||1022|2529||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|8708|13108|lyfalmen|V0459|11526|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||8708||8708|13108||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|713|2104|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||713||713|2104||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1047|2563|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1047||1047|2563||1 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1275|2877|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1275||1275|2877||1 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|962101|1202164|lyfsjukr|||1|180|0||Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||962101||962101|1202164||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1720|3380|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1720||1720|3380|| 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12182|17890|lyfalmen|V0349|17890|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12182||12182|17890||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3324|lyfalmen|V0552|3201|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3324||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4446|8605|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4446||4446|8605||1 403524|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|24606|18465|lyfalmen|V0683|17377|2|56|0|37,3300|LYFIS ehf|ratiopharm GmbH|Aripiprazól||12600||12600|18465||2 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4760|7674|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||4760||4760|7674||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|31989|43160|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||31989|43160||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|926|2397|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||926||926|2397||1 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|16982|24496|lyfalmen|||1|6|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||16982||16982|24496||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||1885||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|56343|73963|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||56343||56343|73963||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1041|2555|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1041||1041|2555||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|592|1937|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||592||592|1937||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|8961|13456|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||8961||8961|13456||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1398|3046|lyfalmen|V0559|2143|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3046||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2737|4717|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2737||2737|4717||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2106||1 405535|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.11.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|10757|lyfalmen|V0197|10757|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7000||7000|10757||2 405589|J07BD5203|Priorix|sts|||0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1661|3408|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1661||1661|3408|31.5.2016|1 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|16607|23980|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||16607||16607|23980||1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|3158|5469|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3158||3158|5469||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15880|22979|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15880||15880|22979||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|424|1706|lyfalmen|V0502|1706|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||424||424|1706||1 406106|C10A00001|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|181716|231584|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||181716|231584||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17158|24738|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17158||17158|24738||1 406356|L01XX4601|Lynparza|hylki|50|mg|112|stk|4|glös||L01XX46|01.07.2016||R|0|0|0|1|0|0|AZA|0|0|0|100|SEK|688548|861941|lyfalmen|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||688548||688548|861941||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|51747|68150|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||51747||51747|68150||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|59641|78135|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||59641||59641|78135||1 406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1519|3213|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1519||1519|3213||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|62561|81828|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||62561||62561|81828||1 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|15990|30507|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||15990|30507||2 407923|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1320|2939|lyfalmen|V0319|2939|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1320||1320|2939||2 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|145|1322|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||145||145|1322||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|298|1532|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||298||298|1532||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|14724|21388|lyfalmen|||1|100|0|12,5000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||14724||14724|21388||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|4068|lyfalmen|V0020|2344|2|90|0|45,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||2140||2140|4068||1 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1689|2821|lyfalmen|V0310|2821|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1234||1234|2821||2 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1483|3163|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1483||1483|3163||1 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2836|4888|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2836||2836|4888||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|3332|5708|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3332||3332|5708||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3302|5667|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3302||3302|5667||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8831|13277|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||8831||8831|13277||1 409488|N03AX1609|Pregabalin Sandoz GmbH|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|3263|4588|lyfalmen|V0732|3107|2|56|0|14,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||2518||2518|4588||1 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|55135|72435|lyfalmen|V0728|72435|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||55135||55135|72435||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|53819|70771|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||53819||53819|70771||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7162|10980|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7162||7162|10980||1 409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5650|4150|lyfalmen|V0234|4150|2|18|0|36,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||2200||2200|4150||2 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|14930|21672|lyfalmen|V0651|21672|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||14930||14930|21672||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|6773|7147|lyfalmen|V0196|6628|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||4377||4377|7147||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|3189|5512|lyfalmen|V0620|4827|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||3189||3189|5512||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3206|4925|lyfalmen|V0093|4925|2|100|0|133,3300|Alvogen|Orion Corporation|Spírónólaktón||2763||2763|4925||1 410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|47718|63054|lyfsjukr|||2|1|0|26,6700|Alvogen|Celltrion Healthcare Hungary Kft.|Infliximab||47718||47718|63054||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|MAB|0|0|0|100|SEK|924|2394|lyfalmen|||1|20|0|6,2000|Vistor hf|Meda AB|Klórókín||924||924|2394||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RAT|0|0|0|100|IKR|820|2251|lyfalmen|||2|14|0|7,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||820||820|2251||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|552|1882|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||552||552|1882||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1441|3106|lyfalmen|V0557|3106|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1441||1441|3106||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RAT|0|0|1|100|XEU|417|1627|lyfalmen|V0230|1612|2|100|0|16,6667|LYFIS ehf|ratiopharm GmbH|Paracetamól||367||367|1627||2 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|2288|2566|lyfalmen|V0692|2460|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1049||1049|2566||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5612|8847|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5612||5612|8847||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|6204|6800|lyfalmen|V0624|6800|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4125||4125|6800||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|22073|30619|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||22073||22073|30619||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1916||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|5756|9045|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||5756||5756|9045||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|17774|24560|lyfalmen|V0183|22171|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||17028||17028|24560||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|2655|4777|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2655||2655|4777||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2685|5264|vetalmen|||0|100|0||Vistor hf|Merial|||2685||2685|5264||1 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|89020|115293|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||89020||89020|115293||2 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TBB|0|0|0|100|NOK|46409|61399|lyfalmen|V0711|59617|1|112|0|112,0000|Vistor hf|Teva B.V.|Rasagilín||46409||46409|61399||1 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|48179|63638|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||48179||48179|63638||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2774|4940|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2774||2774|4940||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2862|5061|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||2862||2862|5061||2 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|29134|39549|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||29134||29134|39549||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414097|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1810|1747|lyfalmen|V0247|1717|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||454||454|1747||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|13768|7043|lyfalmen|V0342|6902|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4302||4302|7043||2 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|123887|159661|lyfsjukr|||1|12|0|24,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||123887||123887|159661||1 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|3292|5653|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||3292||3292|5653||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1060|2581|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1060||1060|2581||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1459|3130|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1459||1459|3130||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|175889|224337|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer Pharma AG|Riociguatum||175889||175889|224337||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|7341|5930|lyfalmen|V0253|5930|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3493||3493|5930||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1643|3229|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1643||1643|3229||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8213|8574|lyfalmen|V0088|2308|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5414||5414|8574||1 416589|N03AX1604|Brieka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4367|3673|lyfalmen|V0686|3180|2|56|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1853||1853|3673||1 416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.10.2014||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|7729|lyfalmen|V0657|7729|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4800||4800|7729||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4025|6662|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||4025||4025|6662||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2497|4559|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2497||2497|4559||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|874|2325|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||874||874|2325||2 417674|J01DH0203|Meropenem Mylan|stl/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.07.2016||R|0|0|0|0|0|1|MHS|0|0|0|100|DKK|14095|20523|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Mylan Hospital AS|Meropenem||14095||14095|20523||2 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VII|0|0|0|100|GBP|36129|48397|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||36129||36129|48397||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|85966|111431|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuþáttur IX||85966||85966|111431||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|27876|37958|lyfalmen|V0460|37958|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||27876|37958||1 418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|0|0|AGP|0|0|0|100|XEU|25596|18386|lyfalmen|V0682|17377|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||12543||12543|18386||1 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|116495|150467|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||116495||116495|150467||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|5231|8322|lyfalmen|V0014|8156|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5231||5231|8322||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2388|4409|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2388||2388|4409||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6154|9593|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6154||6154|9593||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|43056|57158|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||43056||43056|57158||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5050|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5050||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|32527|43841|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||32527||32527|43841||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|628|1987|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||628||628|1987||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|10431|15479|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||10431||10431|15479||1 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|138016|177233|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||138016||138016|177233||2 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|2801|lyfalmen|V0006|2774|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1220||1220|2801||2 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|2242|3806|lyfalmen|V0479|3806|2|60|0|6,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1950||1950|3806||2 420568|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|960|1810|lyfalmen|V0023|1810|2|90|0|135,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1810||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|853|2296|lyfalmen|V0036|2295|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||853||853|2296||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|29274|55709|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||29274||29274|55709||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|XEU|1933|3422|lyfalmen|V0458|3422|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín||1671||1671|3422||2 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|524|1843|lyfalmen|V0596|1843|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||524||524|1843||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2763|4925|lyfalmen|V0049|3371|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2763||2763|4925||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4543|7375|lyfalmen|V0054|5528|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||4543||4543|7375||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|57873|75898|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||57873||57873|75898||2 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2795|4969|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2795||2795|4969||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|8265|12498|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8265||8265|12498||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2791|4964|lyfalmen|V0192|4126|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||2791|4964||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3875|lyfalmen|V0011|2956|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3875||2 423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|662|2033|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum með öðrum efnum||662||662|2033||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|18897|27132|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||18897||18897|27132||1 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|5084|8120|lyfalmen|V0373|4409|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5084||5084|8120||2 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|875|2327|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||875||875|2327||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3772|6314|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3772||3772|6314||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|3519|lyfalmen|V0213|3206|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||1741||1741|3519||1 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|14369|20900|lyfalmen|V0729|20900|1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||14369||14369|20900||2 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|549|1878|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||549||549|1878||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|717|2109|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||717||717|2109||1 426859|N03AX1407|Levetiracetam Teva|filmhtfl|250|mg|50|stk|1|þpakki||N03AX14|01.02.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|2129|1673|lyfalmen|V0515|1673|2|50|0|8,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||400||400|1673||2 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7353|11243|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7353||7353|11243||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|7020|10785|lyfalmen|V0658|10785|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||7020||7020|10785||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2892||1 427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|21080|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|21080||2 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1967||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|36848|49306|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||36848|49306||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|31520|lyfalmen|||3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31520||2 429093|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|glas|með skammtadælu|G03CA03|01.06.2016||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|1051|2569|lyfalmen|||2|64|0||Vistor hf|Takeda Oy|Estradíól||1051||1051|2569||1 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3211|5542|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3211||3211|5542||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|83541|108363|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||83541||83541|108363||1 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3924|6523|lyfalmen|V0093|4925|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3924||3924|6523||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|9234|13832|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9234||9234|13832||3 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|949|2428|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||949||949|2428||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1842|3658|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1842||1842|3658||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4426|7516|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||3872||3872|7516||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|83671|108528|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||83671||83671|108528||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|17292|5005|lyfalmen|V0184|5005|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2821||2821|5005||2 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|5622|8860|lyfalmen|V0730|8860|1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5622||5622|8860||2 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010|31.05.2016|R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2717|2373|lyfalmen|||3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||909||909|2373||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|20797|29005|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||20797|29005||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|858|2303|lyfalmen|V0173|2303|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||858||858|2303||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|957|2439|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||957||957|2439||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8479|12793|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||8479||8479|12793||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1223|2806|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1223|2806||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3758|6295|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3758||3758|6295||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17221|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17221||2 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|1|0|1|TPA|0|1|0|100|DKK|320826|404598|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||320826||320826|404598||1 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1794|3591|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1794||1794|3591||1 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|3669|lyfalmen|V0693|3669|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1850||1850|3669||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|14279|20776|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||14279|20776||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2698|5289|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||||2698|5289||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1801||1 433194|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1441|3106|lyfalmen|V0557|3106|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1441||1441|3106||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|9566|14289|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||9566||9566|14289||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2171|4110|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2171||2171|4110||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4888|7850|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||4888||4888|7850|30.6.2016|1 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|403391|507285|lyfsjukr|||1|96|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||403391||403391|507285||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|151697|194249|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||151697||151697|194249||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2013|30.06.2016|R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7305|5608|lyfalmen|||2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||3259||3259|5608||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5571|2243|lyfalmen|V0490|2243|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||814||814|2243||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|67585|103432|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||64164||64164|103432||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|7615|11603|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||7615||7615|11603||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3931|3600|lyfalmen|V0010|3600|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3600||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|729|2126|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||729||729|2126||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4597|7450|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4597||4597|7450||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4597|7450|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4597||4597|7450||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|8877|13341|lyfalmen|V0315|5330|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||8877||8877|13341||2 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|APC|0|0|1|100|IKR|||lyfalmen|V0458|3422|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3472||1 435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8793|lyfalmen|||2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8793|31.7.2016|2 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|188435|239940|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||188435||188435|239940||2 436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3060|5334|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||3060||3060|5334||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|37312|49893|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||37312||37312|49893||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|937|2412|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||937||937|2412||1 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|63359|82837|lyfsjukr|||1|60|0|0,7500|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||63359||63359|82837||3 436877|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011|31.05.2016|R|0|0|0|1|0|1|AST|0|1|0|100|DKK|215107|273113|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||215107||215107|273113||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|736|2135|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||736||736|2135||1 437223|V10XX0301|Xofigo|stl|1000|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|553449|693916|lyfsjukr|||1|6|0||Icepharma hf|Bayer Pharma AG|radium-223 dichloride||553449||553449|693916||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín||||||| 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|18216|26195|lyfalmen|V0712|26195|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||18216||18216|26195||1 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|1018|2523|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1018||1018|2523||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|54175|71221|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||54175||54175|71221||2 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1888|3721|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1888||1888|3721||1 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1244|2834|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1244||1244|2834||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|6982|4883|lyfalmen|V0605|4883|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||2732||2732|4883||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|209196|265761|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||209196||209196|265761||2 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|142345|182617|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||142345||142345|182617||1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5067|8096|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||5067||5067|8096||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18499|26584|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||18499||18499|26584||1 439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|49342|26254|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||18259||18259|26254||2 439680|A10BX0401|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BX04|01.10.2015||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|13898|20251|lyfalmen|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||13898||13898|20251||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2340|4343|lyfalmen|V0658|3595|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2340||2340|4343||1 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1066|2360|lyfalmen|V0163|2014|1|70|0|5,6000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||899||899|2360||1 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5410|lyfalmen|V0483|5410|2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5410||2 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1218|2799|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1218||1218|2799||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1922|3768|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1922||1922|3768||1 440731|N05AX1209|Aripiprazole Sandoz|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|30217|32107|lyfalmen|V0717|31791|2|56|0|112,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||23250||23250|32107||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|889|2346|lyfalmen|V0046|1965|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||889||889|2346||1 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|995|2492|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||995||995|2492||1 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|909|2373|lyfalmen|V0046|1965|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||909||909|2373||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|104604|135678|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||104604||104604|135678||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|907|2371|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||907||907|2371||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2302|2722|lyfalmen|V0283|2722|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1162||1162|2722||2 442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1804|1673|lyfalmen|V0731|1673|2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||400||400|1673||2 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|75062|97639|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||75062||75062|97639||3 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9876|14716|lyfalmen|V0460|12653|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||9876|14716||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2903|5118|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2903||2903|5118||1 443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1165|2290|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1165||1165|2290||2 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|23037|31838|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||23037||23037|31838||1 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|21263|29594|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||21263||21263|29594||1 443500|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3074|5353|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3074||3074|5353||1 443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|653|1901|lyfalmen|V0038|1901|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||566||566|1901||2 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1772|2947|lyfalmen|V0039|2947|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1326||1326|2947||2 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4838|lyfalmen|||2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4838||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|6935|10668|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||6935||6935|10668||1 444098|L01BA0110|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2658|4781|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2658||2658|4781||2 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|870|2320|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||870||870|2320||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|2703|4843|lyfalmen|V0061|2918|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2703||2703|4843||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|20724|28912|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||20724||20724|28912||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1864|3688|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1864||1864|3688||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|RPO|0|0|0|100|IKR|2018|3900|lyfalmen|||2|100|0|33,3300|LYFIS ehf|ratiopharm Oy|Betahistín||2018||2018|3900||2 444722|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.07.2016||R|0|0|0|0|G|0|AGP|0|0|1|100|XEU|1007|2508|lyfalmen|V0677|2508|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón||1007||1007|2508||1 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|4757|7670|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4757||4757|7670||1 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|15838|22922|lyfalmen|V0705|22922|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||15838||15838|22922||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|4663|7540|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4663||4663|7540||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1373|3012|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1373||1373|3012||1 445357|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.03.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1810|lyfalmen|V0329|1810|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|5530|8734|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5530||5530|8734||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|4405|7185|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||4405|7185||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|15707|22741|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||15707||15707|22741||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|10413|lyfalmen|V0694|10413|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||6750||6750|10413||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|10423|15468|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10423||10423|15468||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|5978|9350|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5978||5978|9350||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|7341|11226|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7341||7341|11226||1 447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.09.2014||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|783|2200|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||783|2200||2 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|9074|13612|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9074||9074|13612||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|2887|5096|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm GmbH|Carvedílól||2887||2887|5096||2 447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1810|lyfalmen|V0330|1810|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5664|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5664||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2156|4090|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2156|4090||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1801|3601|lyfalmen|V0202|3240|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1801||1801|3601||1 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|55135|72435|lyfalmen|V0727|72435|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||55135||55135|72435||1 449125|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3875|lyfalmen|V0323|3232|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3875||2 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|990|2485|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||990||990|2485||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|5465|3660|lyfalmen|V0686|3180|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1844||1844|3660||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|936|2295|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||852||852|2295||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|4557|7394|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||4557||4557|7394||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|2992|5240|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||2992||2992|5240||2 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|4408|7189|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4408||4408|7189||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4193|8125|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4193||4193|8125||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1090|2622|lyfalmen|||1|30|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1090||1090|2622|30.6.2016|1 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|116692|150712|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||116692||116692|150712||1 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|346672|436743|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||346672||346672|436743||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2160|3342|lyfalmen|V0313|2595|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1613||1613|3342||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|7198|12406|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7198||7198|12406||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|18468|26542|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||18468|26542||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33857|45523|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||33857||33857|45523||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|42159|56023|lyfalmen|||1|1|0|30,0800|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||42159||42159|56023||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37642|50310|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||37642||37642|50310||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|50190|66181|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||50190||50190|66181||2 451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7883|11972|lyfalmen|V0610|11972|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7883||7883|11972||1 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|39392|52524|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||39392||39392|52524||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|7118|10919|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||7118||7118|10919||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1255|2850|lyfalmen|V0800|2850|1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1255||1255|2850||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9642|16619|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||9642||9642|16619||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5437||1 452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRL|0|1|0|100|DKK|838292|1048181|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration Limited|Cobimetinib||||838292|1048181||2 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2499|lyfalmen|||2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2499|30.6.2016|2 452814|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1546|2891|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||1471||1471|2891||1 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|8608|12970|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóð||8608||8608|12970||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|7121|10924|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||7121||7121|10924||2 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1201|2775|lyfalmen|V0597|2269|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1201||1201|2775||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3604|6083|lyfalmen|V0598|4682|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3604||3604|6083||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2295|4281|lyfalmen|V0584|3081|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2295||2295|4281||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1274|2196|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1274||1274|2196||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6918|10644|lyfalmen|V0585|7765|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||6918||6918|10644||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3862|6438|lyfalmen|V0586|4704|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3862||3862|6438||2 453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1870|1721|lyfalmen|V0685|1226|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||435||435|1721||1 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|12903|18882|lyfalmen|V0587|12739|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||12903||12903|18882||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2382|4401|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2382||2382|4401||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2767|4931|lyfalmen|V0706|4931|1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2767||2767|4931||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|8972|13471|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||8972||8972|13471||1 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|4593|8884|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4593||4593|8884||2 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10467|15529|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||10467||10467|15529||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|35778|38352|lyfalmen|V0342|6902|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||28187||28187|38352||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WEI|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|51298|67508|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||51239||51239|67508||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|993|1952|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||993||993|1952||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1274|2876|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1274||1274|2876||1 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4194|6895|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4194||4194|6895||1 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6184|9634|lyfalmen|V0713|8732|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6184||6184|9634||1 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1187818|1482893|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1187818||1187818|1482893||2 455406|L01XA0102|Cisplatin Mylan|irþ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013|31.07.2016|R|0|0|0|1|0|1|MHS|0|0|0|100|IKR|6344|9854|lyfsjukr|||2|100|0||Icepharma hf|Mylan Hospital AS|Cisplatín||||6344|9854||2 455501|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.02.2015|31.05.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5063|9776|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5063||5063|9776||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|453|1746|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||453||453|1746||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|782|2199|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||782||782|2199||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1597|3320|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1597||1597|3320||1 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5630|6353|lyfalmen|V0277|6353|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||3800||3800|6353||2 456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|27288|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|27288||2 457149|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4950|2774|lyfalmen|V0327|2774|2|98|0|196,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1200||1200|2774||2 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|48503|56198|lyfalmen|V0451|56198|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||42297||42297|56198||1 457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5470|3600|lyfalmen|V0326|3600|2|98|0|147,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1800||1800|3600||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|IPI|0|0|0|100|GBP|6088|9502|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6088||6088|9502||1 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2835|5024|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2835||2835|5024||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2350|1648|lyfalmen|V0003|1648|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||382||382|1648||1 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9642|16619|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||9642||9642|16619||2 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|990|2485|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||990||990|2485||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|595115|745736|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||595115||595115|745736||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1141|2693|lyfalmen|V0577|2305|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1141||1141|2693||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1182|2749|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1182||1182|2749||2 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|114835|148403|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||114835|148403||3 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|9104|12534|lyfalmen|V0653|12466|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||8291||8291|12534||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|1114347|1391516|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||1114347||1114347|1391516||1 459225|M05BA0805|Zoledronic Acid Hospira|irl|5|mg|100|ml|1|poki|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|0|VOG|0|0|0|100|IKR|39258|52354|lyfalmen|V0715|52354|2|100|0|1,2500|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||39258||39258|52354||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|111272|143971|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||111272||111272|143971||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|741|2142|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||741||741|2142||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1358|2991|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1358||1358|2991||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|18358|34999|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||18358||18358|34999||2 459678|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2448|2530|lyfalmen|V0692|2460|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||1023||1023|2530||2 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2155|lyfalmen|V0284|2088|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||750||750|2155||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1448|3115|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1448||1448|3115||1 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|1|0|1|ACC|0|1|0|100|DKK|65279|85266|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Bendamústín||65279||65279|85266||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3474|5904|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3474||3474|5904||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|7123|10926|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||7123||7123|10926||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|210811|267770|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||210811||210811|267770||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|5426|10465|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||5426||5426|10465||2 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|4826|7765|lyfalmen|V0585|7765|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||4826||4826|7765||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|75490|98180|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||75490||75490|98180||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|483610|607055|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||483610||483610|607055||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|LYFIS ehf|ratiopharm GmbH|Flúkónazól|||||1916||2 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1224547|1528574|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1224547||1224547|1528574||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|291730|368410|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||291730||291730|368410||1 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|202|1400|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||202||202|1400||1 461774|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr||M09AX01|01.08.2015||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|6280|9766|lyfalmen|V0209|9766|2|2|0|5,7222|Vistor hf|Takeda Pharma A/S|Natríumhýalúrónat||6280||6280|9766||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|409|1685|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||409||409|1685||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|456|1750|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||456||456|1750||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2485|4543|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||2485|4543||2 462070|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BX09|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|17936|25809|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||17936||17936|25809||1 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3772|6314|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3772||3772|6314||1 462358|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|5622|8860|lyfalmen|V0730|8860|1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5622||5622|8860||2 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|14406|20951|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||14406||14406|20951||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5801|11176|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||5801|11176||2 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1711|lyfalmen|V0108|1711|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1711||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|6196|5085|lyfalmen|V0605|4983|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2879||2879|5085||2 463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2698|1948|lyfalmen|V0325|1948|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||600||600|1948||2 463378|J01DH0203|Meropenem Mylan|stl/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.07.2016||R|0|0|0|0|0|1|MHS|0|0|0|100|DKK|12150|17845|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Mylan Hospital AS|Meropenem||12150||12150|17845||2 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4716|9118|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4716||4716|9118||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|609|1960|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||609||609|1960||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|49258|65002|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||49258|65002||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1887|3719|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1887||1887|3719||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|2614|4720|lyfalmen|||2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Carvedílól||2614||2614|4720||2 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|8251|12479|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||8251||8251|12479||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1756|3539|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1756||1756|3539||2 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|1578|3294|lyfalmen|V0376|3294|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1578||1578|3294||1 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|GPB|0|0|0|100|DKK|1678|3432|lyfalmen|||1|98|0|49,0000|Vistor hf|BGP Products AB|Verapamíl||1678||1678|3432|| 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3141|5445|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3141||3141|5445||2 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1540|2223|lyfalmen|V0038|1901|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Flúoxetín||800||800|2223||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3844|3462|lyfalmen|V0039|2947|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Flúoxetín||1700||1700|3462||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|542|1868|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||542||542|1868||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1687|3444|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1687||1687|3444||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1118|2661|lyfalmen|V0545|1885|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1118|2661||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1279|2883|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1279||1279|2883||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4432|7222|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4432||4432|7222||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|244788|310028|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||244788||244788|310028||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|17859|25703|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||17859||17859|25703||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2378|4395|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2378||2378|4395||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6468|10025|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6468||6468|10025||1 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3912|6507|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||3912||3912|6507||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|18378|26418|lyfalmen|V0728|24145|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||18378||18378|26418||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|2967|5206|lyfalmen|V0063|4325|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||2967||2967|5206||1 467432|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015|31.07.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8105|15547|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8105||8105|15547||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5847|9170|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5847||5847|9170||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|12655|18541|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||12655||12655|18541||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|5376|8522|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||5376||5376|8522||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|24181|33285|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||24181||24181|33285||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|8961|13456|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||8961||8961|13456||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|76584|99564|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||76584||76584|99564||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|393|1663|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||393||393|1663||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5342|6063|lyfalmen|V0317|2993|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3590||3590|6063||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|265|1487|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||265||265|1487||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|8074|6033|lyfalmen|V0318|4128|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3568||3568|6033||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2030|3499|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2030||2030|3499||2 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013|30.06.2016|R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|353|1608|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||353||353|1608||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2540|lyfalmen|V0207|2540|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1030||1030|2540||1 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5386|10389|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||5386||5386|10389||2 468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6333|9839|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6333||6333|9839||1 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5246|lyfalmen|V0467|4463|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5246||1 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6184|9634|lyfalmen|V0712|8732|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6184||6184|9634||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3528|5978|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3528||3528|5978||1 469422|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|APP|0|0|0|100|DKK|2161|4097|lyfalmen|||1|66|0|66,0000|Artasan ehf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2161||2161|4097||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6697|10340|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6697||6697|10340||1 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5302|8420|lyfalmen|V0228|8058|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||5302||5302|8420||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|2172|2459|lyfalmen|V0037|2033|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||971||971|2459||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4410|7192|lyfalmen|V0227|6244|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4410||4410|7192||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|2812|4993|lyfalmen|V0226|4521|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||2812||2812|4993||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|8015|8801|lyfalmen|V0622|8801|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5579||5579|8801||1 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3832|6397|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3832||3832|6397||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|23513|32440|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||23513||23513|32440||1 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|5685|8947|lyfalmen|V0478|8947|1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||5685||5685|8947||1 470551|H05BX0103|Cinacalcet Sandoz|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|19843|25304|lyfalmen|V0720|24090|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Cinacalcet||17569||17569|25304||1 470933|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.03.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3883|7537|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||3883||3883|7537||2 471042|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|964|1895|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||964||964|1895||2 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|798|2221|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||798||798|2221||1 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4120|7987|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4120||4120|7987||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1702|3465|lyfalmen|V0048|2455|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1702||1702|3465||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2739|4892|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2739||2739|4892||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|10700|15850|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||10700||10700|15850||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6868|5417|lyfalmen|V0012|5012|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5417||2 472756|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.10.2015||R|1|0|0|0|0|0|SHS|0|0|1|100|DKK|995|2014|lyfalmen|V0231|2014|2|300|0|50,0000|Artasan ehf|Sandoz A/S|Paracetamól||648||648|2014||1 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.11.2012|31.07.2016|R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|3905|6497|lyfalmen|||1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||3905||3905|6497||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|2771|4936|lyfalmen|V0670|4101|1|5|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||2771||2771|4936||1 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1255|2850|lyfalmen|V0800|2850|1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1255||1255|2850||2 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|9960|14831|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||9960||9960|14831||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|2419|4452|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||2419||2419|4452||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7248|5820|lyfalmen|V0687|5326|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3413||3413|5820||1 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|26306|50078|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||26306||26306|50078||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|27823|11427|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||7487||7487|11427||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|690|2072|lyfalmen|V0266|2066|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||690||690|2072||2 474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|985|2478|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||985||985|2478||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|1100|2636|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2636||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|497|1806|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||497||497|1806||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|627|1985|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||627||627|1985||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|AGP|0|0|1|100|IKR|1364|3000|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1364||1364|3000||1 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|57272|75138|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||57272|75138||1 476580|R03AC0206|Ventoline|innönd.l|2|mg/ml|20|lykjur|1|pakki|lausn f. eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|1146|2700|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||1146||1146|2700||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4223|6935|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4223|6935||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|15243|22103|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||15243||15243|22103||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|4225|6937|lyfalmen|||1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4225||4225|6937||1 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|51155|67402|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe Limited|Apremilast||51155||51155|67402||2 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|28055|33688|lyfalmen|V0272|33688|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||24500||24500|33688||2 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3024||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3103||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|636|1998|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||636||636|1998||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3024||1 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|500|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3048||1 477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stl|V07AB|01.11.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|1000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2712||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|395|1666|lyfalmen|V0500|1587|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||395||395|1666||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|6558|12612|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||6558||6558|12612||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|22396|31027|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||22396||22396|31027||2 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|105885|137271|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||105885||105885|137271||1 480223|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.04.2015|31.05.2016|R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4770|8222|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||4770||4770|8222||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|11069|7043|lyfalmen|V0341|6902|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4302||4302|7043||2 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|12160|17859|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||12160||12160|17859||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|673|2049|lyfalmen|||0|30|0||Vistor hf|Galenica AB|Mómetasón||673||673|2049||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4170|6862|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||4170||4170|6862||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|126|1296|lyfalmen|V0055|1296|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||126||126|1296||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|14095|20523|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||14095||14095|20523||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|59462|65794|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||49884||49884|65794||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|28709|39012|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||28709|39012||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5698|8965|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5698||5698|8965||2 483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1765|2499|lyfalmen|V0467|2499|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2499||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2399|4424|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2399||2399|4424||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|5878|9213|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||5878||5878|9213||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001|30.06.2016|R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4242|6961|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4242||4242|6961||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1719|3488|lyfalmen|V0374|3488|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1719||1719|3488||1 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|879|2332|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||879||879|2332||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|251|1468|lyfalmen|V0055|1296|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||251||251|1468||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|49478|65280|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||49478||49478|65280||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|4765|7681|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||4765||4765|7681||1 484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|322260|406381|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||322260||322260|406381||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|116786|150829|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||116786||116786|150829||1 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1120|2664|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||1120||1120|2664||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|8977|13478|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8977||8977|13478||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|43906|58233|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||43906||43906|58233||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1074|2600|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1074||1074|2600||1 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9092|13636|lyfalmen|V0714|13636|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9092||9092|13636||2 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|354313|446246|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer Pharma AG|Riociguatum||354313||354313|446246||1 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|12621|18494|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||12621||12621|18494||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|76060|98901|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Dolutegravír||76060||76060|98901||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|475|1776|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||475||475|1776||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|565|1900|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||565||565|1900||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|10749|13345|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||8880||8880|13345||1 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|2308|4299|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||2308||2308|4299||1 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|28588|38859|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||28588||28588|38859||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|47977|63382|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||47977||47977|63382||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|26687|32281|lyfalmen|V0453|32281|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||23387||23387|32281||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|IKR|1033|1948|lyfalmen|V0469|1944|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Díklófenak||600||600|1948||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995|30.06.2016|R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|657|2026|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||657||657|2026||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998|30.06.2016|R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|1623|3356|lyfalmen|||1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||1623||1623|3356||1 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|243177|308024|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||243177||243177|308024||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|6061|9465|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6061||6061|9465||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|9698|14471|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||9698||9698|14471||1 489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2636|lyfalmen|V0331|2636|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2636||2 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|6028|9419|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6028||6028|9419||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|78143|101536|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||78143|101536||1 489348|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|15314|19058|lyfalmen|V0684|17377|2|56|0|56,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||13031||13031|19058||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|784|1693|lyfalmen|V0188|1505|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||415||415|1693||1 490198|N03AX1606|Pregabalin Mylan|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|6527|5652|lyfalmen|V0734|5652|2|56|0|42,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||3291||3291|5652||2 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1916|3759|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1916||1916|3759||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1775|3565|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1775||1775|3565||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4633|7082|lyfalmen|V0133|7082|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4330||4330|7082||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3633|6123|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3633||3633|6123||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9367|9481|lyfalmen|V0112|2499|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6073||6073|9481||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3468|5896|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3468||3468|5896||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11435|12757|lyfalmen|V0113|2567|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||8453||8453|12757||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13427|15806|lyfalmen|V0114|2567|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10668||10668|15806||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|117179|151318|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||117179|151318||1 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3660|3813|lyfalmen|V0693|3424|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1955||1955|3813||2 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|sk-pokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3250|5596|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||3250||3250|5596||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|476479|598186|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||476479||476479|598186||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2616|4723|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2616||2616|4723||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6299|9792|lyfalmen|V0002|4545|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6299||6299|9792||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15095|21899|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15095||15095|21899||1 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|24167|33267|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24167||24167|33267||1 493226|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|14|0|14,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3325|5699|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||3325||3325|5699||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|966|2452|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||966||966|2452||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2135|4061|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2135||2135|4061||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|62485|81732|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||62485||62485|81732||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|156212|199864|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||156212||156212|199864||2 494466|J05AE1401|Olysio|hylki|150|mg|7|stk|1|pakki||J05AE14|01.09.2014|31.07.2016|R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|325446|410344|lyfsjukr|||1|7|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||325446|410344||1 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1958|3817|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1958||1958|3817||1 494574|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|8787|13217|lyfalmen|V0252|13217|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||8787||8787|13217||2 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|APC|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1954|3812|lyfalmen|V0128|1981|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1954||1954|3812||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2840|5031|lyfalmen|V0410|4269|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2840||2840|5031||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2377|4672|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||2377||2377|4672||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1580|3297|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1580||1580|3297||1 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|791993|990598|lyfsjukr|||1|250|0|9,3700|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||791993||791993|990598||3 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|19009|6596|lyfalmen|V0384|4346|1|15|0|7,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||3977||3977|6596||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|7393|6713|lyfalmen|V0389|6713|1|10|0|1,2500|Vistor hf|Novartis Healthcare A/S|Ondansetrón||4062||4062|6713||1 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5580|8803|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||5580||5580|8803||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2474|4527|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||2474||2474|4527||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33649|lyfalmen|||3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33649||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3959|7682|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3959||3959|7682||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|6208|5375|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||3090||3090|5375||1 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|452|1744|lyfalmen|||2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||452||452|1744||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|405|1680|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||405||405|1680||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|732|2130|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||732||732|2130||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|170394|217502|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||170394||170394|217502||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|213909|271623|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||213909||213909|271623||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1524|3024|lyfalmen|V0127|3024|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1382||1382|3024||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2792|4965|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2792||2792|4965||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|755|2161|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||755||755|2161||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2038|lyfalmen|V0056|1970|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|þpakki||C09AA02|01.07.1990|30.06.2016|R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|301|1536|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||301||301|1536||1 497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|0|0|APC|0|0|0|100|NOK|8227|4567|lyfalmen|V0207|2540|1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2503||2503|4567||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|587|1930|lyfalmen|V0448|1930|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||587||587|1930||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1068|2592|lyfalmen|V0449|2567|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1068||1068|2592||1 497885|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1509|2966|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1509||1509|2966||2 497983|N04BC0407|Ropinirol Actavis|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.12.2012|31.07.2016|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7015|9840|lyfalmen|||2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||6334||6334|9840||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1089|2621|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1089||1089|2621||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4288|lyfalmen|V0472|4288|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4288||2 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|69334|111766|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||69334||69334|111766||1 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14668|21311|lyfalmen|V0608|10365|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||14668||14668|21311||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15164|21994|lyfalmen|V0609|11700|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15164||15164|21994||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16745|24170|lyfalmen|V0610|11972|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16745||16745|24170||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|22997|31787|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||22997||22997|31787||1 499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|954|2435|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||954||954|2435||1 499109|N05AH0410|Quetiapin Actavis|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11049|12471|lyfalmen|V0275|12471|2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||8245||8245|12471|| 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|8379|12655|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||8379|12655||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|5426|8591|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||5426||5426|8591||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|10756|15927|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||10756||10756|15927||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4880|3907|lyfalmen|||2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|3907||2 501277|N06AX2109|Duloxetine ratiopharm|sþ-hylki|60|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|11839|10413|lyfalmen|V0694|10413|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Duloxetín||6750||6750|10413||2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5116|8164|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5116||5116|8164||1 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|10340|15354|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||10340||10340|15354||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|24419|33586|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||24419||24419|33586||2 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2457|4504|lyfalmen|V0434|4098|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2457||2457|4504||2 502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4085|6745|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4085||4085|6745||2 502904|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BX09|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|5551|8763|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||5551||5551|8763||1 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|13056|19092|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||13056|19092||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|18107|26045|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||18107||18107|26045||1 503265|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2090|3999|lyfalmen|||2|28|0|42,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2090||2090|3999||2 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|20153|28190|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||20153||20153|28190||1 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4756|7668|lyfalmen|V0707|7668|1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4756||4756|7668||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|8359|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8359||2 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3714|6234|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3714||3714|6234||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1429|2372|lyfalmen|V0494|1810|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríð||908||908|2372||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|6640|10261|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||6640||6640|10261||1 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|32825|44218|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Limited|Síldenafíl||32825||32825|44218||1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988|30.06.2016|R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1516|3209|lyfalmen|||1|90|0|45,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1516||1516|3209||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1004|2504|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1004||1004|2504||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|12112|23149|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||12112||12112|23149||1 505495|J01CE0107|Benzylpenicillin Panpharma|sts/irs|3|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016||R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|4557|7394|lyfsjukr|||2|10|0|8,3300|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||4557|7394||2 505503|J01CE0107|Benzylpenicillin Panpharma|sts/irs|0,6|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016||R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|1218|2799|lyfsjukr|||2|10|0|1,6700|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||1218|2799||2 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1561|3271|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1561||1561|3271||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3117|5412|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3117||3117|5412||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7114|10914|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7114||7114|10914||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|20153|28190|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||20153||20153|28190||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2314|4307|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2314||2314|4307||2 506809|N05AX1207|Lemilvo|töflur|5|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|0|0|AGP|0|0|0|100|XEU|45421|31030|lyfalmen|V0682|31030|2|100|0|33,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||22398||22398|31030||1 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2132|4057|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2132||2132|4057||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|346|1598|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||346||346|1598||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|570|982|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||570||570|982||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|111674|144471|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||111674||111674|144471||1 507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9794|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9794||2 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|RPO|0|0|0|100|IKR|3105|5396|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm Oy|Betahistín||3105||3105|5396||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1688|3446|lyfalmen|V0092|3446|2|100|0|66,6600|Alvogen|Orion Corporation|Spírónólaktón||1688||1688|3446||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|926|2397|lyfalmen|||1|5|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||926||926|2397||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|8856|5807|lyfalmen|V0687|5326|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3404||3404|5807||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1897|lyfalmen|V0555|1842|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1897||1 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2212|4167|lyfalmen|V0710|4167|1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2212||2212|4167||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4420|8556|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4420|8556||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3982|7725|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3982||3982|7725||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11798|22554|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||11798||11798|22554||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|509867|639712|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||509867||509867|639712||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8258|12489|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8258||8258|12489||1 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||||5425|10463||2 509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|953|2292|lyfalmen|V0336|2292|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||850||850|2292||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BGB|0|0|0|100|DKK|1903|3741|lyfalmen|V0134|2984|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||1903||1903|3741||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|41929|55733|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||41929||41929|55733||1 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|77814|101120|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||77814|101120||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|14392|20931|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||14392||14392|20931||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|21544|29950|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||21544||21544|29950||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|35338|47396|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||35338||35338|47396||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|54619|71783|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||54619||54619|71783||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|416|1695|lyfalmen|V0601|1546|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||416||416|1695||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|142737|183105|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||142737|183105||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3600|4482|lyfalmen|V0445|4482|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||2441||2441|4482||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2328|4326|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2328||2328|4326||1 511361|A10BB1203|Glimepirid Bluefish|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|593|1397|lyfalmen|V0021|1397|2|90|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||200||200|1397||2 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|18965|27226|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||18965||18965|27226||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|11864|17452|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||11864||11864|17452||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|14042|20450|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||14042||14042|20450||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4545|7378|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4545||4545|7378||1 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2038|lyfalmen|V0057|2038|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1841|lyfalmen|V0109|1841|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1841||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|23915|32948|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23915||23915|32948||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2328|4575|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2328||2328|4575||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1830|3597|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1830||1830|3597||2 513947|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9187|17600|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9187||9187|17600||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3875|lyfalmen|V0450|3875|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3875||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1488|3170|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1488||1488|3170||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|17692|25473|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||17692|25473||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3800|2636|lyfalmen|V0692|2636|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1100||1100|2636||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4386|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4386||1 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|12132|17821|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||12132||12132|17821||3 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4648|6631|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4002||4002|6631||1 516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LEP|0|0|1|100|DKK|16494|23825|lyfalmen|||1|0,94|0||Vistor hf|LEO Pharma A/S|Ingenol mebutate||||16494|23825||1 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|8700|8692|lyfalmen|V0384|8692|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||5500||5500|8692||2 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|18600|23420|lyfalmen|V0273|23147|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||16200||16200|23420||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2555|4639|lyfalmen|V0462|3380|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2555||2555|4639|| 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|29717|40287|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||29717||29717|40287||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2782|4951|lyfalmen|V0471|3441|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2782||2782|4951||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2992|5240|lyfalmen|V0472|3216|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2992||2992|5240||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|29226|39666|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||29226||29226|39666||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|48669|59617|lyfalmen|V0711|59617|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||45000||45000|59617||2 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|941|2417|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||941||941|2417||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3459|5883|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3459||3459|5883||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1803|3604|lyfalmen|V0590|2585|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1803||1803|3604||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1094|2453|lyfalmen|V0004|2453|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||967||967|2453||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|16657|24049|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||16657||16657|24049||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|942|2419|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||942||942|2419|31.5.2016|1 519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|2018|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8363||2 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3455|5878|lyfalmen|||2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3455||3455|5878||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1346|2975|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1346||1346|2975||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|6280|9766|lyfalmen|V0209|9766|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||6280||6280|9766||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7329|3911|lyfalmen|V0515|3346|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2026||2026|3911||1 520160|J01XA0108|Vancomycin Actavis|st/irþ|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|776|1600|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||347||347|1600||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|20339|28425|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||20339|28425||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4082|6741|lyfalmen|||1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4082||4082|6741||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5488|8676|lyfalmen|V0143|1406|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5488||5488|8676||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15495|22450|lyfalmen|V0143|4219|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15495||15495|22450||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5042|8062|lyfalmen|V0144|1566|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5042||5042|8062||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13951|20324|lyfalmen|V0144|4699|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||13951||13951|20324||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2086|lyfalmen|V0056|1970|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2086||1 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|10627|15749|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||10627||10627|15749||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2086|lyfalmen|V0057|2038|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2086||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|290|1521|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||290||290|1521||1 520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8369|16048|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||8369||8369|16048||1 522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9561|6626|lyfalmen|V0688|6132|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3999||3999|6626||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|111272|143971|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||111272||111272|143971||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|152599|195370|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||152599||152599|195370||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2259|4231|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2259||2259|4231||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2182|4126|lyfalmen|V0192|4126|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2182||2182|4126||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|982|2474|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||982||982|2474||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4398|3942|lyfalmen|V0285|3875|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||2049||2049|3942||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1541||1 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|165145|210974|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||165145||165145|210974||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|284098|358918|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||284098||284098|358918||1 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|894|2353|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||894||894|2353||1 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|1423|3081|lyfalmen|V0584|3081|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1423||1423|3081||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|335|1583|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||335||335|1583||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2084|3991|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2084||2084|3991||1 524257|L02BB0401|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB04|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|422063|530508|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||422063||422063|530508||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6125|lyfalmen|V0010|3600|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6125||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.07.2010|31.05.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1687|3316|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1687||1687|3316||2 524937|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|16539|19058|lyfalmen|V0683|17377|2|56|0|37,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||13031||13031|19058||1 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|6563|10156|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6563||6563|10156||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|598|1945|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||598||598|1945||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|669|2043|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||669||669|2043||1 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1482|3162|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1482||1482|3162||1 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4294|7032|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4294||4294|7032||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|1|0|0|1|0|0|TBP|0|0|0|100|DKK|6464|8259|lyfalmen|V0657|7729|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||5185||5185|8259||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|12185|23288|vetalmen|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||12185||12185|23288||2 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|29681|40241|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||29681|40241||2 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4682|7567|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríð||4682||4682|7567||1 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4263|6990|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríð||4263||4263|6990||1 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2231|4193|lyfsjukr|||2|1000|0|4,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2231|4193||2 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4487||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4549||1 526367|N02BE0119|Therimin Honung & Citron|mixtduft|500|mg|10|skpokar|1|pakki||N02BE01|01.01.2015|31.07.2016|L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|16,6700|Artasan ehf|Novartis Healthcare A/S|Paracetamól|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3731|6258|lyfalmen|V0435|6258|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3731||3731|6258||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|5369|8512|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5369||5369|8512||1 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|14604|13236|lyfalmen|V0111|13232|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||8801||8801|13236||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3403|5806|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3403||3403|5806||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|10808|15998|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||10808||10808|15998||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|16352|5813|lyfalmen|V0516|5806|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3408||3408|5813||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1255|2850|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1255||1255|2850||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1575|3096|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1575||1575|3096||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|867|1965|lyfalmen|V0046|1965|2|100|0|33,3333|Alvogen|Orion Corporation|Spírónólaktón||612||612|1965||1 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|12319|15161|lyfalmen|V0635|14992|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||10200||10200|15161||2 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9800|6125|lyfalmen|V0011|5278|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3635||3635|6125||1 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1934|3784|lyfalmen|||0|100|0||Vistor hf|Galenica AB|Mómetasón||1934||1934|3784||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|5478|8662|lyfalmen|V0356|7825|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5478||5478|8662||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|5942|9301|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||5942||5942|9301||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|4037|3718|lyfalmen|V0621|3718|2|18|0|18,0000|LYFIS ehf|ratiopharm GmbH|Rizatriptan||1886||1886|3718||2 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4240|8215|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4240||4240|8215||2 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|59269|77664|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||59269||59269|77664||1 529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|245426|310821|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||245426||245426|310821||1 529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1736|3412|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1736||1736|3412||2 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10069|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10069||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530172|J05AX1601|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AX16|01.10.2015||R|1|0|0|1|0|1|ABV|0|1|0|100|DKK|148197|189896|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Ltd.|Dasabuvir||148197||148197|189896||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|5779|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6219||1 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1408|2767|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1408||1408|2767||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2468|4519|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2468||2468|4519||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5495|8686|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5495||5495|8686||1 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2350|4357|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2350||2350|4357||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|4013|6646|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||4013||4013|6646||3 531829|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1810|lyfalmen|V0329|1810|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|608|1959|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||608||608|1959||1 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|40011|53307|lyfalmen|V0711|53229|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||40011||40011|53307||2 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|1|0|1|WEH|0|0|0|100|XEU|101677|132038|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||101677||101677|132038||2 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1871|3697|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1871||1871|3697||2 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1637|3375|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1637||1637|3375||1 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2420|2779|lyfalmen|V0006|2774|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||1204||1204|2779||1 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|16160|23365|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||16160||16160|23365||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|50731|66865|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||50731||50731|66865||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|1860|3656|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||1860||1860|3656||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|6765|lyfalmen|V0117|6765|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4100||4100|6765||2 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5017|8028|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5017||5017|8028||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1941|3794|lyfalmen|V0092|3446|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1941||1941|3794||1 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1735|2530|lyfalmen|V0692|2460|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1023||1023|2530||1 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|364|1623|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||364||364|1623||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|379|1644|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||379||379|1644||1 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|þpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|349|1461|lyfalmen|V0502|853|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||246||246|1461||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|25796|35328|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||25796||25796|35328||1 536384|N03AX1609|Pregabalin Sandoz GmbH|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|5865|6525|lyfalmen|V0733|4719|2|56|0|28,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||3925||3925|6525||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|87757|113696|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||87757||87757|113696||1 536712|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|9432|14104|lyfalmen|V0690|14104|2|28|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||9432||9432|14104||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2509|4576|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2509||2509|4576||2 536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7685|11700|lyfalmen|V0609|11700|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7685||7685|11700||1 536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LEP|0|0|1|100|DKK|16314|23577|lyfalmen|||1|1,41|0||Vistor hf|LEO Pharma A/S|Ingenol mebutate||||16314|23577||1 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5371|8515|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5371||5371|8515||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1954||1 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6715|10365|lyfalmen|V0608|10365|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6715||6715|10365||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|100325|130356|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||100325||100325|130356||2 538555|L01BA0110|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2575|4666|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2575||2575|4666||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3328|3462|lyfalmen|V0678|3462|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||1700||1700|3462||2 538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|4484|7294|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||4484||4484|7294||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|6176|9623|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||6176||6176|9623||1 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|75173|97780|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||75173||75173|97780||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|558|1890|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||558||558|1890|31.7.2016|1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|710|2099|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||710||710|2099||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1552|3258|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1552||1552|3258||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18953|27209|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||18953||18953|27209||1 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2410|4439|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2410||2410|4439||2 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|39536|41928|lyfalmen|V0721|41928|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||31015||31015|41928||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|1388|2474|lyfalmen|V0621|1239|2|6|0|6,0000|LYFIS ehf|ratiopharm GmbH|Rizatriptan||982||982|2474||2 540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|20317|18386|lyfalmen|V0684|17377|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||12543||12543|18386||1 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|630197|789369|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||||630197|789369||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012|31.05.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2289|3945|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2289||2289|3945||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|175889|224337|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer Pharma AG|Riociguatum||175889||175889|224337||1 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5071|8102|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5071||5071|8102||1 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|0|0|WEH|0|0|0|100|XEU|17831|18386|lyfalmen|V0682|17377|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||12543||12543|18386||2 542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|22236|18386|lyfalmen|V0683|17377|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||12543||12543|18386||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6853|10555|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6853|10555||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|498|1808|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||498||498|1808||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|14104|20535|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||14104|20535||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3281|2709|lyfalmen|V0203|2709|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1153||1153|2709||2 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2513|4581|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2513||2513|4581||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|971|2459|lyfalmen|V0373|1470|2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||971||971|2459||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|66610|86949|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||66610|86949||2 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3400|4219|lyfalmen|V0143|4219|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||2250||2250|4219||2 544374|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|491051|616310|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||491051||491051|616310||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|243261|308129|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||243261||243261|308129||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|11225|16572|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||11225||11225|16572||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|32957|32297|lyfalmen|V0636|31872|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||23400||23400|32297||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|224376|284641|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||224376||224376|284641||2 545110|H05BX0103|Cinacalcet Sandoz|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|54507|65455|lyfalmen|V0722|62144|2|28|0|42,0000|Artasan ehf|Sandoz A/S|Cinacalcet||49616||49616|65455||1 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RAT|0|0|0|100|XEU|1495|2984|lyfalmen|V0134|2984|2|63|0|84,0000|LYFIS ehf|ratiopharm GmbH|Cýpróterón og östrógen||1353||1353|2984||2 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|756|2163|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||756||756|2163||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1846|3663|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1846||1846|3663||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26129|35749|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||26129||26129|35749||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21066|29345|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||21066||21066|29345||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26282|35942|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||26282||26282|35942||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22328|30941|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||22328||22328|30941||1 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||1 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1093|2627|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1093||1093|2627||1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3218|2774|lyfalmen|V0580|2774|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2774||2 546838|J01CE0107|Benzylpenicillin Panpharma|sts/irs|1,2|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016||R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|1923|3769|lyfsjukr|||2|10|0|3,3300|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||1923|3769||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|3931|3737|lyfalmen|V0010|3673|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1900||1900|3737||1 547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2881|2924|lyfalmen|V0251|2924|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||1309||1309|2924||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4958||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2499|lyfalmen|V0004|2453|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2499||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|GBP|8954|13446|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||8954||8954|13446||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|GBP|2879|5085|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||2879||2879|5085||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9536|14248|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||9536|14248||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|92263|119395|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||92263||92263|119395||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|573|1911|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||573||573|1911||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||1726||1 548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|13543|11226|lyfalmen|V0694|10205|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||7341||7341|11226||2 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|143758|184375|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||143758||143758|184375||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|7304|11175|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||7304||7304|11175||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013|30.06.2016|R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4529|5240|lyfalmen|||2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||2992||2992|5240||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|28709|39012|lyfalmen|||1|98|0|73,5000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||28709|39012||2 550020|J07AP0302|Typherix|stl|||0,5|ml|1|spr|m/ aðsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2177|3703|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Taugaveiki, hreinsaðir mótefnavakar||1875||1875|3703|31.5.2016|1 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1794|lyfalmen|V0551|1783|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|1794||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4588|lyfalmen|V0471|4588|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4588||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1491|3174|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1491||1491|3174||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7362|11255|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7362||7362|11255||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|4452|7250|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||4452||4452|7250||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1486|3168|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1486||1486|3168|| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2380|4398|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2380||2380|4398||1 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1900|lyfalmen|V0466|1777|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1900||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3752|3590|lyfalmen|V0467|2499|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3590||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1151|lyfalmen|V0003|824|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1151||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1900|lyfalmen|V0003|1648|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1900||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7272|3590|lyfalmen|V0010|2057|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3590||1 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1578|3294|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1578||1578|3294||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|15315|24688|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||15315||15315|24688||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2781|4950|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2781||2781|4950||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10376|15404|lyfalmen|V0237|15404|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||10376|15404||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3260|2499|lyfalmen|V0112|2499|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1000||1000|2499||2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3548|6006|lyfalmen|V0237|5135|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3548||3548|6006||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|483610|607055|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||483610||483610|607055||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|39153|52221|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||39153|52221||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|6477|12459|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||6477||6477|12459||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6101|6187|lyfalmen|V0029|6168|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3680||3680|6187||1 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1206251|1505818|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1206251||1206251|1505818||2 554721|J01XA0108|Vancomycin Actavis|st/irþ|1000|mg/hgl|1|hgl|1|pakki||J01XA01|01.07.2016||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|1348|1962|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||610||610|1962||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|141400|155981|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||120928||120928|155981||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1964|3825|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1964||1964|3825||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2239|4204|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2239||2239|4204||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1690|3448|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1690||1690|3448||1 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|495367|621678|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||495367||495367|621678||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|12692|16557|lyfalmen|V0440|16556|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||11214||11214|16557||1 556377|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.06.2016||L|0|0|0|0|G|0|EVO|0|0|1|100|IKR|||lyfalmen|V0677|2508|2|140|0|35,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón|||||2748||2 556694|C10A00001|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|63098|82507|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||63098|82507||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|18486|26566|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||18486||18486|26566||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4214|6922|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4214||4214|6922||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8217|12432|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8217||8217|12432||1 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2478|4299|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2308||2308|4299||2 558175|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3937|7640|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||3937||3937|7640||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|212136|269418|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||212136|269418||1 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1286|2892|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1286||1286|2892||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|4278|7010|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4278||4278|7010||1 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|2768|4932|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2768||2768|4932|31.5.2016|1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1506||1 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|1|0|1|CLC|0|1|0|100|XEU|42203|56079|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe Limited|Paklítaxel||42203||42203|56079||2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|1122|2569|lyfalmen|V0044|2249|1|25|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1051||1051|2569||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|1328|2950|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1328||1328|2950||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|4539|7370|lyfalmen|||1|125|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4539||4539|7370||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|4995|7997|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4995||4995|7997||1 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|84856|110027|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||84856||84856|110027||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|390338|491051|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||390338||390338|491051||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|POF|0|1|0|100|DKK|147516|134424|lyfsjukr|||2|60|0||Alvogen|Alvogen|Imatiníb||103596||103596|134424||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1406|3057|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1406||1406|3057||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|175889|224337|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer Pharma AG|Riociguatum||175889||175889|224337||1 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1700|2567|lyfalmen|V0098|2461|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1050||1050|2567||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|43046|57145|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuþáttur IX||43046||43046|57145||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4036|6677|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4036||4036|6677||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|241632|306103|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||241632||241632|306103||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|79766|103589|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||79766||79766|103589||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|98074|126745|lyfalmen|V0484|126745|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||98074||98074|126745||2 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5227|8317|lyfalmen|V0705|7641|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||5227||5227|8317||1 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|597|1944|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||597||597|1944||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|593|1938|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||593||593|1938||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1194|2766|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1194||1194|2766||1 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|21594|24090|lyfalmen|V0720|24090|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||16687||16687|24090||2 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2981|5225|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2981||2981|5225||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3089|5374|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3089||3089|5374||2 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1486|2921|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1486|2921||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|401222|504588|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||401222||401222|504588||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|579|1919|lyfalmen|V0596|1843|2|28|0|1,8600|LYFIS ehf|ratiopharm GmbH|Oxýcódon||579||579|1919||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|60216|78862|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||60216||60216|78862||1 564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|20203|28253|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||20203||20203|28253||3 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|920|2388|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||920||920|2388||1 564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2289|4273|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2289||2289|4273||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|7178|lyfalmen|V0286|7122|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||4400||4400|7178||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9092|13636|lyfalmen|V0714|13636|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9092||9092|13636||1 565625|M01AE0102|Ibufen|mixtúra|20|mg/ml|100|ml|1|glas||M01AE01|01.08.2016||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|100|0|1,6700|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|7483|14367|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||7483|14367|| 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|21209|29526|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||21209||21209|29526||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1402|3052|lyfalmen|V0444|2223|1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||1402||1402|3052||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2656|4778|lyfalmen|V0193|4778|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2656||2656|4778||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|12801|18741|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||12801||12801|18741||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|211332|268418|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||211332||211332|268418||1 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|14930|21672|lyfalmen|V0651|21672|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||14930||14930|21672||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|APP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól|||||2768|31.5.2016|1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5017|8028|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5017|8028||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2472|4525|lyfalmen|V0291|2361|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2472||2472|4525||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|2521|4592|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||2521||2521|4592||1 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4788|7712|lyfalmen|V0292|3806|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||4788||4788|7712||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|GBP|954|2435|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||954||954|2435||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5038|8057|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5038||5038|8057||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2505|2519|lyfalmen|V0058|2499|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1015||1015|2519||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3378|3916|lyfalmen|V0059|3875|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2030||2030|3916||1 568945|N05AX1206|Aripiprazole ratiopharm|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|20454|18465|lyfalmen|V0684|17377|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Aripiprazól||12600||12600|18465||2 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VII|0|0|0|100|GBP|123808|159562|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||123808||123808|159562||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|10066|14977|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10066||10066|14977||2 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|4800|2912|lyfalmen|V0001|2602|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1300||1300|2912||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|13299|19427|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13299||13299|19427||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|15295|22174|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||15295||15295|22174||1 570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|7729|lyfalmen|V0657|7729|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4800||4800|7729||2 570421|L01BA0110|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2467|4518|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2467||2467|4518||2 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|2931|5731|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||2931||2931|5731||1 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3100|5389|lyfalmen|V0384|4346|2|15|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||3100||3100|5389||2 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|71558|93207|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||71558||71558|93207||1 571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|38260|51092|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||38260|51092||3 571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|256759|324916|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||256759||256759|324916||1 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|471630|592156|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||471630||471630|592156||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 571628|N06AX2109|Duloxetine ratiopharm|sþ-hylki|30|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|7600|8692|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Duloxetín||5500||5500|8692||2 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|69001|89973|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||69001||69001|89973||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|3828|5417|lyfalmen|V0011|5172|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5417||2 573069|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2751|3245|lyfalmen|V0248|3216|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1542||1542|3245||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3550|lyfalmen|V0245|3528|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3550||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3597|6073|lyfalmen|V0464|4804|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3597||3597|6073||1 573382|J05AX6501|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AX65|01.09.2015||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|2179723|2716545|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir og ledipasvir||||2179723|2716545|| 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2013|30.06.2016|R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|13143|11365|lyfalmen|||2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||7442||7442|11365||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|74142|96476|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||74142||74142|96476||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|14470|21039|lyfsjukr|||1|10|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||14470||14470|21039||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|23723|32706|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||23723||23723|32706||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2131|2625|lyfalmen|V0189|2097|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1092||1092|2625||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4963|4699|lyfalmen|V0144|4699|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2599||2599|4699||2 574357|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|0|0|WEH|0|0|0|100|XEU|71768|45408|lyfalmen|||2|500|0|500,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||33766||33766|45408||2 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|361260|454886|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||361260||361260|454886||2 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|9250|13854|lyfalmen|V0388|13854|1|50|0|2,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||9250||9250|13854||1 574900|N05AH0410|Quetiapin Actavis|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|19527|23147|lyfalmen|V0273|23147|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||16002||16002|23147|| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2138|2101|lyfalmen|V0151|1689|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||711||711|2101||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6662|6300|lyfalmen|V0322|2414|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3762||3762|6300||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3944|2101|lyfalmen|V0152|2101|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||711||711|2101||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|12006|6300|lyfalmen|V0323|3167|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3762||3762|6300||1 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|744976|932122|lyfsjukr|||1|1|0|0,1600|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||744976||744976|932122||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1117|1948|lyfalmen|V0159|1948|2|20|0|10,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||600||600|1948||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1285|2361|lyfalmen|V0160|2361|2|30|0|15,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||900||900|2361||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1453|2361|lyfalmen|V0158|2361|2|20|0|15,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||900||900|2361||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|ACA|0|0|0|100|IKR|945|1585|lyfalmen|V0243|1405|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1585||1 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1169468|1460071|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1169468||1169468|1460071||2 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|8779|13206|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||8779||8779|13206||1 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|18378|26418|lyfalmen|V0727|24145|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||18378||18378|26418||1 577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|2567|lyfalmen|V0113|2567|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1050||1050|2567||2 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|10840|16042|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||10840||10840|16042||2 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4158|6845|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4158||4158|6845||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5764|9935|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5764||5764|9935||2 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|17910|25774|lyfalmen|V0422|25774|2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||17910||17910|25774||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1013|2516|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1013||1013|2516||1 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|GPB|0|0|0|100|DKK|2212|4167|lyfalmen|V0710|4167|1|98|0|98,0000|Vistor hf|BGP Products AB|Verapamíl||2212||2212|4167|| 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|187550|238840|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||187550||187550|238840||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|1671|2499|lyfalmen|V0005|2344|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2499||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|316|1557|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||316||316|1557||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|7017|3746|lyfalmen|V0107|3737|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||1906||1906|3746||1 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|13372|lyfalmen|V0111|13232|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||8900||8900|13372||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|645|2010|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||645||645|2010||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7405|11314|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||7405||7405|11314||1 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|1|0|1|PLC|0|0|0|100|DKK|6531|10111|lyfsjukr|||1|8|0||Icepharma hf|Fresenius Kabi Oncology Plc.|Docetaxel||6531||6531|10111||2 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1494|3179|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1494||1494|3179||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2809|4989|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2809||2809|4989||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|3134|4827|lyfalmen|V0620|4827|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2692||2692|4827||1 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|12423|23739|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||12423||12423|23739||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2340|4343|lyfalmen|V0669|3708|0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2340||2340|4343||1 581991|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5994|11542|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||5994||5994|11542||2 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|18864|27087|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||18864||18864|27087||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|36915|49391|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||36915||36915|49391||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|16511|23848|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||16511||16511|23848||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|73829|96080|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||73829||73829|96080||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22258|30853|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||22258||22258|30853||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25533|34995|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||25533||25533|34995||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|57978|76031|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||57978||57978|76031||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22634|31328|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||22634||22634|31328||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|31384|42395|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||31384||31384|42395||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2181|3552|lyfalmen|V0376|1098|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1765||1765|3552||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46239|61184|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||46239||46239|61184||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|893|2351|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||893||893|2351||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|78086|101464|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||78086||78086|101464||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|24739|33991|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||24739||24739|33991||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|39582|52764|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||39582||39582|52764||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|74216|96569|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||74216||74216|96569||2 583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|173336|221161|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||173336||173336|221161||1 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|15994|23136|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||15994||15994|23136||1 584610|N03AX1609|Pregabalin Sandoz GmbH|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|1714|1875|lyfalmen|V0731|1673|2|56|0|4,6667|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||547||547|1875||1 585516|A10BX1201|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|17865|25712|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||17865||17865|25712||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5219|8306|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5219||5219|8306||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3893|6481|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3893||3893|6481||1 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|2774|lyfalmen|V0006|2774|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1200||1200|2774||2 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|3865|6442|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3865||3865|6442|| 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|þpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|404|1484|lyfalmen|V0541|1484|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||263||263|1484||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|26598|36342|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||26598||26598|36342||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|12201|17916|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||12201||12201|17916||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|326542|411707|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||326542||326542|411707||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|25463|34906|lyfalmen|V0652|34906|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||25463|34906||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|7789|6763|lyfalmen|V0196|6628|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||4098||4098|6763||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|137391|176456|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||137391||137391|176456||1 587613|A02BC0112|Omezolmyl|sþ-hylki|40|mg|100|stk|1|þpakki||A02BC01|01.03.2015||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|6068|2964|lyfalmen|V0001|2602|2|100|0|200,0000|Icepharma hf|Mylan AB|Ómeprazól||1338||1338|2964||2 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3993|6618|lyfalmen|V0095|6618|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||3993||3993|6618||1 588001|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1522|1810|lyfalmen|V0494|1810|2|90|0|180,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1810||2 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|17831|18386|lyfalmen|V0683|17377|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||12543||12543|18386||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1886|3718|lyfalmen|V0461|3717|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1886||1886|3718||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|6776|10449|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||6776||6776|10449||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|20153|28190|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||20153||20153|28190||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8070|5579|lyfalmen|V0282|5579|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3238||3238|5579||1 588912|N03AX1609|Pregabalin Sandoz GmbH|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|7760|7591|lyfalmen|V0734|5652|2|56|0|42,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||4700||4700|7591||1 588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7729|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7729||2 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|742898|929537|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||742898||742898|929537||1 589358|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004|30.06.2016|R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5369|9254|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5369||5369|9254||2 589366|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004|30.06.2016|R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2081|3587|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2081||2081|3587||2 589374|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004|30.06.2016|R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5150|8877|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5150||5150|8877||2 589382|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2730|4705|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2730||2730|4705||2 589390|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004|30.06.2016|R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2906|5009|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2906||2906|5009||2 589408|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004|30.06.2016|R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2805|4835|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2805||2805|4835||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|10620|15740|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||10620||10620|15740||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|125503|161671|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||125503||125503|161671||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2643|2633|lyfalmen|V0041|2593|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1098||1098|2633||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|147216|188675|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||147216||147216|188675||1 591110|C10AA0507|Atorvastatin Hexal|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2155|2803|lyfalmen|V0113|2567|2|100|0|100,0000|Artasan ehf|Hexal A/S|Atorvastatín||1221||1221|2803||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|11178|16508|lyfalmen|V0347|16508|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||11178||11178|16508||3 591317|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|13372|lyfalmen|V0111|13232|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||8900||8900|13372||2 591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|7990|12120|lyfalmen|V0409|10300|2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||7990||7990|12120||2 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1215|2795|lyfalmen|V0168|2795|1|21|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1215||1215|2795||1 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3281|6395|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3281||3281|6395||1 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14198|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14198||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|644896|807650|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||644896||644896|807650||1 593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|20202|28252|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||20202|28252||3 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|446|1736|lyfalmen|V0238|734|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||446||446|1736||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|785|2203|lyfalmen|V0238|2203|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||785||785|2203||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1150|2705|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1150||1150|2705||2 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|14066|10231|lyfalmen|V0694|10205|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||6618||6618|10231||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|16763|24195|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||16763||16763|24195||1 594542|N03AX1604|Brieka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9512|6613|lyfalmen|V0689|6119|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3989||3989|6613||1 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|291|502|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||291||291|502||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|4879|7838|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||4879||4879|7838||1 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|14930|21672|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||14930||14930|21672||1 595250|D01BA0206|Terbinafin Bluefish|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2016||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7265|9381|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||6000||6000|9381||2 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|20130|28161|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||20130||20130|28161||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|539|1864|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||539||539|1864||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|47727|63066|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||47727|63066||1 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|14696|21350|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||14696||14696|21350||1 597041|R06AX2702|Aerius (Lyf og heilsa)|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.06.2016||R|1|0|0|0|G|0|HOL|0|0|1|100|NOK|3023|5283|lyfalmen|V0458|3080|3|90|0|90,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3023||3023|5283||2 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2015|3896|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2015||2015|3896||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|555917|696985|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||555917||555917|696985||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|111272|143971|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||111272||111272|143971||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2268|4244|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||2268||2268|4244||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|320|1563|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||320||320|1563||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1784||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|532315|667631|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||532315||532315|667631||1 599052|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|6853|10555|lyfalmen|V0690|7052|2|14|0|4,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||6853||6853|10555||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|3900|7570|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||3900||3900|7570||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2055||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|25917|35481|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||25917|35481||1 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0334|3100|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|111624|144409|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||111624||111624|144409||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21933|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21933||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4715|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4715||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1610|3338|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3338||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1030|2540|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2540||2 965858|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2014||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|6144|10590|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||6144||6144|10590||1 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|9381|lyfalmen|||2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||6000||6000|9381||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1522|3217|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3217||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27095|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27095||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10848|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10848||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5154|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5154||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6146|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6146||2 969991|N06BA0105|Amfetamine sulfate - forskriftarlyf|töflur|5|mg|30|stk|1|glas||N06BA01|01.08.2015||R|0|0|1|0|0|0|PAR|0|0|0|100|IKR|2495|4556|lyfalmen|||0|30|0|10,0000|PharmArctica ehf|PharmArctica - forskriftarlyf|Amfetamín||2495||2495|4556||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6611|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6611||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|7997|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|7997||2